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ABSTRACT 
 
Inherited rickets, lower motor neuron disease and chondrodysplasia were recently reported 
genetic disorders that had been identified on sheep farms in New Zealand.  Animals with 
rickets showed softening and weakening bone, and were characterized by decreased growth 
rate, thoracic lordosis and angular limb deformities.  Sheep diagnosed with lower motor 
neuron disease were characterized by poor muscle tone and progressive weakness from about 
one week of age, leading to severe tetraparesis, recumbency and muscle atrophy.  
Chondrodysplasia in Texel sheep was characterized by dwarfism and angular deformities of 
the forelimbs.  These three disorders were determined likely simple autosomal recessive by 
backcross breeding trials.  One complex disease called cryptorchidism was found with high 
prevalence in Siberian Husky dogs.  This disease is a congenital disorder characterized by 
failure of one or both testicles to descend into the scrotum.  In order to map gene loci and 
thus the mutations involved, genome wide association studies were conducted using the 
Illumina OvineSNP50 BeadChip for the three monogenic disorders and the Illumina 
CanineHD BeadChip for cryptorchidism.  Several mapping strategies were utilized including 
homozygosity mapping, Bayesian inference, case-control analysis and these were followed 
by fine mapping with a candidate gene approach. 
In results, a nonsense mutation 250C > T in exon 6 of the dentin matrix protein 1 gene 
(DMP1) was revealed as the putative cause of inherited rickets in Corriedale sheep.  The 
missense mutation c.2909G > C on exon 21 of the ATP/GTP-binding protein 1 gene 
(AGTPBP1) was identified likely being responsible for lower motor neuron disease in 
Romney sheep.  A 1-bp deletion (g.25513delT) on exon 3 in the solute carrier family 13, 
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member 1 gene (SLC13A1) was discovered for chondrodysplasia seen in Texel sheep.  The 
100% concordant rate of genotypes for mutations in certain sheep populations with the 
recessive pattern of inheritance for the three disorders indicates a causative relationship 
between these mutations with their related monogenic disorders.  Gene knockout mice and 
studies of similar diseases in humans provide more evidence to support this conclusion.  In 
the cryptorchidism study, the anti-mullerian hormone type II receptor gene (AMHR2) was 
found located in a 1Mb window on dog chromosome CFA27 which is associated with 
cryptorchidism using a BayesB approach in a subgroup of Siberian Husky dogs.  Previous 
human studies support AMHR2 is a very promising functional candidate gene for the 
development of cryptorchidism.  In conclusions, we have successfully identified putative 
causative mutations responsible for the three monogenic disorders in sheep, and also found a 
promising candidate gene in a putative region associated with cryptorchidism in dogs.  Our 
finding could shed light on further investigations of the role of involved genes and the 
affected animals could be used as animal models for human diseases with similar 
mechanisims. 
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CHAPTER1. GENERAL INTRODUCTION 
INTRODUCTION 
Genetic disorders in humans and animals include illnesses caused by abnormalities in genes 
or chromosomes, those abnormalities typically existing at birth.  Disorders can be passed 
down from the parents’ genes, or caused by de novo mutations to the DNA loci.  Disorders 
caused by a single mutated gene are called single or monogenic defects.  Over 4,000 human 
diseases belong to this kind (Wikipedia, http://en.wikipedia.org/wiki/Genetic_disorder).  
Single gene disorders are relatively easy to be studied especially when a supportive pedigree 
exists.  In this dissertation, we described detection of causative mutations involved in three 
sporadically occurring heritable disorders in sheep including inherited rickets, lower motor 
neuron disease and chondrodysplasia.  These defects all show an inheritance pattern that 
reflects a simple gene autosomal recessive basis.  Homozygosity mapping was applied to 
locate the genomic regions and then the positional candidate gene approach was carried out 
to search for the causative mutation responsible for each of these disorders. 
Genetic disorders might not be monogenic, but can be caused by complex, multifactorial or 
so-called polygenic effects.  The effects of multiple genes and environmental factors would 
contribute to the development of complex diseases.  Compared to monogenic disorders, the 
genetic basis underlying complex disorders are not simply deciphered.  Different strategies 
implemented in the genetic analyses were utilized for this kind of diseases.  Here we did a 
whole genome scan for a complex disorder called cryptorchidism in Siberian Husky dogs.  
Cryptorchidism is an abnormality whereby one or both testes fail to descend into the scrotum.  
Undescended testes could reduce fertility, and increase the risk of testicular tumors.  For 
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certain purebred breeds of dogs, the incidence of cryptorchidism is as high as 14% of the 
population.  Dogs with cryptorchidism will not be qualified by their breed organizations for 
either breeding purposes or most of the dog competitions or dog shows in the United States.  
It is essential to remove affected dogs and prevent carriers from contributing to the next 
generation of a dog breed.  In this dissertation, we integrate information from a genome-wide 
association study with biological functions and comparative genomics to predict possible 
genomic regions and candidate genes that might be the cause of cryptorchidism. 
RESEARCH OBJECTIVES 
In this dissertation, the first goal is to explore the genetic basis for each of the disorders 
above.  The causative mutations can be used as genetic markers for breeding purposes in 
order to exclude carriers to avoid at risk mating, and to improve animal welfare and decrease 
the economic losses.  Second, due to the body size and relatively low cost of maintenance, 
sheep with rickets, lower motor neuron disease or chondrodysplasia could be used as animal 
models for studies of similar disorders in humans.  Third, the results from the dog 
cryptorchidism study may provide valuable information for human research on 
cryptorchidism. 
DISSERTATION ORGANIZATION 
This dissertation was written by starting with a literature review (Chapter 1) followed by four 
manuscripts published in peer-reviewed journals (or prepared for submission).  Chapter 2 is a 
manuscript that explores the causative mutation responsible for inherited rickets in 
Corriedale sheep.  Dorian Garrick designed this experiment and assisted to uncover the 
identical by descent regions.  The fine mapping in this research and manuscript was 
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conducted and written by Xia Zhao under the direction of Dorian Garrick and Max 
Rothschild.  Keren Dittmer provided suggestions for good candidate genes and contributed a 
lot for manuscript preparation.  This work has been published in PLoS One 2011;6:e21739.  
Chapter 3 is a manuscript that examines the genetic basis causing a lower motor neuron 
disease that occurred in an extended family of Romney lambs in New Zealand.  Dorian 
Garrick designed this experiment and helped to uncover the identical by descent regions.  
Searching for priority candidate genes in the homozygous regions, mutation discovery and 
mutation analyses were performed by Xia Zhao.  Suneel Onteru contributed initial 
sequencing during the screening of positional candidate genes.  The manuscript was written 
by Xia Zhao under the supervision of Dorian Garrick and Max Rothschild.  This work has 
been published in Heredity 2012;109:156-62.  Chapter 4 is a manuscript that unravels the 
cause of chondrodysplasia in Texel sheep by a whole genome scan.  With the help from 
Dorian Garrick, the identical by descent region was located.  Fine mapping of positional 
candidate genes was carried out by Xia Zhao and Suneel Onteru.  Eventually, the putative 
causal mutation was identified and the manuscript was written by Xia Zhao under the 
supervision of Dorian Garrick and Max Rothschild.  This work has been published in a 
special issue of Animal Genetics 2012;43 Suppl 1:9-18.  Chapter 5 is a manuscript that 
exams the associated genomic regions and candidate genes for cryptorchidism in Siberian 
Huskies using a whole genome association study built on a foundation of Bayesian inference.  
This research was conducted by Xia Zhao under the supervision of Max Rothschild and 
Dorian Garrick.  Max Rothschild helped to design this experiment.  Suneel Onteru and 
Mahdi Saatchi conducted the Bayes B analyses.  The manuscript was written by Xia Zhao 
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under the supervision of Max Rothschild and Dorian Garrick.  Chapter 6 discribed 
conclusions summarized from Chapters 2, 3, 4 and 5. 
LITERATURE REVIEW 
1. Current Trends in Characterizing The Underlying Basis of Genetic 
Disorders 
The completed whole genome sequence in humans and many animal species, and subsequent 
generation of widespread markers of genetic variations have allowed investigators to obtain 
dramatic improvement in their ability to map gene loci associated with monogenic or 
polygenetic diseases.  Monogenic disorders are rare at a population level and result from a 
single mutated gene.  These disorders typically follow Mendelian patterns of transmission 
(autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive) or non-
Mendelian patterns of transmission (Y-linked and mitochondrial or maternal inherited).  As a 
result, monogenic disorders are easily studied when supportive pedigrees are available with 
many affected members.  The database OMIM (Online Mendelian Inheritance In Man, 
http://www.ncbi.nlm.nih.gov/Omim/mimstats.html) reported in September 21st, 2012, a total 
of 3571 human phenotypes with a known molecular basis.  The database OMIA (Online 
Mendelian Inheritance in Animals, http://omia.angis.org.au/home/) also provides a list of 473 
Mendelian traits with a known important mutation in animals, and 1,218 potential animal 
models for human diseases.  The two databases may exhibit overlap with similar 
characterized disease phenotypes and this helps to establish the basis for comparative 
genomics to facilitate further disease studies in humans or animal species.   
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More recently, researchers have shifted their focus from rare monogenic to more common 
polygenic disorders.  Unlike monogenic disorders, polygenic disorders do not usually follow 
Mendelian inheritance pattern, and appear to be caused by an unknown number of genes.  
Only a small fraction of affected individuals in some complex diseases such as 
cardiovascular defects, diabetes and several cancers, have been found to result from a single 
mutant gene transmitted with Mendelian inheritance (Scheuner et al., 2004).  The effects of 
multiple genes and environmental factors might contribute together to the development of 
these kinds of diseases.  The genetic mechanisms of many complex diseases are still unclear.  
Studying complex disorders for their genetic basis is more difficult than studying monogenic 
diseases.  Genome wide association studies (GWAS) represent a major tool for unraveling 
complex traits (Stranger et al., 2011).  Linkage mapping can be used in studies of complex 
multifactorial disease.  Additionally, studies of monogenic diseases will contribute greatly to 
knowledge of polygenic forms of human diseases (Antonarakis and Beckmann, 2006).  The 
following section describes the basic principles of a list of mapping methods and their 
applications for uncovering mutations responsible for monogenic disorders and complex 
diseases. 
2. Gene Mapping Strategy 
Understanding the genetic basis of human diseases was extremely challenging for biomedical 
researchers before the 20th century.  A big improvement has been obtained with the 
development of novel genetic tools and technologies, such as single nucleotide 
polymorphism (SNP) chips, microarrays and next generation sequencing (NGS).  Several 
gene mapping strategies have been broadly performed in many studies for human and animal 
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diseases including linkage mapping, GWAS, homozygosity mapping, and whole genome 
sequencing. 
2.1 Linkage Mapping 
Linkage mapping was widely applied as a traditional mapping strategy for qualitative and 
quantitative trait loci (QTL) mapping over the last few decades.  This mapping strategy is 
based on the assumption that linked genes are on the same chromosome, whereas the chance 
of two gene loci located at different chromosomes or more than 50 centimorgan (cM) apart 
being co-inherited in one meiotic event is 0.5.  According to this principle, detecting markers 
being inherited together with a given phenotype having a probability much larger than 0.5 
will help discover phenotype related genes or QTL regions.  Linkage mapping is usually 
conducted in certain families that can provide informative meioses for linkage detection.  A 
meiosis is informative for linkage when one can identify whether or not the resulting gamete 
is a recombinant in a particular region. 
Different types of markers have been used for linkage map construction.  Restriction 
fragment length polymorphisms (RFLPs) are differences between samples of homologous 
DNA molecules that come from differing locations of restriction enzyme sites.  The differing 
locations of restriction enzyme sites could be caused by nucleotide substitutions, 
rearrangements, insertions, or deletions (Chang et al., 1988).  Amplified fragment length 
polymorphisms (AFLPs) were improved markers produced by adding ligation of adaptors to 
the ends of digested restriction fragments and that were amplified by polymerase chain 
reaction (PCR) (Tan et al., 2001).  These two types of markers (RFLPs and AFLPs) are less 
employed in practice now, compared to simple sequence repeats (SSR or microsatellites) and 
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SNPs for linkage mapping (Ball et al., 2010).  Microsatellites or SSR are repeating sequences 
of 2-6 base pairs of DNA, with advantages for linkage mapping such as being PCR-based, 
highly reproducible and polymorphic, generally co-dominant and abundant in animal and 
plant genomes (Miao et al., 2005).  Single nucleotide polymorphisms are single nucleotide 
variations in a DNA sequence.  The high-resolution linkage map using high density SNP 
markers facilitates fine mapping of QTLs and enables the identification of genomic regions 
associated with high recombination rates (Groenen et al., 2009).  More recently, a novel 
genetic marker called restriction-site associated DNA (RAD) was developed.  This kind of 
marker is a short fragment of DNA nearby each side of a particular restriction enzyme 
recognition site (Miller et al., 2007).  Integrating next-generation sequencing as a RAD 
genotyping platform, RAD has been rapidly applied for linkage map construction in many 
species since a high-density genetic map can be available and simultaneously sufficient 
sequence information will meet the demand of mutation analysis (Baird et al., 2008; Wang et 
al., 2012). 
The implementation of linkage mapping at genome wide scale using commercial SNP chips 
has been widely applied for many interesting traits.  The density of SNP chips, haplotype 
frequency in the population and the amount of linkage disequilibrium (LD) in the genome 
will strongly affect the ability to detect genomic regions harboring the real causative 
mutations (Teo et al., 2010).  Alleles that are in non-random association are said to be in LD.  
Linkage disequilibrium represents the chance of co-inheritance of alleles at different loci.  It 
can be the result of physical linkage of genes or due to selection, mutation, migration, 
crossing or genetic drift.  Owing to the longer LD structure and artificial selection, livestock 
are preferred study populations for linkage mapping for many economically important traits 
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such as reproduction traits, disease resistance, behavior traits, lactation (milk production) and 
meat quality (Georges, 2007; Rosendo et al., 2012; Heifetz et al., 2009; Glenske et al., 2011; 
Marques et al., 2011; Nones et al., 2012).  On the other hand, mapping gene loci using 
linkage data is extremely inefficient in humans due to typically few progeny for calculating 
reliable map distance, traits being difficult to follow for many generations, and large distance 
between the known genes compared to livestock populations (Griffiths et al., 2000). 
2.2 Homozygosity Mapping 
Homozygosity mapping was first proposed in 1987 (Lander et al., 1987) as a powerful 
method of mapping genes underlying recessive traits in humans.  The principle of this 
approach is based on the assumption that the homozygous genotype of a mutation resulting 
from a recessive disease gene is “identical by descent (IBD)” by the transmission of the 
affected allele to the affected child from a common ancestor occuring through both parents.  
The adjacent chromosomal region surrounding the mutated locus is likely homozygous by 
descent in closely related offspring and this short segment of homozygosity can be detected 
in the affected group but not in carriers.  This mapping strategy has been used successfully in 
both human and animal recessive diseases (Lander et al., 1987; Drielsma et al., 2012; 
Charlier et al., 2008).  Traditional homozygosity mapping requires suitable consanguineous 
families with multiple affected offspring.  However, the limited availability of suitable 
families has hampered the discovery of genes for many diseases.  Moreover, too closely 
related family members provide large homozygous segments that contain too many candidate 
genes.  This hinders efficient identification of causative genes.  Applying homozygosity 
mapping to single affected individuals from outbred populations may aid in the discovery of 
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short candidate chromosome segments and accelerate the identification of novel disease 
genes (Hildebrandt et al., 2009).   
For many years, microsatellite markers were used in the analysis of homozygosity mapping.  
With the development of high throughput genotyping platforms like array-based genotyping, 
this mapping approach is mainly based on data generated by commercially available chips 
with hundreds of thousands of SNPs.  The decreasing costs of NGS technique drives 
researchers to try homozygosity mapping using sequencing data on some diseases such as 
exome sequencing data in a study for a cohort of Crohn’s Disease cases.  A new algorithm 
was implemented in this study by detecting IBD from exome sequencing data to find small 
slices of matching alleles between pairs of individuals and then to extend them into full IBD 
segments.  However, the detection accuracy of this method is low in assessing the causative 
regions (Zhuang et al., 2012).   
There are several freely available online computational tools for homozygosity mapping to 
facilitate the analysis of large datasets for gene discovery, for example HomozygosityMapper 
(Seelow et al., 2009, http://www.homozygositymapper.org/), IBDFinder (Carr et al., 2009, 
http://www.insilicase.co.uk/Desktop/Ibdfinder.aspx), and KinSNP (Amir et al., 2010, 
http://bioinfo.bgu.ac.il/bsu/software/KinSNP/).  
2.3 Genome Wide Association Study  
The recent use of genome wide association studies has become a powerful tool for 
investigating the genetic basis of common diseases such as Crohn’s disease (Barrett et al., 
2008), type 2 diabetes (Zeggini et al., 2008) and obesity (Wang et al., 2011).  This approach 
searches for associations between DNA sequence variants (SNPs) across the whole genome 
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and phenotypes of interest.  In an attempt to pinpoint genes that contribute to the etiology of 
a disease, scientists use GWAS to determine if one variant of an SNP is statistically more 
common in individuals with a given phenotype than in the ones without.  This mapping 
strategy became available for human diseases since the completion of the Human Genome 
Project in 2003 and the HapMap in 2005.  The map of genetic variants and a list of new 
technologies assist the accurate analysis of samples for genetic variations contributing to the 
onset of a disease.  However, the associated variants themselves may not be the causative 
mutations, but may just be in LD with the actual causal genetic variants.  A genome wide 
association analysis is usually followed by fine mapping with a larger number of 
recombinant individuals to narrow the region of interest, and may include targeted 
sequencing of genome libraries prepared for the candidate genomic regions.  Genome wide 
association studies can be confounded by population stratification caused by systematic 
ancestry differences between cases and controls (Price et al., 2010).  Population stratification 
will drive spurious associations when allele frequencies are different between subpopulations 
(Campbell et al., 2005).  Therefore, correcting for stratification is critical in performing 
GWAS. 
2.4 Gene Hunting for Diseases with Whole Genome Sequencing 
With the development of novel biomedical technologies and dramatically decreased prices 
for sequencing, whole genome sequencing is more affordable that in the past.  Gene hunting 
for diseases with whole genome sequencing is a modern approach for revealing the 
underlying causal gene locus not only on Mendelian diseases but also on complex diseases.  
This approach avoids the need for routine molecular analysis in the lab which is often labor 
intensive and time consuming, and effectively provides genetic information for doctors to 
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counsel at risk patients.  Whole genome sequencing may also quickly allow suitable patients 
the option of gene therapy.  For example, remarkable advances would be obtained for 
understanding disease-specific genetic alterations associated with cancers by the application 
of whole genome sequencing, especially for the detection of structural variation (Mardis & 
Wilson, 2009).  Artificial selection in livestock will also be easily conducted when genetic 
markers are quickly identified by whole genome sequencing (Larkin et al., 2012). 
Phenotypes of Mendelian diseases might not be genetically homogeneous.  The causal type 
of mutation like point mutations or segmental variations may vary between disease affected 
individuals with the same syndromes.  Additionally, different patterns of inheritance can be 
involved in the same phenotype.  For instance, Charcot-Marie-Tooth disease (CMT) is an 
inherited peripheral neural disease but can be separated into an autosomal dominant, 
recessive, or X-linked causes and both SNPs and copy number variants confer susceptibility 
to CMT (Lupski et al. 2010).  Different genetic variants in the same gene locus might cause 
similar phenotypes.  For instance, cystic fibrosis (CF) is a recessive inherited disease.  Over 
1,000 mutations have been found in the cystic fibrosis transmembrane conductance regulator 
gene (CFTR) to be associated with CF (Jaffe and Bush, 2001).  There is not usually a 100% 
success in discovering the causative mutation for a new CF patient even by screening all 
known mutation loci.  To detect the genetic basis underlying these genetically heterogeneous 
or polymorphic disorders, performing whole genome sequencing within individual families 
who have well characterized pathologic records will be quick and efficient (Lupski et al., 
2010).   
Most complex diseases result from the combined small effects from multiple genes.  
Mapping novel genes by whole genome sequencing for complex diseases is a powerful tool 
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(Casals et al., 2012).  Whole genome sequencing could detect any alterations on the entire 
genome and provide new insights into the mutational spectra.  For example, a whole genome 
sequencing analysis of a group of hepatocellular carcinoma (HCC) patients revealed the 
influence of etiological background of somatic mutation patterns, and also identified 
recurrent mutations in chromatin regulators in the development of HCC (Fujimoto et al., 
2012).  
3. Gene Mapping of Genetic diseases 
In order to understand the applications of different mapping strategies for detecting genetic 
components underlying heritable diseases, gene mapping of three monogenetic disorders 
including inherited rickets, chondrodysplasia, and lower motor neuron disease, as well as one 
of the polygenic complex diseases, cryptorchidism are reviewed here.  
3.1 Gene Mapping of Inherited Rickets 
Rickets is a metabolic bone disease due to nutritional deficiencies of vitamin D, phosphorus, 
magnesium and/or calcium.  The lack of those micronutrients will lead to defective 
mineralization of cartilage at sites of endochondral ossification.  The weakening or softening 
bones will often result in fractures and limb deformities (Fitch, 1943; Dittmer et al., 2009; 
Ozkan, 2010).  Inherited rickets is an inborn error of metabolism, resulting from mutations 
that disrupt the normal bone metabolism.  Several different forms of inherited rickets have 
been described including X-linked hypophosphatemic rickets, autosomal dominant 
hypophosphatemic rickets (ADHR), autosomal recessive hypophosphatemic rickets (ARHR), 
hereditary hypophosphataemic rickets with hypercalciuria (HHRH) and two types of Vitamin 
D-dependent rickets (VDDR-I and VDDR-II).   
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X-linked hypophosphatemic rickets is commonly known as HYP or XLH.  For this review, 
HYP will be the acronym used.  Based on pedigree analysis, HYP was considered a 
dominant disorder and is the most common form of familial hypophosphatemic rickets.  To 
map the causative locus, a multilocus linkage analysis using a series of X chromosome 
markers was conducted in eleven HYP relevant human families, and eventually located a 
region on the X chromosome (Read et al., 1986).  The laboratory mouse mutation (Hyp) has 
been identified on a homologous segment of the mouse X chromosome and the mice 
exhibited similar symptoms to human HYP (Eicher et al., 1976).  Using a positional cloning 
approach, the HYP consortium successfully isolated a new gene named phosphate regulating 
gene with homologies to endopeptidase on the X chromosome (PHEX; MIM 300550).  The 
causative mutations responsible for HYP patients were then determined (HYP consortium, 
1995).  
Similarly, a genome-wide multilocus linkage mapping was performed for ADHR using a 
large family and determined the gene responsible for this disorder was on human 
chromosome 12p13 in the 18-cM interval (Econs et al., 1997).  Combining the results in this 
large study with another small ADHR pedigree, the disease locus was mapped to a reduced 
region of a 1.5-Mb region.  The following direct sequencing of coding and promoter regions 
in the positional candidate genes detected missense mutations in fibroblast growth factor 23 
gene (FGF23; MIM 605380), a member of the FGF family (ADHR consortium, 2000). 
Gene mapping of ARHR was carried out using a series of mapping tools.  In one study, 
homozygosity mapping using a SNP array identified a 4.6 Mb candidate regions on human 
chromosome 4q21.  Mutation screening by direct sequencing found loss-of-function 
mutations in a positional plausible candidate gene called DMP1 (dentin matrix protein 1; 
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MIM 600980).  The elevated phosphaturic protein FGF23 suggested that dysfunctional 
DMP1 mis-regulated the expression of FGF23 to results in ARHR (Lorenz-Depierux et al., 
2010).  Similar methods were used in another study for ARHR human patients, but mutations 
in a different causative gene called ecto-nucleotide pyrophosphatase/phosphodiesterase 1 
(ENPP1) were found.  Biochemical experiments confirmed that the inactive mutations in 
ENPP1 reduce enzymatic activity in hypophosphatemic patients but may not affect 
phosphate (Pi) renal reabsorption (Levy-Litan et al., 2010).   
Another form of autosomal recessive hypophosphatemic rickets is HHRH (Tieder et al., 
1985).  The distinctive characteristic of HHRH compared to other forms of 
hypophosphatemic rickets is hypercalciuria due to increased serum 1,25-dihydroxyvitamin D 
levels and increased intestinal calcium absorption.  A genome-wide linkage scan with 
homozygosity mapping, followed by the candidate gene method were performed to map a 
single nucleotide deletion in solute carrier family 34 (sodium phosphate), member 3 gene 
(SLC34A3; MIM 241530).  This gene encodes the renal sodium-phosphate cotransporter 
NaPi-IIc (Bergwitz et al., 2006).   
Two other recessively inherited forms of rickets in humans were due to disruptions of either 
the synthesis or metabolism of vitamin D.  Vitamin D-dependent rickets, type I (VDDR-I) is 
caused by mutations in the CYP27B1 gene, which encodes vitamin D 1-alpha-hydroxylase 
(Fu et al., 1997).  The mutation in this gene was initially mapped by linkage mapping with 
big pedigrees followed by the candidate gene method which involved sequencing for 
causative genetic variants (Labuda et al., 1990; Fu et al., 1997).  Vitamin D-dependent 
rickets, type II (VDDR-II), is called hereditary vitamin D - resistant rickets (HVDRR) (MIM 
277440).  Shortly after the successful cloning of a full-length cDNA sequence of the vitamin 
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D receptor gene (VDR) in 1988, researchers discovered many mutations in VDR that were 
found to be associated with HVDRR (Malloy et al., 1999). 
3.2 Gene Mapping of Lower Motor Neuron Disease 
Motor neuron diseases (MND) are a group of progressive neurological disorders involved 
with selective degeneration of upper motor neurons (UMN) and/or lower motor neurons 
(LMN).  Messages from neurons in the brain (UMN) are initially transmitted to neurons in 
the brain stem and spinal cord (LMN) and then are transmitted from LMN to particular 
muscles to produce movements such as walking, chewing or blinking.  When there are 
disruptions in the signals between LMN and the muscle, it is commonly called LMN disease.  
The incidence of MND varies between different ethnic human populations from 0.6 to 2.4 
individuals per 100,000 person-years (Lee, 2010).  Common characteristics of MND are 
muscle weakness and/or spastic paralysis.  Symptoms for UMN degeneration include spastic 
tone, hyperreflexia and upgoing plantar reflex.  Signs of LMN degeneration are represented 
as muscle atrophy, fasciculations and weakness when associated LMN degenerate (Lee, 
2010).  Different types of MND have been classified based on their time of onset, type of 
motor neuron involvement and detailed clinical features.  These MND include amyotrophic 
lateral sclerosis (ALS), hereditary spastic paraplegia (HSP), primary lateral sclerosis (PLS), 
spinal bulbar muscular atrophy (SBMA), spinal muscular atrophy (SMA) and lethal 
congenital contracture syndrome (LCCS).  Among these diseases, both UMN and LMN are 
involved in the development of ALS and LCCS (Dion et al., 2009). 
Previous evidence has shown genetic variants within more than 30 genes might be 
responsible for MND (Dion et al., 2009).  Amyotrophic lateral sclerosis is a fatal 
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degenerative disorder of motor neurons.  Linkage mapping using single-strand 
conformational polymorphisms (SSCP) was applied to discover markers near the Cu/Zn-
binding superoxide dismutase (SOD1) gene being in significant linkage with ALS.  
Mutations in this gene were identified by direct sequencing to explain about 20% of patients 
with familial ALS (Rosen et al., 1993).  Hereditary spastic paraplegia with an autosomal 
dominant inheritance pattern is characterized by progressive spasticity of the lower limbs.  
Pathogenic mutations in spastin gene (SPAST) were revealed by a positional cloning strategy 
involving construction of BAC (bacterial artificial chromosome) contigs for sequencing.  The 
spastin gene was shown to be the most common causal gene locus of autosomal dominant 
HSP patients (Hazan et al., 1999).  Spinal muscular atrophy is a common fatal autosomal 
recessive disorder, leading to progressive paralysis with muscular atrophy.  Genomic regions 
linked with SMA were first determined by means of linkage analysis.  Further analysis using 
yeast artificial chromosome (YAC) contigs were applied to narrow down the linked regions, 
and finally identified loss of function mutations or deletions on SMN1 (survival of motor 
neuron 1, telomeric) responsible for SMA (Lefebvre et al., 1995).  Lethal congenital 
contractual syndrome type 2 is an autosomal recessive neurogenic form of arthrogryposis, 
characterized by multiple joint contractures and markedly distended urinary bladder.  To map 
gene loci for this MND, linkage analyses and homozygosity mapping using microsatellite 
markers were used.  One base pair substitution on exon 11 of ERBB3 (receptor tyrosine-
protein kinase erbB-3) was identified as being associated with LCCS2 (Narkis et al, 2007). 
3.3 Gene Mapping of Chondrodysplasia 
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Chondrodysplasia is a genetically diverse group of diseases characterized by abnormal 
development of cartilage that are present in humans and many animals.  Defective genes 
disrupt normal chondrogenesis and cartilage development leading to abnormal shape and 
structure of the skeleton.  The inheritance patterns of chondrodysplasia are diverse. 
Mutations in several genes related to the synthesis of collagen or proteoglycans, or the 
signal-transduction mechanisms have been reported to be involved in inherited 
chondrodysplasia.  Collagen II is the major collagenous component of cartilage.  Traditional 
genetic tools such as genomic cloning and sequencing indicated that several point mutations 
in human collagen, type II, alpha 1 gene (COL2A1) interrupt the normal formation of type II 
collagen and causes an autosomal dominant achondrogenesis type II (Vissing et al., 1989; 
Chan et al., 1995).  Partially disrupted Col2a1 has been identified with a phenotype of 
chondrodysplasia in transgenic mice (Vandenberg et al., 1991).  Successive genetic linkage 
and positional candidate cloning studies have shown that disruption of genes encoding other 
cartilage-specific collagen could cause different types of chondrodysplasia.  Mutations in 
families with an autosomal dominantly inherited chondrodysplasia, multiple epiphyseal 
dysplasia (MED), have been reported in genes coding the α1, α2 and α3 chains of collagen 
IX.  A mutation in intron 8 of COL9A1 (collagen, type IX, alpha 1) causing a splicing defect 
was found in one family with MED (Czarny-Ratajczak et al. 2001).  Several mutations were 
described to cause the skipping of COL9A2 (collagen, type IX, alpha 2) exon 3 in families 
with MED (Muragaki et al., 1996; Spayde et al., 2000; Holden et al. 1999).  Separate 
families with MED have been described to show that mutations in the acceptor splice site of 
intron 2 in COL9A3 (collagen, type IX, alpha 3) caused the skipping of exon 3, and resulted 
phenotypes of MED (Paassilta et al. 1999b, Bönnemann et al. 2000).  Type X collagen is a 
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short chain collagen expressed by hypertrophic chondrocytes during endochondral 
ossification.  A nonsense mutation of the collagen, type X, alpha 1 (COL10A1) gene has been 
found to be responsible for Schmid type metaphyseal chondrodysplasia (MCDS) in a human 
patient (Woelfle et al., 2011). 
Sulfated glycosaminoglycan is very important for maintaining the elasticity and water-
binding capacity in the cartilage matrix (Jerosch, 2011).  Absorption and re-absorption of 
sulfate ions is very critical for the normal cartilage and bone development.  Different forms 
of chondrodysplasia in humans including multiple epiphyseal dysplasia, atelosteogenesis 
type II and diastrophic dysplasia are due to mutations in the solute carrier family 26, member 
2 gene (SLC26A2), which encodes a sulfate transporter protein (DTDST).  These results were 
supported by genetic analyses with techniques of positional cloning and direct sequencing.  
The impaired sulfate uptake prevents the normal development of cartilage (Cho et al., 2010; 
Hästbacka et al., 1996; Hästbacka et al., 1999).   
Mutations in genes encoding a number of functionally osteogenic growth factors/signaling 
molecules have been also reported to be associated with different forms of chondrodysplasia.  
A 22-bp tandem duplication resulting in a frameshift of CDMP1 (designated cartilage-
derived morphogenetic protein 1) was found to be associated with chondrodysplasia in 
human patients (Thomas et al., 1996).  A multi-breed association study in domestic dogs 
demonstrated that an evolutionarily recently acquired retrogene encoding fibroblast growth 
factor 4 (fgf4), an extra copy of the FGF4 gene, was strongly associated with 
chondrodysplasia (Parker et al., 2009).  The most common inherited chondrodysplasia of 
sheep is “spider lamb syndrome” (SLS) in the Suffolk breed.  By means of direct sequencing, 
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it was found that the mutation responsible for the disease was a non-synonymous 
transversion on the highly conserved tyrosine kinase II domain of the fibroblast growth factor 
receptor 3 gene (FGFR3) (Cockett et al., 1999; Beever et al., 2006).  
3.4 Gene Mapping of Cryptorchidism 
Cryptorchidism, also known as undescended testicle, is the absence from the scrotum of one 
or both testes.  It is the most common genital problem encountered in pediatrics.  The 
incidence of this defect in human studies varies from 0.2% to 13% (Thonneau et al., 2003).  
Cryptorchidism has also been seen in domestic animals such as dogs (Cox et al., 1978), cats 
(Yates et al., 2003), horses (Cox et al., 1979), pigs (Rothschild et al., 1988), goats (Singh and 
Ezeasor, 1989), sheep (Smith et al., 2007) and cattle (St Jean et al., 1992), and wild animals 
such as maned wolves (Burton and Ramsay, 1986), black bears (Dunbar et al., 1996) and 
reindeer (Leader-Williams, 1979).  An undescended testicle is considered a risk factor for 
testicular cancer and male infertility (Berkowitz et al., 1993; Carizza et al., 1990).   
In most mammals, the testis must descend from the abdomen to the scrotum to provide an 
environment with a lower temperature than deep body temperature which is too high for 
normal spermatogenesis.  The elephant is an exception since its testes are completely inside 
the body (Short, 2005).  Normal testicular descent involves a two-phase process including 
transabdominal and inguinoscrotal descents (Hutson, 1985; Figure 1).  Key anatomical 
events to release the testes from their urogenital ridge location and to guide the gonad into 
the scrotum are the degeneration of the cranio-suspensory ligament, the swelling, outgrowth 
and regression of the gubernaculum and the elevation of the intro-abdominal pressure 
(Hutson and Hasthorpe, 2005).  Insulin-like hormone 3 plays an important role for the normal 
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Gill et al., 1979).  Various genes implicated in the regulation of testicular descent have been 
investigated for cryptorchidism.  Previous reports have identified approximately 20 genes 
that might be associated with cryptorchidism (Klonisch et al., 2004; Amann and 
Veeramachaneni, 2007).  Androgens might play the role on both transabdominal and 
inguinoscrotal processes via regulating the release of a calcitonin gene-related peptide by the 
genitofemoral nerve.  Several androgen related genes have been investigated while studying 
cryptorchidism.  Androgen receptor (AR) was found to be strongly expressed in the 
gubernaculums (George and Peterson, 1988) and a case-control study showed that the GGN 
trinucleotide repeat length variant in AR was associated with a risk of cryptorchidism and 
penile hypospadias in an Iranian population (Radpour et al., 2007).  Calcitonin gene-related 
peptides are encoded by two genes including CGRP-alpha (CALCA) and CGRP-beta 
(CALCB).  Exogenous calcitonin gene-related peptide injection into the scrotum can change 
the direction of gubernacular migration in the mutant trans-scrotal (TS) rat (Griffiths et al., 
1993; Clarnette and Hutson 1999).  However, no pathogenic sequence changes were 
identified in CALCA and CALCB for 90 selected human patients with unilateral or bilateral 
cryptorchidism by mutation screening performed through SSCP analyses (Zuccarello et al., 
2004).  According to the previous reports, a minority of affected cases have mutations either 
in insulin-like hormone 3 gene (INSL3) or affecting its receptor gene, called relaxin/insulin-
like family peptide receptor 2 (RXFP2), the latter also known as leucine-rich repeat-
containing G protein-coupled receptor 8 gene (LGRF8).  Insulin-like factor 3 is expressed in 
the pre-and postnatal Leydig cells of the testis and postnatal theca cells of the ovary, and is a 
member of the insulin-like hormone superfamily (Zimmermann et al., 1997).  Targeted 
disruption of this gene prevents gubernaculum growth and causes bilateral cryptorchidism in 
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mice (Nef and Parada 1999; Zimmermann et al., 1999).  The receptor gene LGR8 has been 
found highly expressed in the gubernaculum and is responsible for mediating hormonal 
signals that control normal testicular descent in humans (Gorlov et al., 2002).  Knockout 
mice models for this gene exhibit bilateral intra-abdominal cryptorchidism (Bogatcheva et al., 
2007).  Disruptions of other hormone related genes also show associations with aberrant 
testicular descent.  Müllerian inhibiting substance (MIS), or anti-Mullerian hormone (AMH), 
encoding a 140-kDa glycoprotein produced by Sertoli cells is critical for the mullerian duct 
during male sexual differentiation (Bashir and Wells, 1995) and is associated with the 
swelling reaction of gubernaculum occurring during the first phase of testicular descent 
(Kubota et al., 2002).  In mice, the testicular feminization (Tfm) mutation with the deletion of 
the Mis gene was found with a phenotype of undescended testis suggesting a causal 
relationship between Mis and cryptorchidism (Behringer et al., 1994).  The mutated 
gonadotropin-releasing hormone receptor gene (Gnrhr) has failed to initiate testicular descent 
in male mice as well (Pask et al., 2005).  Estrogen receptor 1 (ESR1) is a ligand-activated 
transcription factor that is important in the process of testicular descent in children 
(Przewratil et al., 2004).  Esr1 knockout male mice with retracted gonads suggest estrogens 
may play a role in the scrotal positioning of the testicle (Donaldson et al., 1996).  Moreover, 
investigations were carried out on HOX genes for studying cryptorchidism.  Homeobox A10 
(Hoxa10) is highly expressed in the gubernaculum and this gene has been found to be 
essential for the gubernacular migration during testicular descent in mice.  Disruption of this 
gene implicates its role in the development of cryptorchidism ((Nightingale et al., 2008; Rijli 
et al., 1995).  A single SNP variant in HOXD13 (homeobox D13), has been identified to be 
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significantly associated with cryptorchidism in humans via a case-control analysis (Wang et 
al., 2007).  
4. Animal Models for Human Diseases 
Using appropriate model organisms for human disease studies will help understand the 
genetic components behind disorders.  Domestic animals have proven to be good research 
models due to their large body size and many anatomical and physiological similarities to 
humans.  Numerous genetic defects have been identified in domestic animals, and inherited 
disorders in these animal models can provide valuable information to assist in the 
identification of human disease genes and the study of gene therapy. 
4.1 The Sheep model 
Sheep (Ovis aries) were initially domesticated approximately 11,000 years ago for 
agricultural purposes including the production of fleece, skins, meat and milk (Colledge et al., 
2005; Chessa et al., 2009).  The top three sheep meat producing countries, in order of 
quantity, are China, Australia and New Zealand based on data from the Food and 
Agricultural Organization of the United Nations in 2010 
(http://faostat.fao.org/site/569/DesktopDefault.aspx?PageID=569#ancor).  Large animal 
models like sheep have received extensive clinical attention for human genetic diseases due 
to their advantages over rodent models, such as greater physiological similarity to human 
patients, a longer life span and larger body size.  Sheep are considered as excellent models 
for studying respiratory physiology (Meeusen et al., 2009), renal physiology (Ramchandra et 
al., 2012), reproductive physiology (Vinet et al., 2012), cardiovascular physiology (Wylie et 
al., 2012) and the endocrine system (Recabarren et al., 2005).  The body size of sheep allows 
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for frequent blood sampling and easy insertion of monitoring devices into organs.  These 
advantages allow performing prenatal gene therapy to be performed in sheep prior to disease 
onset to achieve long-term expression of the exogenous gene without modifying the germ 
line of the recipient (Porada et al., 1998). 
The construction of the reference sheep genome sequence was started in 2009 by the 
International Sheep Genomics Consortium.  Genome sequence will enable accelerated 
genetic gain and improved understanding of the etiology of diseases deleterious for the sheep 
breeding programs (The International Sheep Genomics Consortium et al., 2010).  Most 
modern sheep breeds have maintained high levels of genetic diversity due to strong gene 
flow between individuals of different lines and breeds (Kijas et al., 2012).  The initial 
analysis of LD structure in sheep was conducted across over 3,000 sheep from 74 diverse 
breeds.  The results suggest substantially lower LD in sheep compared with cattle but higher 
when compared to humans.  Moreover, substantial variation in LD structure exists between 
ovine breeds (Raadsma et al., 2010).  The new reference sheep genome sequence would help 
biomedical researchers to overcome previous challenges of limited gene sequence 
availability. 
4.2 The Dog Model 
The domestic dog (Canis lupus familiaris) may be the first animal to be domesticated 
approximately 15,000 years ago (Savolainen et al., 2002).  The purposes of domestication of 
dogs at the beginning were for working or hunting.  More recently, the dog has been used 
extensively as a model organism for complex human disease research because of the 
similarities between canine and human diseases including disease manifestation and genetic 
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predisposition of diseases such as cancers (Khanna et al., 2006), diabetes (Srinivasan and 
Ramarao, 2007), heart disease (Kohler et al., 1984), kidney disease (Aresu et al., 2008) 
(Karlsson and Lindblad-Toh, 2008).  Additionally, many anatomic and physiological aspects, 
particularly in the cardiovascular, urogenital, nervous and musculoskeletal systems between 
canine and humans are similar (Khanna et al., 2006).  The similar spectrum of diseases, 
specific dog population structure, the close social relationship and similar living environment 
between humans and dogs, drive the domestic dog as an ideal model for mapping human 
diseases.  With the first version of Dog Genome Sequencing draft being completed in 2005, 
the dog genome was found to exhibit relatively small size (2.4 Gb compared to 3.2 Gb in 
humans), with less divergence from the human when compared to the mouse genome 
(Lindblad-Toh et al., 2005; International Human Genome Sequencing Consortium, 2004).  
This similarity allows the dog to be a suitable animal model for human diseases with a 
genetic component. 
Additionally, the dog genome has a favorable LD structure for investigating complex 
disorders.  Two population bottlenecks have occurred during domestication of the dog.  This 
created an advantageous linkage structure which is ideal for gene mapping.  First, long-range 
LD, from hundreds of kilobases to several megabases, exists within a breed, unlike the tens 
of kilobases observed in the human genome.  Second, short-range LD exists in the whole dog 
population due to its long domestication period (Lindblad-Toh, et al., 2005).  By knowing the 
patterns of limited LD across whole dog populations and extensive LD within breeds, a two-
stage mapping including identification of the disease locus in a breed and then finding the 
narrowed genomic region using multiple breeds is a favored strategy (Karlsson and Lindblad-
Toh, 2008).  An example of this occurred with the mapping of white spotting in dogs.  
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Initially, 19 boxer dogs were used to discover an 800kb region.  A second breed, bull terriers, 
was used to confirm and narrow the regions to a 100kb region that contained a gene called 
microphthalmia-associated transcription factor (MITF).  Candidate regulatory mutations were 
identified to be associated with the spotting trait (Karlsson et al., 2007).  
The most powerful and commonly used mapping approach in dogs for disease research is 
GWAS.  Less than 50 individuals are sufficient to map a simple Mendelian recessive trait 
using GWAS, but many more dogs are needed to map complex diseases (Karlsson and 
Lindblad-Toh, 2008).  There are many successful cases using GWAS to map Mendelian 
traits in dogs.  Some examples include a missense mutation on SOD1 (superoxide dismutase 
1) associated with canine degenerative myelopathy (DM) (Awano et al., 2009), a 23 kb 
deletion in the canine ADAM9 (a disintegrin and metalloprotease domain, family member 9) 
associated with a canine cone-rod dystrophy (crd3) (Goldstein et al., 2010), and a missense 
mutation in a conserved functional domain of β-glucuronidase (GUSB) confirmed to cause 
mucopolysaccharidosis VII (MPS VII) in a population of Brazilian terriers (Hytönen et al., 
2012).   
Other mapping strategies including QTL mapping, across-breed mapping and selective 
sweep mapping have also been applied in dogs (Karlsson and Lindblad-Toh, 2008; Sutter et 
al., 2007).  The selective sweep mapping is to identify the selective sweeps that are 
associated with a strongly selected phenotype.  A selective sweep is the region where there is 
a reduction or elimination of genetic variations in DNA neighboring a mutation, due to recent 
and strong positive natural or artificial selection (Palaisa et al., 2004).  Artificial selection for 
breeding purposes in dogs over hundreds of years causes big morphological differences 
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among modern breeds and uniform physical features within pure-bred dogs (Wayne and 
Ostrander, 2007).  This special characteristic of dog populations provides suitable resources 
for QTL mapping and selective sweep mapping to discovery of genes underlying breed-
specific characteristics.  For example, a common haplotype in insulin-like growth factor 1 
gene (IGF1) associated with body size in dogs was successfully identified by QTL mapping 
and selective sweep mapping using small and giant dog breeds (Sutter et al., 2007).  To avoid 
the confounding of long haplotypes and extensive homozygosity within the breed, across-
breed selection sweep mapping is helpful to find interesting loci.  A study used this mapping 
strategy to analyze genetic variation in 46 dog breeds identified 44 chromosomal regions that 
are extremely variable between breeds and are likely to control many of the morphological 
and behavioral traits that vary between them (Vaysse et al., 2011).  By contrast, the 
limitation of offspring from crosses in large numbers restricts the application of QTL 
mapping in dogs comparing to livestock animals.   
Genetic diseases consititute huge public healthy problems for humans, and also cause big 
economic losses in animal industry.  Finding the causative mutations will help to improve 
this situation.  Applying suitable gene mapping tools for scientists could make gene hunts 
faster, cheaper and practical for genetic diseases.  Animal models are preferable for 
experimental disese research due to their advantages reviewed above.  The gene discoveries 
in animal models will facilitate the study of human genetic diseases. 
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ABSTRACT 
Inherited rickets of Corriedale sheep is characterized by decreased growth rate, thoracic 
lordosis and angular limb deformities.  Previous outcross and backcross studies implicate 
inheritance as a simple autosomal recessive disorder.  A genome wide association study was 
conducted using the Illumina OvineSNP50 BeadChip on 20 related sheep comprising 17 
affected and 3 carriers.  A homozygous region of 125 consecutive single-nucleotide 
polymorphism (SNP) loci was identified in all affected sheep, covering a region of 6 Mb on 
ovine chromosome 6.  Among 35 candidate genes in this region, the dentin matrix protein 1 
gene (DMP1) was sequenced to reveal a nonsense mutation 250C/T on exon 6.  This 
mutation introduced a stop codon (R145X) and could truncate C-terminal amino acids.  
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Genotyping by PCR-RFLP for this mutation showed all 17 affected sheep were “T T” 
genotypes; the 3 carriers were “C T”; 24 phenotypically normal related sheep were either “C 
T” or “C C”; and 46 unrelated normal control sheep from other breeds were all “C C”.  The 
other SNPs in DMP1 were not concordant with the disease and can all be ruled out as 
candidates.  Previous research has shown that mutations in the DMP1 gene are responsible 
for autosomal recessive hypophosphatemic rickets in humans.  Dmp1_knockout mice exhibit 
rickets phenotypes.  We believe the R145X mutation to be responsible for the inherited 
rickets found in Corriedale sheep.  A simple diagnostic test can be designed to identify 
carriers with the defective “T” allele.  Affected sheep could be used as animal models for this 
form of human rickets, and for further investigation of the role of DMP1 in phosphate 
homeostasis. 
Keywords: nonsense mutation; DMP1 gene; inherited rickets; sheep; genetic disease 
INTRODUCTION 
Rickets is a metabolic bone disease in humans and animals with most cases caused by a 
nutritional deficiency of either vitamin D or phosphorus.  This disease leads to softening and 
weakening of bone caused by defective mineralization of cartilage at sites of endochondral 
ossification and potentially causes fractures and limb deformities [1], [2], [3].  Rickets may 
also result from genetic mutations that disrupt genes whose functions are critical for normal 
bone metabolism.  Five types of rickets have been described in humans with common clinical 
characteristics of renal phosphate wasting, including X-linked hypophosphatemic rickets 
(XLH), autosomal dominant hypophosphatemic rickets (ADHR), autosomal recessive 
hypophosphatemic rickets (ARHR) type 1 and 2, and hereditary hypophosphataemic rickets 
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with hypercalciuria (HHRH).  A large number of different mutations comprising single base 
pair deletions, nonsense and missense mutations have been identified in PHEX (phosphate 
regulation gene with homologies to endopeptidases on the X chromosome) as being 
responsible for XLH [4], [5], [6].  ADHR is caused by gain of function mutation leading to 
increased activity of fibroblast growth factor 23 encoded by gene FGF23 [7], and mutations 
in the dentin matrix protein 1 gene (DMP1) and ecto-nucleotide 
pyrophosphatase/phosphodiesterase 1 (ENPP1) have been identified in autosomal recessive 
hypophosphataemic rickets type 1 and 2, respectively [8], [9], [10].  The mutation for HHRH 
occurs in the gene for the NaPi-IIc protein (or SLC34A3, human chromosome 9q34), a renal 
Na-P co-transporter [11].  Two other recessively inherited forms of rickets in humans are due 
to the disruptions of either the synthesis or metabolism of vitamin D.  Vitamin D-dependent 
rickets type I (VDDR-I) is caused by mutations in the CYP27B1 gene, which encodes 
vitamin D 1-alpha-hydroxylase [12].  Loss of function mutations in the vitamin D receptor 
gene (VDR) are the genetic basis for vitamin D-dependent rickets type II (VDDR-II), which 
is also called hereditary vitamin D - resistant rickets (HVDRR) [13], [14].  
Inherited forms of rickets have been uncovered frequently in humans but were rare in 
domestic animals.  Recently, an inherited form of rickets has been described in purebred 
Corriedale sheep from a commercial flock in New Zealand, with an incidence of up to 20 
lambs out of 1,600 over a 2-year period.  Affected sheep were characterized by decreased 
growth rate, thoracic lordosis and angular limb deformities (Figure 1) [15], with low serum 
calcium and phosphate concentrations and normal 25 hydroxyvitamin D and 1,25 
dihydroxyvitamin D3 concentrations [16].  Embryo transfer and backcross breeding trials 
have determined that this disease is likely a simple autosomal recessive disorder [16]. 
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Large animal models of human genetic diseases have received extensive clinical attention 
due to their advantages over rodent models, including greater physiological similarity to 
human patients, a longer life span and larger body size.  Sheep have been used as an animal 
model for gene therapy (GT) of human diseases, such as post-traumatic osteoarthritis [17] 
and steroid-induced ocular hypertension [18].  The convenience of performing in utero GT 
prior to disease onset will help to achieve long-term expression of the exogenous gene 
without modifying the germ line of the recipient [19].  Based on the hypothesis that inherited 
rickets-affected Corriedale sheep could be a potential model for human rickets; and a genetic 
marker could help sheep breeders to avoid at-risk matings, we performed a genome-wide 
association study by genotyping 54,241 evenly distributed single nucleotide polymorphisms 
(SNPs) for 17 affected Corriedale sheep and 3 carriers using the Illumina Ovine SNP50 
BeadChip.  It has been shown that the analysis of genome-wide high-density SNPs is an 
effective strategy to map and identify causal mutations for recessive diseases [20]. 
RESULTS 
Homozygosity Mapping 
The genotyping data using a SNP BeadChip for this study was submitted to the NCBI Gene 
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under Super Series accession no 
GSE26310.  In our study, exactly 3 homozygous regions of more than 10 consecutive SNPs 
were identified in all 17 affected sheep whereas the 3 carriers exhibited heterozygosity in 
those regions.  The largest homozygous segment consisted of 125 consecutive SNP loci, 
whereas the other two segments had only 19 or 11 consecutive SNPs.  The largest 125-SNP 
region started from SNP OAR6_109334543.1 and extended to SNP s03175.1, covering a 
region of 5.95 Mb (109,334,543 to 115,285,275 bp) on the long arm of sheep chromosome 6 
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(OAR 6).  There were 35 genes located in this region based on the bovine reference sequence 
(Figures 2a, 2b and Table S2).  The size of the second homozygous segment was about 0.70 
Mb (OAR6: 118,884,834 to 119,587,883 bp) and had only 3.2 Mb separation from the first 
homozygous segment on the same chromosome (OAR 6).  The third homozygous segment 
covered a 0.66 Mb region (OAR15: 1,131,166 to 1,654,496 bp) on the short arm of OAR 15.  
Within the second and third homozygous regions there were 8 and 6 positional candidate 
genes, respectively (Table S2).  One gene called DMP1 in the largest 125-SNP region was 
considered the most plausible candidate due to its biological functions involved in 
mineralization and phosphate homeostasis and previous reports of its involvement in human 
rickets [8], [21].  By comparing with the bovine genomic reference sequence it was found 
that this gene was at 112.20 Mb on OAR6q (Table S2), spanned over 16 kb of size and 
contained 6 exons. 
Candidate Gene Sequencing 
Fine mapping was carried out by individual PCR amplification and sequencing of all the 
exons of the DMP1 gene to identify the mutation for this disease (Table S1).  After blasting 
the sheep genomic reference sequence with bovine DMP1 coding sequence 
(ENSBTAT00000025468), there were several alignments for exon 6 with high identity rates 
(91%-96%).  As exon 6 is the last and also the largest exon covering 88% of the open reading 
frame of DMP1, it was prioritized for re-sequencing.  Direct sequencing from 3 carriers and 
1 normal control revealed 1 published SNP (s18093.1, OAR6: 112,213,812 bp) and 8 novel 
ones in this exon (Figure 2e).  The complete genomic sequence of exon 6 for sheep DMP1 
gene was submitted to GenBank (http://www.ncbi.nlm.nih.gov/genbank/) under accession no. 
HQ600592.  
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Moreover, we successfully amplified exon 1, exon 3, exon 4 and exon 5 of sheep DMP1 gene 
using exon flanked intronic sequences of cow reference for each exon.  The amplifications of 
exon 2 failed after using several pairs of primers.  Intronic SNPs (SNP1 and SNP2) and a 1-
bp insertion/deletion (indel: A) were identified respectively in intron 1, intron 5 and intron 3 
by direct sequencing (Table S1). 
Mutation Analysis 
Seventeen base pairs upstream of SNP s18093.1, a SNP (C/T, OAR6:112,213,795 bp) 
located at +250bp of exon 6 caused a non-synonymous amino acid change in the DMP1 
protein.  This C -> T transition introduced a stop codon (R145X) that led to a truncated 
DMP1 protein at the 145th amino acid (Figure 3a, Figure 3b and Figure S1).  Genotyping of 
this mutation by PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length 
Polymorphism) (Figure 3c) and direct sequencing showed all 17 affected animals had the “T 
T” genotype; the 3 carriers were “C T”; 24 phenotypically normal related sheep were either 
“C T” or “C C”; and 46 unrelated control sheep of other breeds were only “C C” genotypes 
(Table 1).  This mutation was 100% concordant with the recessive pattern of inheritance in 
affected, carrier and normal individuals.  Moreover, genotyping of the other 8 SNPs in exon 
6 which surrounded the R145X mutation in DMP1, found incomplete linkage disequilibrium 
for these markers with either the disease or the mutant SNP (Figure 2f).  The 3 genomic 
variants in introns 1, 3 and 5 identified were not located at either the splicing receptor or 
acceptor sites.  Therefore, those mutations could be ruled out as candidate mutation loci.  RT-
PCR/RFLP (Figure 3d) was performed for the R145X mutation and showed the same 
digestion pattern as PCR-RFLP.  
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Taken together, our results strongly suggest that the R145X substitution is causative for 
inherited rickets in Corriedale sheep, disrupting the function of the DMP1 protein, preventing 
successful bone mineralization and phosphate homeostasis. 
DISCUSSION 
Homozygosity mapping is a powerful method to map simple recessive traits since the regions 
immediately flanking the mutation locus will likely be homozygous by descent in closely 
related offspring.  The affected animals in this study resulted from consanguineous mating 
between pairs of offspring descended from one common male ancestor in the embryo transfer 
and backcross studies used to characterize the inheritance of the disease [15], [16].  The 
region containing the mutation should in these circumstances span a large chromosome 
segment that would be progressively diminished in subsequent meioses when recombination 
events occur near to the mutation.  This mapping strategy has been used successfully for 
recessive diseases in both animal and human studies [20], [22].  The homozygosity mapping 
in this study was conducted from knowledge of the SNP genotypes in affected individuals 
and their genomic location, and used command line UNIX tools including awk, sort and join 
to identify any regions of at least 10 consecutive homozygous SNPs, equivalent to about 0.5 
cM or more.  It was presumed that one such region would contain the mutation associated 
with inherited rickets in Corriedale sheep.  In this study, 3 homozygous regions met the 
criteria of exceeding 10 consecutive homozygous SNP markers.  Previously reported rickets 
genes including PHEX, FGF23, ENPP1, SLC34A3, CYP27B1 and VDR did not show up in 
any of these homozygous segments based on the ovine genome assembly v1.0, whereas 
DMP1 was contained in the largest region.  This is not surprising because PHEX or FGF23 
related rickets have a distinctive inheritance mode that differs from the autosomal recessive 
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inheritance of the rickets studied here.  The severe hypophosphatemia in affected sheep 
indicates disturbed phosphate balance within the body.  Therefore, the DMP1 gene was 
considered to be a high priority candidate gene.  The nonsense mutation we identified in the 
DMP1 gene was 100% concordant with the recessive pattern of inheritance for the disease 
studied. 
DMP1 encodes a serine-rich acidic protein and is a member of Small Integrin-Binding 
Ligand, N-linked, Glycoprotein family (SIBLING) which mineralizes tissue such as bones 
and teeth by binding strongly to hydroxyapatite using an Arg-Gly-Asp (RGD) tripeptide [23].  
Dual functions of the DMP1 protein have been reported based on the in vitro studies.  The 
nonphosphorylated cytoplasmic DMP1 protein translocates to the cell nucleus and initially 
acts as a transcriptional factor to enhance gene transcription of the osteoblast-specific genes 
such as alkaline phosphatase and osteocalcin, and then it moves out to the extracellular 
matrix during the osteoblast to osteocyte transition phase, to promote mineralization and 
phosphate homeostasis [24], [25].  Loss of function mutations in the human DMP1 gene have 
been shown to cause autosomal recessive hypophosphatemic rickets in different ethnic 
groups including Turkish, consanguineous Spanish, Lebanese and Japanese populations.  
These variant mutations in DMP1 include deletions in exon 6, nucleotide substitution in the 
splice acceptor sequence of intron 2, and missense mutations in exon 2 or exon 3 that 
introduce the premature termination codon [8], [21], [26].  The Dmp1-null mouse model also 
exhibits hypophosphatemic rickets, which indicates the important role of the DMP1 gene in 
the development of normal bone formation [21].  Since the majority of the dentin matrix 
protein 1 is encoded by the sixth and last exon of DMP1, typical for proteins in the SIBLING 
family [27], the novel nonsense mutation (250C/T, R145X) identified here in ovine DMP1 
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gene is a plausible mutation leading to loss of function following nonsense-mediated mRNA 
decay shown to occur in human patients.  The nonsense-mediated mRNA decay is a post-
transcriptional mechanism in eukaryotic species.  It likely eliminates the abnormal transcripts 
produced by prematurely terminated translation [28].  The previous studies strongly support 
the nonsense mutation we identified in exon 6 as causing loss of function of the DMP1 
protein and being responsible for ARHR type 1 in Corriedale sheep. 
Despite the wide variety of mutated genes that result in the different forms of hereditary 
hypophosphatemic rickets, the clinical features are relatively similar (with the exception of 
HHRH).  In XLH, ADHR, ARHR type 1 and 2, the overriding common feature is increased 
serum concentration and activity of FGF23.  FGF23 inhibits a NPT-2a co-transporter (Na-Pi 
co-transporter) in the kidneys leading to loss of phosphate from renal tubules into the urine 
(phosphaturia).  FGF23 also inhibits the activity of CYP27B1, thereby inhibiting active 
vitamin D (1,25-dihydroxyvitamin D3) production [29].  As a result of the increased FGF23 
concentrations patients with XLH, ADHR, ARHR type 1 and 2 present with rickets, 
hypophosphatemia, phosphaturia and inappropriately normal serum 1,25-dihydroxyvitamin 
D3 concentrations [9], [30].  Corriedale sheep with the mutation in DMP1 also developed 
rickets, were severely hypophosphataemic and had normal serum 1,25(OH)2D3 
concentrations [1], [16]. The mechanism by which mutations in PHEX, DMP1 or ENPP1 
result in upregulation of FGF23 is unknown.  An unusual feature of ARHR type 2 is that 
mutations in ENPP1 are also associated with generalized arterial calcification of infancy, 
again the mechanism by which a mutation in ENPP1 can result in a disease characterised by 
hypomineralization and one characterised by hypermineralization is unknown [9].  In HHRH, 
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CYP27B1 is actually upregulated, resulting in increased 1,25(OH)2D3 concentrations, and 
perhaps explaining the hypercalciuria [11]. 
In conclusion, this is the first report of ARHR type 1 caused by a mutation in the DMP1 gene 
in a sheep population.  In this study, we demonstrate successful use of applying high density 
SNP arrays for localization of a mutation locus causing a recessive inherited defect.  The 
results can be rapidly applied as a selection marker to identify carriers with the defective “T” 
allele in order to avoid at-risk matings to improve animal welfare and decrease economic 
losses.  At this stage, the incidence of the mutation in the Corriedale sheep population is 
unknown, however it is suspected to be widespread and testing of New Zealand Corriedale 
sheep is planned.  More importantly, due to their size and relatively low cost of maintenance, 
Corriedale sheep with inherited rickets could be used as an animal model for this form of 
human rickets.  Even though the human and sheep mutations are not exactly the same, both 
disrupt the function of the DMP1 protein.  The sheep model can be used for further 
investigation of the role of DMP1 in phosphate homeostasis and to explore the potential for 
early medical intervention to reduce the development of the disease in homozygous 
individuals.  
MATERIALS and METHODS 
Ethics statement 
Approvals dealing with DNA or tissue collection from animals were obtained from the 
Massey University Animal Ethics Committee (APPROVAL NUMBER 05/123) and Iowa 
State University Animal Care & Use Committee did not require additional approvals. 
Animals 
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In total, 17 affected Corriedale sheep (9 males, 8 females) and 27 phenotypically normal 
crossbred Corriedale sheep (6 males, 21 females) as well as 46 normal controls (Texel and 
crossbred Perendale sheep) were examined.  The age of examined animals ranged from a 
fetus of 133 days gestation to a 3 year-old animal.  Eight affected sheep were from the 
original commercial property at Marlborough, New Zealand, and 9 affected sheep were their 
offspring.  The 27 phenotypically normal crossbred Corriedale sheep were progeny from the 
mating of unrelated  Romney ewes with the Corriedale carrier ram (F1 generation from 
outcross), or progeny of the F1 generation daughters mated back to the carrier ram (F2 
generation from backcross).  SNP genotypes were obtained for the 17 affected and 3 carrier 
Corriedale sheep, while fine mapping was conducted on all 44 pure or crossbred Corriedale 
sheep.  The 46 normal control sheep used for validation of the mutation were from unrelated 
populations without evidence of rickets.  
SNP genotyping 
DNA was extracted from blood using a Roche MagNA Pure automated analyser.  DNA 
samples were randomized on genotyping plates according to disease status.  The genotyping 
was performed using the Ovine SNP50 BeadChip containing 54,241 SNPs (Illumina, San 
Diego, CA, USA) with standard procedures at GeneSeek Inc. Lincoln, NE, USA.  The SNPs 
retained had to get a call rate > 80% and a minimum GenTrain score of 0.25.  All genotypes 
with satisfactory call rate and GenTrain score were used regardless of minor allele frequency 
(MAF). 
SNP chip data analyses 
The IBD program used awk, join and sort UNIX commands to scan the whole genome of the 
genotyped affected cases, to produce a list of all the strings of consensus homozygous 
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markers with a length of more than 10 SNPs.  The same process was repeated in the carriers 
to ensure the regions identified in the affected individuals were not homozygous in the 
carriers.  The homozygosity mapping algorithm involved the following: first, SNPs in the 
Illumina ovine 50K map file were sorted by chromosome and position, and numerically 
coded in contiguous order.  Second, the names of the “A/B” genotypes (provided by 
GeneSeek Inc.) for each individual were joined with the renumbered map file to identify the 
genotypes by their locations.  The joined file was separated into three groups according to the 
disease status of affected, carrier and normal.  Third, the number of occurrences of genotypes 
(“AA”, “AB”, “BB” and no call “--”) for each SNP was counted in the affected and carrier 
groups.  Fourth, the genotype frequencies were calculated for each SNP.  In the frequency 
calculation, the numerator was the count of genotypes being either “AA”, “AB” or “BB”, and 
the denominator was the total count excluding the category of no call.  Finally, if the highest 
genotype frequency for a SNP was equal to 1 and the two alleles of this genotype were the 
same, such as “AA” or “BB”, this SNP was considered a homozygous locus.  The span of 
contiguous homozygous loci were accumulated and reported if the region included more than 
10 loci.  Genes in these IBD regions were examined for potential involvement using 
comparative maps between the ovine and bovine genomes through the Ovine Genome 
Assembly v1.0 (http://www.livestockgenomics.csiro.au/perl/gbrowse.cgi/oar1.0/#search).  
DMP1 gene sequencing 
Primers were designed to amplify all 6 exons for sheep DMP1 (Table S1).  Cow DMP1 
genomic sequence was used as a template for primer designing in order to amplify the first 5 
exons of sheep DMP1 gene.  PCR was performed using a 10 µl system with GoTaq DNA 
polymerase (Promega, Madison, WI).  The annealing temperatures were 58° C or 60° C.  
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PCR products were purified with ExoSAP-IT® (USB, Cleveland, OH), before pooling from 
3 carriers and sequencing commercially using a 3730xl DNA Analyzer.  
Mutation analyses 
Sheep EST sequence (DY509762) encompassing exon 1 to exon 5 of sheep DMP1 along 
with re-sequencing results were used to predict the DMP1 protein sequence by applying the 
ExPASy translate tool (http://ca.expasy.org/tools/dna.html).  The predicted sheep DMP1 
protein was compared to the wild type (normal) of sheep and cow (AAI49017) using the 
CLUSTALW alignment tool (http://align.genome.jp/).  Each SNP variant was analyzed to 
check whether it could induce a missense or nonsense mutation.  The identified SNPs were 
genotyped on all 44 related Corriedale sheep and/or 46 normal controls by restriction enzyme 
digestion (PCR-RFLP) or direct sequencing.  The genotyping results from all 9 SNPs 
distributed in exon 6 of the DMP1 gene were formatted and put into Haploview software 
(http://www.broadinstitute.org/haploview/haploview).  The linkage disequilibrium (LD) 
between pairs of SNPs in exon 6 was analyzed by Haploview software.  Under the LD tabs, 
r2, the correlation coefficient, was saved to show the LD between each pair of SNPs.  The 
related LD color scheme was produced accordingly. 
RNA extraction and Reverse transcriptase-polymerase chain reaction (RT-PCR) 
RNA was extracted from fibroblast cells cultured in vitro from skin biopsies of affected and 
control sheep to confirm the mutation existed at the transcript level.  The fibroblast cell 
culture is as previously described [16].  Total RNA was extracted using Tri Reagent as per 
the manufacturer’s instructions (Sigma-Aldrich Co., USA).  RT-PCR was performed using 
the Superscript® one-step RT-PCR system with Platinum® Taq polymerase (Invitrogen 
 
 
51
Corp., USA).  The RT-PCR conditions were: 55ºC for 30 min, 94ºC for 2 min, 40 cycles of 
30 s at 94ºC, 30 s at 58º and 30 s at 72ºC, and finally a 5 min elongation step at 72ºC.   
Restriction enzyme digestion 
The nonsense mutation (C -> T) created a new recognition site for the restriction enzyme 
NIaIII (New England Biolabs Inc., USA).  DNA fragments from the PCR and RT-PCR 
reactions were subjected to restriction enzyme digestion with NlaIII.  The reaction mix was 
incubated at 37ºC overnight, and the products were analyzed on a 2.5% (w/v) ultra-pure 
agarose gel. 
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Table 1. The genotyping results of the causative mutation (R145X) 
Sheep 
Breed 
Phenotype Genotype Rate of 
Concordance 
 Rickets Status # Sheep Genotype # Sheep 
Corriedale Affected 17 T T 17 100% 
 Known Carrier 3 T C 3 100% 
 Phenotype Normala 24 T C , C C 24 100% 
Texel, 
Perendale 
Normal 46 C C 46 100% 
a These sheep are phenotypically normal offspring from F1 generation and F2 backcross 
generations generated by out-crossing and back-crossing trials. 
 
 
 
Figure 1. Corriedale sheep with rickets.  (a) 1½-year-old Corriedale sheep with 
inherited rickets showing angular limb deformities of the forelimbs and lordosis of the 
spine in the mid-thoracic region (white arrow).  (b) 1½-year-old Corriedale sheep with 
inherited rickets showing combined varus and valgus or “windswept” deformity of the 
forelimbs. 
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Figure 2. Work flow chart for discovering the mutation locus of inherited rickets in 
Corriedale sheep.  (a) The sheep chromosome 6 (OAR 6).  (b) The IBD region 
containing the causative locus is located on OAR 6 between 109 and 115 Mb.  (c) The 
black boxes show 35 cow reference genes encompassing the sheep IBD region based on 
the comparative genomic maps.  (d) & (e) The boxes represent exons of the cow and the 
predicted sheep DMP1 genes. The solid parts of boxes demonstrate the coding region 
for DMP1.  The vertical lines on exon 6 are representing the mutant SNP (R145X) with 
the other 8 SNPs.  (f) The number and color in each diamond box shows r2 value for 
each pair of SNPs.  Higher numbers and darker colors indicate SNPs are with higher 
LD.  Four SNPs in block 1 show a complete mutual linkage disequilibrium (LD) but not 
with the causative mutation (R145X). 
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Figure 3. Mutation analyses  (a) The chromatogram shows the location of the mutation 
(Y: C/T).  (b) Protein sequence alignments of DMP1.  The highlighted R145X 
substitution induces a stop codon that leads to premature termination of the protein. 
MUT, R145X mutant; WT, wild type.  (c) PCR-RFLP genotyping results for the 
affected (3 bands) and carrier (4 bands) Corriedale sheep and normal (2 bands) control 
sheep. M, 1kb marker; A, affected; C, carrier; N, normal.  (d) RT-PCR-RFLP results 
for 2 controls (N1 &N2) and 3 affected sheep (A1, A2 &A3).  
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Figure S1. Complete predicted DMP1 protein sequence alignments among rickets 
affected sheep, wild type sheep and cow.  The amino acid (R145X) with a border is the 
position where the “C - > T” transition induced a stop codon and lead to a truncated 
DMP1 protein at the 145th amino acid. 
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Table S1. Primer sequence, annealing temperature, PCR amplicon information and genetic variants identified by 
sequencing.   
Primer 
name 
Primer sequence Anealing 
Temp. (ºC) 
Size 
(bp) 
Fragment 
name 
Genetic variant 
(position in the 
fragment) 
SNP 
name 
SNP 
characteristic 
DMP1e1F 5’- CTTTTCCCATCCTTGGGTCT-3’ 60 560 DMP1e1 C/T (+ 453bp) SNP1 intronic 
DMP1e1R 5’- GCACTGTTCTCCCCATCTTT-3’       
DMP1e3F 5’- CAAAATGTTATCCCCAGACCA-3’ 60 388 DMP1e3 no - no 
DMP1e3R 5’- TTCAGCATTTGCAGTGAAGC-3’       
DMP1e4F 5’- GGCTAAACACAAGCCAAGGA-3’ 60 659 DMP1e4 indel (A) (+284bp) - intronic 
DMP1e4R 5’- GGAGATTGGGAGGGTCATGT-3’       
DMP1e5F 5’- CAGGCCATTTGGAAAGTCAT-3’ 60 411 DMP1e5 C/G (+ 341bp) SNP2 intronic 
DMP1e5R 5’- GAGGAACATTTAGGGCCACA-3’       
DMP1e6_2F a 
DMP1e6_2Ra 
5’- ATGGAAAATGGGGTGACTTG-3’ 
5’- CATCCCTTCATCGTCGAACT-3’ 
 
58 668 DMP1e6_2 C/T (+455bp) 
C/T (+472bp) 
       A/G (+493bp) 
R145X 
S18033.1 
SNP3 
exonic 
exonic 
exonic 
DMP1e6_5F 
DMP1e6_5R 
5’- ATGAGTCCAGGGGTGACAAC-3’ 
5’- CAACAATGGGCATCTTTCCT-3’ 
 
58 703 DMP1e6_5 C/G (+101bp) 
C/T (+134bp) 
C/T (+140bp) 
A/G (+167bp) 
A/C (+218bp) 
C/T (+602bp) 
SNP4 
SNP5 
SNP6 
SNP7 
SNP8 
SNP9 
exonic 
exonic 
exonic 
exonic 
exonic 
3’ UTR 
a These primer sets were used for PCR-RFLP genotyping of the mutation R145X. 
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Table S2. The list of ovine positional candidate genes based on the bovine reference gene sequences. 
 
 
Targeted 
Region 
(size) 
Ovine Chromosome Position Bovine Ref. Gene Symbol Bovine Ref. Gene Name 
Bovine Gene 
Accession No. 
1 
(5.95 Mb) 
OAR6:109103268..109364732 WDFY3 Similar to WD repeat and FYVE domain-containing protein 3 (Autophagy-linked 
FYVE protein) (Alfy) 
XM_617252 
OAR6:110461394..110535578 ARHGAP24 Rho GTPase activating protein 24 NM_001102234 
OAR6:111226629..111449410 PTPN13 Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-
associated phosphatase) 
NM_174590 
OAR6:111458495..111488852 SLC10A6 Solute carrier family 10 (sodium/bile acid cotransporter family), member 6 NM_001081738 
OAR6:111512006..111515283 UBE2D3P Similar to Putative ubiquitin-conjugating enzyme E2 D3-like protein NM_001075135 
OAR6:111512014..111515294 LOC783264 Similar to ubiquitin-conjugating enzyme E2D 3 XM_001249763 
OAR6:111512014..111515294 LOC783114 Similar to ubiquitin-conjugating enzyme E2D 3 XM_001250124 
OAR6:111600842..111740902 AFF1 Similar to AF4/FMR2 family, member 1 XM_001249488 
OAR6:111756587..111811197 KLHL8 Similar to KIAA1378 protein, transcript variant 1 XM_612186 
OAR6:111885205..111904838 HSD17B13 Hydroxysteroid (17-beta) dehydrogenase 13 NM_001046616 
OAR6:111920170..111969527 HSD17B11 Hydroxysteroid (17-beta) dehydrogenase 11 NM_001046286 
OAR6:112013056..112050582 NUDT9 Nudix (nucleoside diphosphate linked moiety X)-type motif 9 NM_001101096 
OAR6:112063439..112116046 SPARCL1 SPARC-like 1 (hevin) NM_001034302 
OAR6:112199546..112216300* DMP1* Dentin matrix acidic phosphoprotein 1 NM_174038 
OAR6:112365289..112411784 MAN2B2 Similar to mannosidase, alpha, class 2B, member 2 XM_601803 
OAR6:112588875..112650749 PPP2R2C Similar to Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B 
gamma isoform 
XM_001250700 
OAR6:112757862..112757903 LOC617028 Hypothetical LOC617028 XM_882441 
OAR6:112759544..112781041 LOC782334 Hypothetical LOC782334 XM_001250977 
OAR6:112780837..112910375 JAKMIP1 Janus kinase and microtubule interacting protein 1 NM_001102251 
OAR6:113024908..113058856 LOC615433 Hypothetical LOC615433 XM_867237 
OAR6:113144679..113208484 CRMP1 Similar to Dihydropyrimidinase-related protein 1 (DRP-1) (Collapsin response 
mediator protein 1) 
XM_580336 
OAR6:113213443..113312073 EVC Ellis van Creveld syndrome NM_174747 
OAR6:113335352..113473188 EVC2 Ellis van Creveld syndrome 2 NM_173927 
OAR6:113451908..113473188 LOC786485 Hypothetical LOC786485 XM_001254147 
OAR6:113787927..114038860 STK32B Similar to serine/threonine kinase 32B XM_607574 
OAR6:114257470..114261815 CYTL1 Similar to Cytokine-like protein 1 precursor (Protein C17) XM_581416 
OAR6:114391388..114395645 MSX1 Msh homeobox 1 NM_174798 
OAR6:114700887..114900429 STX18 Syntaxin 18 NM_001099719 
OAR6:114899716..114940430 NSG1 Neuron specific gene family member 1 NM_001077957 
OAR6:114899716..114901567 LOC789276 Hypothetical LOC789276 XM_001256071 
OAR6:115074361..115095979 ZNF509 Similar to hCG2039195, transcript variant 1 XM_583985 
OAR6:115101064..115121797 LYAR Ly1 antibody reactive homolog (mouse) NM_001031769 
OAR6:115135963..115151278 TMEM128 Transmembrane protein 128 NM_001034454 
OAR6:115207964..115221470 LOC525643 Similar to otopetrin XM_603996 
OAR6:115249664..115251638 DRD5 Dopamine receptor D5 XM_604584 
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Table S2. (continued)
Targeted 
Region 
(size) 
Ovine Chromosome Position Bovine Ref. Gene Symbol Bovine Ref. Gene Name 
Bovine Gene 
Accession No. 
2 
(0.70 Mb) 
OAR6:118851890..118883051 PDE6B Phosphodiesterase 6B, cGMP-specific, rod, beta NM_174418 
OAR6:118941179..118943474 GPI7 GPI7 protein NM_001024518 
OAR6:118976061..119063813 LOC614799 Similar to solute carrier family 2 (facilitated glucose transporter), member 9 XM_866430 
OAR6:119204026..119245137 WDR1 WD repeat domain 1 (WDR1) NM_001046346 
OAR6:119417009..119417107 LOC786062 Similar to Zinc finger protein 518B-like XM_001788422 
OAR6:119417009..119417587 ZNF518B Similar to Zinc finger protein 518B XM_584181 
3 
(0.66 Mb) 
OAR15:1220402..1223574 KIAA1826 Hypothetical protein LOC511226 NM_001046078 
OAR15:1338164..1344393 KBTBD3 Kelch repeat and BTB (POZ) domain containing 3 XM_602528 
OAR15:1418829..1442937 AASDHPPT Similar to aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl 
transferase 
XM_001250765 
OAR15:1484534..1488246 ANKRD49 Ankyrin repeat domain 49 NM_001014965 
OAR15:1503540..1575517 MRE11A Double-strand break repair protein meiotic recombination 11 homolog A XM_603439 
OAR15:1596294..1619791 GPR83 Similar to G protein-coupled receptor 83 XM_615580 
OAR15:1220402..1223574 KIAA1826 Hypothetical protein LOC511226 NM_001046078 
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CHAPTER 3. A MISSENSE MUTATION IN AGTPBP1 WAS IDENTIFIED IN 
SHEEP WITH A LOWER MOTOR NEURON DISEASE   
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ABSTRACT  
A type of lower motor neuron disease inherited as autosomal recessive in Romney sheep was 
characterized with normal appearance at birth, but with progressive weakness and 
tetraparesis after the first week of life.  Here we carried out genome-wide homozygosity 
mapping using Illumina OvineSNP50 BeadChips on lambs descended from one carrier ram, 
including 19 sheep diagnosed as affected and 11 of their parents that were therefore known 
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carriers.  A homozygous region of 136 consecutive single-nucleotide polymorphism (SNP) 
loci on chromosome 2 was common to all affected sheep and it was the basis for searching 
for the positional candidate genes.  Other homozygous regions shared by all affected sheep 
spanned 8 or fewer SNP loci.  The 136-SNP-region contained the sheep ATP/GTP-binding 
protein 1 (AGTPBP1) gene.  Mutations in this gene have been shown to be related to 
Purkinje cell degeneration (pcd) phenotypes including ataxia in mice.  One missense 
mutation c.2909G>C on exon 21 of AGTPBP1 was discovered which induces an Arg to Pro 
substitution (p.Arg970Pro) at amino acid 970, a conserved residue for the catalytic activity of 
AGTPBP1.  Genotyping of this mutation showed 100% concordant rate with the recessive 
pattern of inheritance in affected, carrier, phenotypically normal and unrelated normal 
individuals.  This is the first report showing a mutant AGTPBP1 is associated with a lower 
motor neuron disease in a large mammal animal model.  Our finding raises the possibility of 
human patients with the same etiology caused by this gene or other genes in the same 
pathway of neuronal development.  
INTRODUCTION 
Motor neuron diseases (MND) are a group of disorders involved with selective degeneration 
of upper motor neurons (UMN), and/or lower motor neurons (LMN).  The incidence of MND 
varied from 0.6 per 100,000 person-years to 2.4 per 100,000 person-years in different ethnic 
human populations (Lee, 2010).  UMN originate in the cerebral cortex or the brain stem and 
provides indirect stimulation of the target muscles, while LMN connect the brain stem and 
spinal cord to muscle fibers, and provide nerve signals between the UMN and muscles.  
Common characteristics of MND are muscle weakness and/or spastic paralysis.  Signs of 
LMN lesions are represented as muscle atrophy, fasciculations and weakness when 
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associated LMN degenerate.  Symptoms like spastic tone, hyperreflexia and upgoing plantar 
reflex signs appear as UMN degenerate (Lee, 2012).  The weakness of respiratory or bulbar 
muscle can even cause death of MND patients due to respiratory insufficiency (Borasio et al., 
1998).  Based on the time of onset, types of motor neuron involvement and detailed clinical 
features, MND in humans can be classified into six types of diseases including amyotrophic 
lateral sclerosis (ALS), hereditary spastic paraplegia (HSP), primary lateral sclerosis (PLS), 
spinal bulbar muscular atrophy (SBMA), spinal muscular atrophy (SMA) and lethal 
congenital contracture syndrome (LCCS).  MND are considered incurable and no effective 
treatment is currently available.  However, the gene therapy strategy of performing gene 
transfer to patients by utilizing adeno-associated virus (AAV) vectors is a promising 
therapeutic approach (Nizzardo et al., 2012).  Previous evidence has shown genetic variants 
within more than 30 genes might be responsible for MND (Dion et al., 2009).  For example, 
mutations in the Cu/Zn-binding superoxide dismutase (SOD1) gene have been identified in 
about 20% of patients with familial ALS (Rosen et al., 1993).  However, genetic causes still 
remain unclear for more than half of human patients with MND.  
In 1999, an extended family of Romney lambs was found to have a suspected hereditary 
MND, characterized by poor muscle tone and progressive weakness from about 1 week of 
age, leading to severe tetraparesis, recumbency and muscle atrophy.  Lambs remained alert 
up to four weeks of age when they were euthanized.  The muscles were atrophied and pale, 
and histologically had variation in muscle fiber diameter and small angular fibers.  Large 
foamy macrophages were present in cerebrospinal fluid, and there were degenerate neurons 
in the spinal cord leading to a decrease in the number of motor neurons, consistent with LMN 
diseases.  No histological changes were seen in the cerebellum (Anderson et al., 1999).  
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Outcross and backcross breeding trials were consistent with this LMN disease having simple 
autosomal recessive inheritance. 
In order to find the causative locus responsible for this disease, we performed a genome-wide 
homozygosity mapping process and then fine mapped the mutation using a positional 
candidate gene approach within the largest homogygous genomic region found in the 
affected sheep.  Our goals of this research were to discover the genetic basis of this disease, 
to help sheep breeders avoid matings between carrier animals, and to provide a potential 
animal model for gene therapy treatment of human LMN disease.  
METHODS 
Animals 
Approvals dealing with DNA or tissue collection from animals were obtained from the 
Massey University Animal Ethics Committee (Approval Number 99/135).  Iowa State 
University Animal Care & Use Committee did not require additional approvals. 
A single Romney putative carrier ram was mated in New Zealand to 130 crossbred Finnish 
Landrace ewes to produce 115 daughters that were subsequently backcrossed to their sire.  
The backcrosses produced 5 affected sheep out of 47 lambs in the first lambing, and 11 out of 
71 in the second lambing.  The observed rate of affected sheep was consistent with the 1 in 8 
expectation for a homozygous recessive disorder from this mating scheme.  Any affected 
offspring and their dams now proven to be carriers, formed the basis of the experimental 
population.  High density SNP genotypes were obtained from 19 affected, which included 3 
affected lambs from the original Romney flock, and 11 known carrier sheep.  Fine mapping 
using novel SNPs was conducted on 52 Romney or Romney/Finn crosses including the 
above mentioned 30 ones with clear disease statuses and 22 potential carriers which were 
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phenotypically normal but sired by the carrier ram.  Moreover, 85 control sheep consisted of 
14 normal Romney sheep, 25 crossbred Texel sheep and 46 crossbred Corriedale sheep were 
used for validation of the causative mutation. These sheep were produced from unrelated 
populations without evidence of LMN disease.  
SNP genotyping 
DNA was extracted from blood using the QIAamp DNA Blood Mini Kit (QIAGEN, CA, 
USA) and the Roche MagNA Pure automated analyser (Roche, USA).  The genotyping of 
54,241 evenly distributed polymorphic SNP markers across the genome was performed using 
the Ovine SNP50 BeadChip (Illumina, San Diego, CA, USA) at the commercial company 
GeneSeek Inc. Lincoln, NE, USA.  Standard procedures were performed with a PCR and 
ligation-free protocol, which routinely achieves high average call rates and accuracy.  
Genome wide homozygosity mapping 
In order to define the molecular genetic basis for the LMN disease in these Romney sheep, a 
search for putative homozygous-by-descent (also named identical by descent, IBD) regions 
was initiated by performing a genome wide scan using an in-house UNIX script as described 
in our previous publication (Zhao et al., 2011).  The SNP genotypes were ordered according 
to their genomic location as provided in the Illumina manifest, and used to identify regions of 
consecutive homozygous SNP loci that were common to all affected animals.  The same 
procedure was applied to known carriers to ensure that the identified region was not simply 
fixed across all animals.  A threshold of 10 SNPs defining a candidate consecutive 
homozygous region was chosen after calculating expected IBD fragment size for 19 affected 
lambs produced through the outcross and backcross experiments assuming exactly one 
crossover event occurred every meiosis on the chromosome carrying the causal mutation 
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with uniform probability along the chromosome expressed in linkage units (cM).  The 
homozygous fragment containing the causative mutation would have exceeded 0.5 cM or 
about 10 consecutive SNP with probability > 95%.  The expected size of the IBD region that 
contains the causative mutation depends in part on the number of meioses that separate the 
common ancestor from the affected lambs, and the number of affected individuals.  The IBD 
region that included the causative mutation had 23% probability of being shorter than 2 cM 
and a 32% probability being longer than 5 cM.  The mean expected length of the IBD region 
was about 4 cM.  Genes in the identified IBD regions were examined for potential 
involvement using comparative homology between ovine and bovine genomes as provided 
through the Ovine Genome Assembly v1.0 
(http://www.livestockgenomics.csiro.au/perl/gbrowse.cgi/oar1.0/#search).  
Positional candidate genes sequencing 
Primer3 software (version 0.4.0) and the reference sequences from Ovine Genome Assembly 
v1.0 were used to design PCR primers flanking the coding regions of ovine AGTPBP1 
(Supplementary Table S1).  Among the many genes in the identified homozygous regions, 
AGTPBP1 was considered to be the best candidate gene because of its role in neural 
functions as reported by several publications (Harris et al., 2000; Fernandez-Gonzalez, et al., 
2002).  PCR was performed using a 10 µl cocktail mixture and a standard program as 
previously described (Zhao et al., 2011), with an annealing temperature of 58ºC or 60ºC.  
Negative controls were performed to check for the presence of contaminants in all reactions.  
PCR products were verified by 1.5% agarose gel electrophoresis, and treated with ExoSAP-
IT® (Affymetrix, USA), before pooling them from 2 affected and 2 carrier sheep.  The 
pooled PCR products were sequenced commercially using a 3730xl DNA Analyzer (Applied 
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Biosystems, USA).  The Sequencher software (version 3.0) was used for sequence alignment 
and comparison.  
Mutation analyses 
Since annotation of the ovine genome has not yet been completed, the bovine AGTPBP1 
reference mRNA sequence (GenBank: XM_001252536.3) was used as a query in cross-
species BLAST searches to identify sheep EST.  Both the bovine AGTPBP1 mRNA and 
corresponding ovine EST served as references to search for the coding regions within ovine 
AGTPBP1 gene.  The AGTPBP1 protein sequence was predicted using successfully 
amplified and re-sequenced exonic regions of the gene from the sheep population, the bovine 
AGTPBP1 reference mRNA sequence and ovine EST.  In order to understand the functional 
annotation of this protein, the conserved domains within this sheep protein sequence were 
searched by blasting the complete protein sequence against the Conserved Domains database 
(database: CDD-40526 PSSMs) in NCBI 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) while setting an option of 500 as the 
maximum number of hits.  Multiple sequence alignments provide a basis for conserved 
domain models.  The specific hits and super families were given for the queried protein.  
Moreover, the conserved protein residues involved in conserved features such as binding or 
catalysis were annotated when the query sequence residues were in the Entrez Protein 
database.  The sequence alignments of protein AGTPBP1 from multiple species including 
human, mouse, chicken, frog, purpuratus, sea squirt, trichoplax, zebrafish and sheep, were 
displayed to show the conserved feature sites.  The fold structure of the conserved domain of 
AGTPBP1 in sheep (residues 850-1150) and mouse (residues 800-1110) were predicted 
using the 3D_PSSM program (http://www.sbg.bio.ic.ac.uk/3dpssm/index2.html).  The known 
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crystal structures of carboxypeptidases in the PDB database help to generate the predicted 
structure of AGTPBP1.  Sequence alignment was performed on the ClustalW2 server 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) among sheep and mouse AGTPBP1, human 
(PDB ID: 1DTD) carboxypeptidase A2 (CPA2) and cattle (PDB ID: 1HDU) 
carboxypeptidase A (CPA).  This helped us to be more confident about the conserved 
features of AGTPBP1 secondary structure and the amino acids critical for carboxypeptidase 
catalysis.  A three dimensional macromolecular structure of the conserved domain was 
searched and downloaded using homologous sequences with confirmed crystal structure 
(http://www.ncbi.nlm.nih.gov/Structure/MMDB/mmdb.shtml).  Each SNP variant was 
analyzed to check whether it could induce missense or nonsense mutations.  The identified 
SNPs were then genotyped using restriction enzyme digestion (PCR-RFLP: Polymerase 
Chain Reaction-Restriction Fragment Length Polymorphism) on the affected and carrier 
sheep as well as on other normal controls.  
Restriction enzyme digestion (PCR-RFLP) 
The sequences of PCR primer “LMN_new” (Supplementary Table S1) were 5’ 
TGTTAGCACCTCCTCTTTGCT3’ and 5’ AGCAGACCCTTGGCATGATA3’.  DNA 
fragments from the PCR reactions were subjected to restriction enzyme digestion with AciI 
(New England Biolabs Inc., USA).  The missense mutation in AGTPBP1 removes a 
recognition site of the AciI enzyme.  The 10 µl system reaction mix contained 1 µl of NEB 
buffer 3, 0.5 units of AciI and 2 µl of PCR product.  The reaction mix was incubated at 37ºC 
overnight, and the products were analyzed on a 2.0% (w/v) ultra-pure agarose gel. 
RESULTS 
Detection of IBD regions 
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The whole genome scan discovered 209 homozygous fragments consisting of 3 or more 
consecutive SNPs shared by all 19 affected lambs.  The size distribution of common 
homozygous fragments in these lambs is shown (Figure 1).  Only one large homozygous 
segment exceeded the 10-SNP threshold and it consisted of 136 consecutive SNP loci 
identified in all 19 affected sheep, whereas the 11 carriers exhibited heterozygosity in this 
segment.  The region started from SNP s56017.1 and extended to SNP OAR2_36428027.1.  
This segment is physically positioned on the small arm of ovine chromosome 2 (OAR 2) 
from 29,284,415 bp to 36,428,027 bp, covering a region of 7 Mb (Figure 2a and b).  We 
found this segment likely encompassed 36 genes (Figure 2d and Supplementary Table S2) 
based on the bovine reference sequences.  A gene called ATP/GTP binding protein, transcript 
variant 1 (AGTPBP1), also named Nna1 (Nervous system nuclear protein induced by 
axotomy protein 1 homolog) was the most plausible candidate due to its involvement in 
axonal regeneration and its causal relationship with mouse pcd phenotype (Harris et al., 2000; 
Fernandez-Gonzalez et al., 2002).  The ovine AGTPBP1 gene spans about 0.17 Mb and 
encodes a 1,225-amino-acid intracellular protein that contains a predicted zinc 
carboxypepetidase domain near its C-terminus (Harris et al., 2000).  This gene was initially 
cloned from regenerating spinal cord neurons of the mouse (supplied by OMIM 606830).  
Gene coding region re-sequencing and mutation analyses 
Functional mutations in candidate genes were examined by re-sequencing all available exons 
using primers based on the adjacent intronic sequences of these genes.  The ovine AGTPBP1 
gene was predicted to have 25 exons based on the bovine reference gene and protein 
sequences.  All the exons except exons 11, 12 and 17 for this gene were successfully 
amplified and three exonic SNPs were identified.  The first exonic SNP (called c.2909G>C) 
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was located at the 6th bp of exon 21 of the sheep AGTPBP1 gene.  The other two were 
located at the 93rd and 99th bp of exon 22.  An additional 17 SNPs were identified in either 
introns or the 3’ UTR on this gene.  These were immediately excluded as causative loci since 
none were located either in the splicing donor/receptor regions or other important regulatory 
regions and were not in concordance with sheep phenotypes (data not shown).  After 
comparing our findings with the bovine coding sequence of AGTPBP1, we observed that the 
first exonic SNP (c.2909G>C) introduced a missense transition (Arg>Pro) at amino acid 970 
(p.Arg970Pro) (Figure 2e), and the third exonic SNP (c.3133T>C) also resulted as a 
missense mutation causing a Pro to Ser substitution (p.Pro1045Ser).  The second exonic SNP 
(c.3126C>T) was a synonymous mutation and did not change any amino acid.  A conserved 
domain named M14_Nna1 (CDD: cd06906) spanning from amino acid residue 859 to 1136 
on AGTPBP1 in sheep was predicted in this study using the “CD-search” option available in 
NCBI.  This domain is a zinc-binding carboxypeptidase domain, which hydrolyzes the 
peptide bonds at the C-terminal part of certain amino acids in polypeptide chains.  The 
sequence alignment among multiple species demonstrated 2 specific feature hits including 
metallocarboxypeptidase activity and zinc binding.   Nine conserved amino acid residues 
were involved in these two features hits. (Supplementary Figure S1 and Figure S2; Gomis-
Rṻth et al., 1999; Aloy et al., 2001).  Three conserved residues (His920, Glu923 and 
His1017) expressed as a motif “HXXE…H” are responsible for zinc binding, and all 9 
conserved residues (His920, Glu923, Arg970, Asn979, Arg980, His1017, Gly1018, Met1027 
and Glu1102) are important for substrate binding and catalysis of this protein 
(Supplementary Figure S1 and Figure 3a).  In terms of the size and relative positioning of β-
sheets and α-helices, the overall predicted secondary structures of AGTPBP1 in sheep and 
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mouse were the same as that of other metallocarboxypepdases in human and cattle by using 
the 3D-PSSM program.  Features and conserved amino acids and motifs are located in 
similar positions.  For example, the well-known zinc-binding HXXE…H motif lies between 
the second β-sheet and the first α-helix as reported (Wang et al., 2006).  Six residues (His920, 
Glu923, Arg970, Asn979, Arg980 and Glu1102) remain conserved among these proteins 
(Supplementary Figure S3).  The first exonic missense mutation (c.2909G>C) identified on 
exon 21 is the middle nucleotide within a codon “CGC” which was translated and substituted 
from Arg970 (codon “CGC”), one of the conserved residues responsible for substrate binding 
and catalysis, to Pro970 (codon “CCC”) (Figure 3b).  Molecular modeling based on the 
crystal structure of the homologous protein, putative carboxypeptidase (PBDID: 3K2K), also 
demonstrated that Arg970 forms a part of a loop (the short yellow section of the middle loop 
in Figure 3c), which might be a key site for substrate binding or catalytic activity.  The amino 
acid residue encoded by the exonic missense mutation on exon 22 (c.3133T>C; 
p.Pro1045Ser) varies considerably among different species (Figure 3b).  It indicates that this 
missense mutation may not affect the function of the protein AGTPBP1 as it is neither 
involved in zinc binding nor in substrate binding and catalysis.   
The Arg970Pro mutation was genotyped by PCR-RFLP (Figure 2e).  The 611 base pair 
length of the “LMN_new” PCR fragment amplified from normal sheep had one restriction 
site, which could be recognized by the restriction enzyme AciI and cut into 2 fragments with 
lengths of 519 bp, and 92 bp.  However, the restriction site was removed due to the 
Arg970Pro mutation and the 611 bp fragment amplified from the affected lambs was intact 
after digestion.  Therefore, the PCR fragment amplified from sheep with a genotype of “GG” 
was cut into 2 fragments with lengths of 519 bp, and 92 bp; the one with a genotype of “GC” 
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had 3 fragments with lengths of 611 bp, 519 bp, and 92 bp; the one with a genotype of “CC” 
had a single fragment with length 611bp.  Our genotyping results showed all 19 affected 
sheep were “CC”, the 11 known carriers were “GC”, and the 22 phenotypically normal but 
possible carrier sheep were either “GC” or “GG” genotypes.  In contrast, 85 control 
(unrelated) sheep were only “GG” genotypes (Table 1).  This mutation was 100% concordant 
with the recessive pattern of inheritance in affected, carrier, phenotypically normal and 
unrelated normal individuals.  The two exonic SNP (c.3126C>T and c.3133T>C) on exon 22 
were genotyped by direct sequencing.  However, there is no perfect concordant rate for these 
two SNPs based on the counts for each of the genotypes (Table 1).  At this stage, we 
excluded these two SNP as causative mutations for this defect due to their genotyping results 
and mutation analyses.  Taken together, our results strongly suggest that the Arg970Pro 
substitution is the causative locus for LMN disease in Romney sheep and it could act by 
decreasing the function of protein AGTPBP1 to generate LMN disease in these lambs. 
DISCUSSION 
The AGTPBP1 gene encodes a protein which belongs to a member of the cytosolic 
carboxypeptidase subfamily (M14D subfamily) (Kalinina et al., 2007; Rodriguez de la Vega 
et al., 2007).  This protein plays a role in protein turnover by cleaving proteasome-generated 
peptides into amino acids (Berezniuk et al., 2010), enzymatically removing gene-encoded 
glutamic acids or tyrosine from the C terminus of proteins (Rogowski et al., 2010; Kalinina 
et al., 2007), and also plays a role in neuronal bioenergetics at least in mouse brains 
(Chakrabarti et al., 2010).  Similar to other cytosolic carboxypeptidases, the mouse Nna1 
protein is broadly expressed in brain, pituitary, eye, testis and other tissues (Kalinina et al., 
2007).  Mutations or abnormal expression of Nna1 have been found to cause a Purkinje cell 
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degeneration (pcd) phenotype in mice characterized by degeneration of Purkinje cells, mitral 
cells of the olfactory bulb, thalamic neurons and retinal photoreceptor cells as well as 
degeneration of sperm (Fernandez_Gonzalez et al., 2002; Mullen et al., 1976).  Twelve 
alleles in mouse mutants related to Agtpbp1 have been summarized by the Jackson 
Laboratory (http://www.informatics.jax.org/searches/accession_report.cgi?id=MGI:2159437).  
Among which, loss-of-function of Agtpbp1 was indicated as being responsible for pcd3J and 
pcd5J mouse mutants (Fernandez-Gonzalez, et al., 2002; Wang and Morga, 2007; Chakrabarti 
et al., 2008).  Expression of full-length Nna1 successfully rescued Purkinje cell loss and 
ataxic behavior in pcd3J, and retinal photoreceptor loss and Purkinje cell degeneration in 
pcd5J mice (Wang et al. 2006; Chakrabarti et al., 2008).  
In this study, the missense mutation c.2909G>C on exon 21 of AGTPBP1 induces an Arg to 
Pro substitution (p.Arg970Pro) at amino acid 970 (R970).  Based on the crystal structure of 
human CPA2, it has been reported that arginine 127 (R127) in CPA2 is an electrophile site 
crucially responsible for the catalytic activity along with glutamate 270 (Mangani et al., 1994; 
Garcia-Saez et al., 1997; Christianson et al., 1989).  Similarly, the homologous arginine 
residue R127 (numbered according to mature bovine carboxypeptides A1) in C. elegans 
AGBL4 (AGP/GTP binding like protein 4) has been predicted to stabilize the oxyanion hole 
in the S1’ site of the carboxypeptidase domain (Rodriguez de la Vega et al., 2007).  
Sequence comparison and structural modeling of sheep AGTPBP1 with other 
carboxypeptidases predicted R970 was located in a region known as the substrate-binding 
pocket and catalytic center of metallocarboxypeptidase as mouse Nna1 (Supplementary 
Figure S3; Wang et al., 2006).  These results enforce the view that R970 in sheep is a very 
conserved site being critical for its function of catalytic activity.  Therefore, we concluded 
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the Arg970Pro substitution could be a candidate causative mutation possibly altering the 
characteristic of the AGTPBP1 protein and very likely impairing its function of catalytic 
activity.   
Comparing to the phenotype of the original pcd mouse model, the affected sheep do not have 
apparent degeneration of Purkinje cells but show their specific characteristics including 
degeneration of neurons in ventral horns of the spinal cord and brain stem, Wallerian 
degeneration of motor nerve fibers and atrophy of skeletal muscles.  The phenotype of these 
sheep is more similar to the symptoms in the Sod1 transgenetic mice (mSOD1), which were 
constructed as animal models for human ALS patients (Gurney et al., 1994).  It is interesting 
to note that the Lox (lysyl oxidase) gene, encoding a protein playing an important role in 
formation and repairing of extracellular matrix, was found to be up-regulated in both mSOD1 
mice and Agtpbppcd-sid mice (Li et al., 2004; Li et al., 2010; Lucero and Kagan, 2006).  The 
Agtpbppcd-sid mutant was characterized as a deletion of Agtpbp1 exon 7 that produced a stop 
codon in exon 8.  Absence of protein Agtpbp1 will decrease dendrite development of 
cerebellar Purkinje cells by changing the expression of downstream components, including 
Lox propeptide and the NF-κB signaling pathway in mice (Li et al., 2010).  Therefore, we 
assume the p.Arg970Pro substitution might impair the catalytic activity of AGTPBP1 and 
decrease its ability of protein turnover of LOX.  The overabundant protein LOX would cause 
abnormal development of dendrite in LMN and then develop phenotypes shown in these 
sheep. 
In order to ascertain that the Arg970Pro substitution was really a causative mutation, 
measuring mRNA expression of the genes AGTPBP1 and LOX and their enzymatic activities 
in the spinal cord, brain stem and cerebellar tissues would be desired.  It could exclude the 
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possibility that the Arg970Pro mutation in protein AGTPBP1 is only a coincidental finding 
from the genetic mapping study or this mutation disrupts expression of another gene in the 
same region of the genome.  Nevertheless, a point mutagenesis of mouse Nna1 gene at 
arginine 962 (R962), the homologous residue of R970 in sheep, to generate transgenic mice 
and then using the intact full-length Nna1 gene to rescue phenotypes in mice will provide 
further evidence for the Arg970Pro substitution being a causative mutation in sheep.   
The missense mutation c.2909G>C (p.Arg970Pro) in AGTPBP1 appears to be a spontaneous 
one arising from a single sheep family.  In order to avoid spreading out this disease 
throughout the sheep population, a simple genetic test can be easily designed based on our 
results to identify and remove carriers with the defective c.[2902C] allele, and to decrease the 
risk of economic losses in the future .  
Regenerating motor neurons expressing protein NNA1 in human nervous tissues indicated 
that NNA1 was a key factor for motor neuronal degeneration (Harris et al., 2000).  To date, 
no human cases have been reported with spontaneous mutations in AGTPBP1 that would 
implicate the gene as a cause for a LMN disease.  Neither have they been reported to occur in 
other large mammalian species.  Mice and hamsters are convenient animal models for studies 
of human neural diseases (Mashimo et al., 2009; Akita et al., 2007).  However, there are still 
significant structural and functional differences between rodent and large mammalian species.  
Even among rodents themselves, the gene distributions could be different.  Hamsters with 
undetectable Nna1 mRNA in the brain did not exhibit distinctive neurodegenerative features 
as serious as mice mutants, which could possibly be explained due to the different 
distributions of Nna1 and other Nna 1-like genes in the brains of mice and hamsters 
(Kalinina et al., 2007; Akita et al., 2007; Akita and Arai, 2009).  Sheep have large brain size 
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and long life span relative to rodents and similar gestation period as humans.  Our finding in 
sheep, a large mammalian species, raises the possibility that human patients with similar 
etiology may also result from this gene or other genes in the same pathway of neuronal 
development.  Since there is no effective treatment available for motor neuron diseases, the 
identification of molecular pathogenetic targets will shed light on the development of gene 
therapy for this type of diseases (Nizzardo et al., 2011).  Here we reported that LMN disease 
originating in a Romney ram was likely caused by a mutation in a gene locus AGTPBP1 
(NNA1).  The affected sheep could be used as a valuable animal model for gene therapy if 
human patients are successfully diagnosed in the future.  
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Table 1. The genotyping results of three exonic SNPs  
Sheep Breed 
LMND 
Status 
Exon 21 
 
Exon 22 
c.2909G>C (p.Arg970Pro) c.3126C>T  c.3133T>C (p.Pro1045Ser) 
C
C 
C
G 
G
G 
Rate of 
Concordan
ce 
 
T
T 
C
T 
C
C 
Rate of 
Concordan
ce 
 
C
C 
C
T 
T
T 
Rate of 
Concordan
ce 
Romney and 
Romney-sired 
crossbreds 
Affected 19 0 0 100%  19 0 0 100%  19 0 0 100% 
Known 
carrier 
0 13 0 100% 
 
3 10 0 76.9%  10 3 0 23.1% 
Phenotyp
e normala 
0 13 9 100% 
 
1 13 6 95.0%  18 2 0 10.0% 
 Normal 0 0 14 100%   
Texel/Corrieda
le 
Normal 0 0 71 100% 
  
aThese sheep are including phenotypically normal and suspected sheep which were died 
without clear reasons. 
 
 
 
Figure 1. The distribution of identical homozygous fragments in LMND affected lambs.  
Based on the different number of SNPs spanning the homozygous fragment, the counts 
of identical homozygous fragments in all affected lambs were shown.  Only one 
homozygous fragment spanning 136 SNPs was identified to be common to all 19 
affected lambs when the “larger than 10-SNP” threshold was applied.  
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Figure 2. Work flow chart for discovering the mutation locus of low motor neuron 
disease in Romney sheep. (a) The sheep chromosome 2 (OAR 2).  (b) The IBD region 
containing the causative locus is located on OAR 2 between 29 and 36 Mb. (c) SNP 
locations on the Ovine SNP50 BeadChip in the IBD region (d) The black boxes show 
reference genes encompassing the sheep IBD region based on the comparative genomic 
maps. The gene AGTPBP1 was depicted by a red lined box. (e) Sequence analyses of 
AGTPBP1 showed a point mutation in exon 21, resulting in an Arg to Pro substitution.  
This missense mutation is located in a highly conserved residue for the catalytic activity 
of this protein.  The PCR-RFLPs show different patterns for affected and carrier 
groups.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 The conserved domain structure
The conserved domains includes Zinc
M14_Nna1 like superfamily genes
with 8 most dissimilar protein sequences from species of
purpuratus, sea squirt, trichoplax
on the top were known to be involved in substrate binding or catalytic activity
missense mutations were labeled
aligned and a read to blue color scale represents the degree of conservation, with red 
showing highly conserved residues.  Lower case, grey amino acids are unaligned.  
Dashes indicate variations in sequence length among multiple sequence alignment.
Three dimensional molecular modeling 
structure of putative carboxypeptidase (
middle loops represents the position of the 
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s of partial protein sequence of
-binding sites and putative active sites shared by 
 (b) Alignment of predicted sheep protein AGTPBP1
 human, mouse, chicken, frog, 
 and zebrafish.  The residues labeled by hash
 on the protein sequence.  Upper case amino acids are 
of the conserved domain based on the 
PBDID: 3K2K).  The short yellow section in the 
mutated amino acid residue. 
 
 AGTPBP1. (a) 
 
-marks 
.  The two 
 (c) 
crystal 
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Table S1. Primer sequences, annealing temperatures, PCR amplicon information and 
targeted encoding regions of gene AGTPBP1. 
Primer 
name 
Primer sequence 
Size 
(bp) 
Annealing 
temperature 
(°C) 
Targeted 
exon 
sAGTe1bF 5’TCAAACATTCTCCTGTGGTTTC3’ 783 60 Exon 1 
sAGTe1bR 5’TGCTCAACACTCATTTTCTGC3’    
sAGTe2F   5’CAGGGTAGGATTTTGGCTTG3’ 443 60 Exon 2 
sAGTe2R 5’ATGGGGAAAGGAGGACAATC3’    
sAGTe3F 5’AGCAACATCAGTGGAAGGAAC3’ 678 60 Exon 3 
sAGTe3R 5’CTCCCATTCACTGGCTCTTC3’    
sAGTe4F 5’GCTCAAGTGATTTGCAAGAATTT3’ 445 60 Exon 4 
sAGTe4R 5’GGTTTGAGGGACACTGGAAG3’    
sAGTe5F 5’CTTCCAGTGTCCCTCAAACC3’ 589 60 Exon 5 
sAGTe5R 5’CTTCCTTTTTCCATCACATGC3’    
sAGTe6F 5’CCCGCCTCCTACTCTTTCTT3’ 521 60 Exon 6 
sAGTe6R 5’TCACCTTTGAGGGAGTGGTT3’    
sAGTe7F 5’GTTGCTTTTGGGCAATTCAC3’ 407 60 Exon 7 
SAGTE7R 5’AAGGCCCCAAATATCAAAGG3’    
sAGTe8F 5’TCCTTTGTGAACTCTGGCCTA3’ 520 60 Exon 8 
sAGTe8R 5’CATCAATCAACTGCACTAAAAGA3’    
sAGTe9F 5’TGTTTTCAATTTGACTTTACCAGTG3’ 321 60 Exon 9 
sAGTe9R 5’CCTATCATTAACAATAACAGGAAGAAA3’    
sAGTe10F 5’GCCATATGAGGTTCTTACAAAGAGA3’ 410 60 Exon 10 
sAGTe10R 5’GAAGCCAGCAAGAAGCATGT3’    
sAGTe13_1F   5’GGTGTAATGAATTTTGTGCTGGT3’ 519 60 Exon 13 
sAGTe13_1R   5’CAACGTAATTCGGTCCAAGG3’    
sAGTe13_2F   5’AGCAGCTCGGTGATGAAAGT3’ 815 60 Exon 13 
sAGTe13_2R   5’TGTCCAATGGCCAGGTTTAT3’    
sAGTe14F 5’TTTACTTGGAGGAAAGTTGTGC3’ 502 60 Exon 14 
sAGTe14R 5’AAACTGCAGCATTCATACAAAATC3’    
sAGTe15_16F 5’GTGAGCGAGCAATAATGGTG3’ 522 60 Exon 15 & 16 
sAGTe15_16R 5’TCCTCTGGATGAACAGACTTCA3’    
sAGTe18F 5’ACAGAATTTTTGTGTGGATGAAT3’ 502 60 Exon 18 
sAGTe18R 5’GAGATTCAATGCTTCTCATTTAAACA3’    
sAGTe19F 5’TGTTTGAGATCTGGATGCATTT3’ 421 60 Exon 19 
sAGTe19R 5’GGCAGCTCCCTCATATTCAA3’    
sAGTe20F 5’ATGAAATCAAGGTAATGTTAAAGAACT3’ 540 60 Exon 20 
sAGTe20R 5’ACACAGGACAGCCACAAAAA3’    
sAGTe21F 5’TTGGAGGGTCCAGATAGCAC3’ 633 60 Exon 21 
sAGTe21R 5’TGCTTTTGAAACTAACATACAGCTT3’    
LMN_newF   5’TGTTAGCACCTCCTCTTTGCT3’ 611 58 Exon 21 
LMN_newR   5’AGCAGACCCTTGGCATGATA3’    
sAGTe22F 5’ACCCTTGGGACAATGATGAA3’ 611 60 Exon 22 
sAGTe22R 5’CAGAATAGCAAAATGGCAACA3’    
sAGTe23F 5’TTTTTATCTTTGCAGACTTTGCCTA3’ 400 60 Exon 23 
sAGTe23R 5’TTCATAAGAACCCAAAGCAACC3’    
sAGTe25_1F 5’AACCCAAATTACTGCTTGCAT3’ 429 60 Exon 25 
sAGTe25_1R 5’CCAAACAGGTCCAAGATGCT3’    
sAGTe25_2F 5’CTTGAACCCTTTGCCATCAC3’ 522 60 Exon 25 
sAGTe25_2R 5’GGTTTCAAGGCAAACTCTGG3’    
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Table S2. The list of ovine positional candidate genes based on the bovine reference gene sequences. 
 
Ovine Chromosome 
Position 
Bovine Gene 
Accession No. 
Bovine Ref. Gene 
Symbol 
Bovine Ref. Gene Name 
OAR2:29285324..29294958 XM_586318 LOC509375 PREDICTED: Bos taurus similar to Ninjurin 1 
OAR2:29285341..29296154 NM_001038082 NINJ1 Bos taurus ninjurin 1  
OAR2:29338280..29380982 XM_590060 SUSD3 PREDICTED: Bos taurus similar to sushi domain containing 3  
OAR2:29382607..29413924 NM_001024527 FGD3 Bos taurus FYVE, RhoGEF and PH domain containing 3 
OAR2:29570653..29607558 XM_599340 IPPK PREDICTED: Bos taurus similar to inositol 1,3,4,5,6-pentakisphosphate 2-kinase  
OAR2:29648909..29688207 NM_001034597 ECM2 Bos taurus extracellular matrix protein 2, female organ and adipocyte specific  
OAR2:29744485..29759383 NM_173947 OMD Bos taurus osteomodulin 
OAR2:29878441..29959955 NM_001101069 IARS Bos taurus isoleucyl-tRNA synthetase  
OAR2:29762217..29777791 NM_173946 OGN Bos taurus osteoglycin  
OAR2:29845850..29871806 XM_001253324 NOL8 PREDICTED: Bos taurus nucleolar protein 8 
OAR2:29995325..30004700 XM_580638 ZNF484 PREDICTED: Bos taurus similar to zinc finger protein 484  
OAR2:30316185..30318955 XM_001788193 LOC616883 PREDICTED: Bos taurus similar to zinc finger protein 782  
OAR2:30350587..30352681 NM_001076436 C8H9orf21 Bos taurus chromosome 9 open reading frame 21 ortholog  
OAR2:30476264..30592054 XM_877619 CDC14B PREDICTED: Bos taurus similar to CDC14 homolog B, transcript variant 6  
OAR2:30610577..30646729 NM_001081523 HABP4 Bos taurus hyaluronan binding protein 4  
OAR2:30685815..30689928 XM_001788164 LOC100140121 PREDICTED: Bos taurus similar to rCG47065  
OAR2:30688798..30713324 XM_613307 ZNF367 PREDICTED: Bos taurus similar to zinc finger protein 367, transcript variant 1  
OAR2:30790734..30845612 NM_001076439 HSD17B3 Bos taurus hydroxysteroid (17-beta) dehydrogenase 3  
OAR2:31108137..31147487 NM_001082606 LOC508357 Bos taurus chromosome 9 open reading frame 102 ortholog  
OAR2:31292157..31295300 NM_001103310 LOC789977 Bos taurus hypothetical LOC789977  
OAR2:31555711..31623497 XM_599250 PTCH1 PREDICTED: Bos taurus patched homolog 1 (Drosophila)  
OAR2:31850742..32286795 NM_174316 FANCC Bos taurus Fanconi anemia, complementation group C  
OAR2:32301777..32654570 XM_610259 AP-O (LOC531757) PREDICTED: Bos taurus similar to Aminopeptidase O (AP-O)  
OAR2:32877326..32920047 NM_001046164 FBP2 Description: Bos taurus fructose-1,6-bisphosphatase 2  
OAR2:33007170..33228793 XM_613544 DAPK1 PREDICTED: Bos taurus similar to death-associated protein kinase 1, transcript variant 1  
OAR2:32942781..32949974 NM_001083686 CTSL2 Bos taurus cathepsin L2  
OAR2:33971137..33971720 XM_593294 GAS1 Bos taurus similar to growth arrest-specific 1  
OAR2:34660860..34718709 XM_590860 ZCCHC6 
PREDICTED: Bos taurus similar to zinc finger, CCHC domain containing 6, transcript 
variant 1  
OAR2:34725688..34738850 NM_001034470 ISCA1 Bos taurus iron-sulfur cluster assembly 1 homolog (S. cerevisiae)  
OAR2:34778116..34782313 XM_001787825 LOC785863 PREDICTED: Bos taurus similar to chromosome 9 open reading frame 153  
OAR2:34874490..34921202 XM_595216 GOLM1 PREDICTED: Bos taurus similar to golgi membrane protein 1  
OAR2:34929288..35016263 XM_868391 MAK10 
PREDICTED: Bos taurus MAK10 homolog, amino-acid N-acetyltransferase subunit, (S. 
cerevisiae)  
OAR2:34929660..35016263 XR_042634 LOC782560 PREDICTED: Bos taurus misc_RNA  
OAR2:35074125..35075486 XR_028207 LOC785119 PREDICTED: Bos taurus misc_RNA  
OAR2:35163069..35333039 XM_001252536 AGTPBP1 PREDICTED: Bos taurus similar to AGTPBP1 protein, transcript variant 1  
OAR2:35990235..36232516 NM_001075225 NTRK2 Bos taurus neurotrophic tyrosine kinase, receptor, type 2  
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Figure S1. Conserved amino acids predicted by “CD-search”.  Alignment of the 
complete predicted sheep protein AGTPBP1 with 8 most dissimilar protein sequences 
from species of human, mouse, chicken, frog, purpuratus, sea squirt, trichoplax and 
zebrafish predicted 2 specific feature hits consisting of 9 conserved amino acid residues.   
His920, Glu923 and His1017 labeled by hash-marks on the top consist as the zinc 
binding motif” HXXE…H”, the conserved feature 1.  The conserved feature 2 
represents metallocarboxypeptidase active sites consisting of all 9 conserved residues 
including zinc binding residues.  These residues include His920, Glu923, Arg970, 
Asn979, Arg980, His1017, Gly1018, Met1027 and Glu1102 which are labeled by hash-
marks on the top. 
  
 
Feature                                                                             #  #           
sheep_A       859 LQKLESahn-PQQIYFRKDVLCETLSGNSCPLVTITAMPESNYYEHIcq----FRNRPYVFLSARVHPGETNASWVMKGT  933 
sheep_N       859 LQKLESahn-PQQIYFRKDVLCETLSGNSCPLVTITAMPESNYYEHIcq----FRNRPYVFLSARVHPGETNASWVMKGT  933 
mice          793 LQKLESahn-PQQIYFRKDVLCETLSGNICPLVTITAMPESNYYEHIcq----FRTRPYIFLSARVHPGETNASWVMKGT  867 
frog          853 LQKLESlhs-PQQIYFRQEVLCETLGGNGCPVITITAMPESNYYEHVyq----FRNRPYIFLTSRVHPGETNASWVMKGT  927 
purpuratus    694 LSKLQAslgeFSDIYYRKQSLCLSLGGNECPVLTITANPTTLDKEGVlq----FRCRRYLFLSARVHPGESNSSYIMKGT  769 
zebrafish     785 LQKLSAlc--TPEIYYRQEDLCETLGGNGCPLLTITAMPESSSDEHIsq----FRSRPVIFLSARVHPGETNSSWVMKGS  858 
human         859 LQKLESahn-PQQIYFRKDVLCETLSGNSCPLVTITAMPESNYYEHIch----FRNRPYVFLSARVHPGETNASWVMKGT  933 
chicken       876 LQKLESmhn-PQQIYFRQDALCETLGGNICPIVTITAMPESNYYEHIcq----FRNRPYIFLSARVHPGETNASWVMKGT  950 
sea squirt    902 LQNLMSnid-TSTMYVRQQTLCNTLSGNSVPVLTITSMPISDNAGSAieavheLRSRPYIFLSARVHPGETNASWTMRGT  980 
trichoplax    218 LEHIRNvad-NNSIYFKCQELCLTLNGNVCNLMTITNSPNKERLNDDky----VPRRPYIFLSARVHPGESNSSWIMKGL  292 
 
Feature                                                            #        ##                     
sheep_A       934 LEYLMSn-------------nPTAQSLRESYIFKIVPMLNPDGVINGNHPCSLSGEDLNRQWQSPNPDLHPTIYHAKGLL 1000 
sheep_N       934 LEYLMSn-------------nPTAQSLRESYIFKIVPMLNPDGVINGNHRCSLSGEDLNRQWQSPNPDLHPTIYHAKGLL 1000 
mice          868 LEYLMSn-------------sPTAQSLRESYIFKIVPMLNPDGVINGNHRCSLSGEGLNRQWQSPNPELHPTIYHAKGLL 934 
frog          928 LEFLMGs-------------sATAQSLRESYIFKIVPMLNPDGVINGNHRCSLSGEDLNRQWQNPNSDLHPTIYHTKGLL 994 
purpuratus    770 LKFLMSt-------------hPTAQALREIFIFKIVPMLNPDGVINGSHRCSLSGEDLNRRWLQPIKELHPTIYHTKGLL 836 
zebrafish     859 LEFLMSc-------------sPQAQSLRQSYIFKIMPMLNPDGVINGNHRCSLSGEDLNRQWQNPNAELHPTIYHAKSLL 925 
human         934 LEYLMSn-------------nPTAQSLRESYIFKIVPMLNPDGVINGNHRCSLSGEDLNRQWQSPSPDLHPTIYHAKGLL 1000 
chicken       951 LEYLMSs-------------nPSAQSLRESYIFKIIPMLNPDGVINGNHRCSLSGEDLNRQWQNPNPDLHPTIYHAKGLL 1017 
sea squirt    981 LKLLLTppasqdqpediriiaSIAEDLRKSYIFKIIPMLNPDGVINGHHRCSLSGEDLNRTWLDPNPQFFPTIYHTKGLL 1060 
trichoplax    293 LDFITSd-------------dDCAIQLRESYIFKIIPMLNPDGVVNGCHRCSLSGHDLNRCWISPDPRIHPTIYHTKGLI 359 
 
Feature                           ##        #                                                      
sheep_A      1001 QYLAAVKRLPLVYCDYHGHSRKKNVFMYGCSiketvwhtndnaapcdvvedvGYRTLPKILSHIAPAFCMSSCSFVVEKS  1080 
sheep_N      1001 QYLAAVKRLPLVYCDYHGHSRKKNVFMYGCSiketvwhtndnaapcdvvedvGYRTLPKILSHIAPAFCMSSCSFVVEKS  1080 
mice          935 QYLAAVKRLPLVYCDYHGHSRKKNVFMYGCSiketvwhthdnsascdivegmGYRTLPKILSHIAPAFCMSSCSFVVEKS  1014 
frog          995 QYLSAIKRVPLVYCDYHGHSRKKNVFMYGCSiketvwhtnanaascdmveesGYKTLPKVLNQIAPAFSMSSCSFVVEKS  1074 
purpuratus    837 QYLKLIERSPLVYCDFHGHSRKKNVFMYGNSaamshspedl-ikfgipsgvsGAKTLPRILSSIAPAFSHSNCSFAVDKG  915 
zebrafish     926 QYLRATGRTPLVFCDYHGHSRKKNVFMYGCSiketmwqssvntstcdlnedlGYRTLPKLLSQMTPAFSLSSCSFVVERS 1005 
human        1001 QYLAAVKRLPLVYCDYHGHSRKKNVFMYGCSiketvwhtndnatscdvvedtGYRTLPKILSHIAPAFCMSSCSFVVEKS  1080 
chicken      1018 QYLAAIKRLPLVYCDYHGHSRKKNVFMYGCAiketmwhtnvntascdlmedpGYRVLPKILSQTAPAFCMGSCSFVVEKS  1097 
sea squirt   1061 QYLQSIQKAPLVYCDYHGHSRKMNVFMYGCShkdsaaaget-sttvggpddtGFKTLPKLLNHFAPSFSLKGCSYVVEKS  1139 
trichoplax    360 QYMVTIGKSPLIFCDFHGHSRRKNIFTYACYpytntn---------hraedqMLRALPRALQEVSPVFSYQLCSFAVEKC  430 
 
Feature                                #                                   
sheep_A      1081 KESTARVVVWREIGVQRSYTMESTLCGCDQGKYKQLQIGTRELEEMGAKFCVGLLR 1136 
sheep_N      1081 KESTARVVVWREIGVQRSYTMESTLCGCDQGKYKQLQIGTRELEEMGAKFCVGLLR 1136 
mice         1015 KESTARVVVWREIGVQRSYTMESTLCGCDQGRYKQLQIGTRELEEMGAQFCVGLLR 1070 
frog         1075 KESTARVVVWKEIGVQRSYTMESTLCGCDQGKYKDLQIGTKELEEMGAKFCVGLLR 1130 
purpuratus    916 KESAARVVVWREIGVARSYTMESTYCGFDQGKYKQLQVTTAMLEEMGQHFCEGLYK 971 
zebrafish    1006 KETTARVVVWREIGVQRSYTMESTLCGCDQGKYKQLQIGTAELEEMGSQFCLALLR 1061 
human        1081 KESTARVVVWREIGVQRSYTMESTLCGCDQGKYKQLQIGTRELEEMGAKFCVGLLR 1136 
chicken      1098 KESTARVVVWREIGVQRSYTMESTLCGCDQGKYKQLQIGTKELEEMGAKFCVGLLR 1153 
sea squirt   1140 KVTTARVVVWKEIGVARSYTMESTYCGCDQGRYRQLQVGTKELEEMGARFVEVLLH 1195 
trichoplax    431 KESTARVVLWRELCILRSYTMESTYCGMDQGVYKQYHINTTALEDMGKDFCRGLLK 486 
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Figure S2. Characteristics of protein AGTPBP1. Letters highlighted in green denotes 
the aspartic acid rich domain; in pink corresponds to the ATP binding domain; in red 
for zinc-binding site; in blue for the carboxypeptidase catalytic site and substrate 
binding sites.  The entire enzymatic domain is indicated by bold lettering. 
  
 
sheep   MSKLKVI PEKSLANNSRI VGLLAQLEKI NTESAESDTARYVTAKI LHLAQSQEKTRREMT 60 
cat t l e  MSKLKVI PEKSLTNNSRI VGLLAQLEKI NTESTESDTARYVTSKI LHLAQSQEKTRREMT 60 
human   MSKLKVI PEKSLTNNSRI VGLLAQLEKI NAEPSESDTARYVTSKI LHLAQSQEKTRREMT 60 
mouse   MSKLKVVGEKSLTNSSRVVGLLAQLEKI NTDSTESDTARYVTSKI LHLAQSQEKTRREMT 60 
        ** ** * * :  *** * : * . ** : * ** ** *** ** * : : . : ** ** ** ** * : * *** *** *** *** ** * *  
 
sheep   AKGSTGMEVLLSTLENTKDLQTTLNI LSI LVELVSAGGGRRASFLVSKGGSQI LLQLLMN 120 
cat t l e  AKGSTGMEVLLSTLENTKDLQTTLNI LSI LVELVSAGGGRRASFLVSKGGSQI LLQLLMN 120 
human   AKGSTGMEI LLSTLENTKDLQTTLNI LSI LVELVSAGGGRRVSFLVTKGGSQI LLQLLMN 120 
mouse   TKGSTGMEVLLSTLENTKDLQTVLNI LSI LI ELVSSGGGRRASFLVAKGGSQI LLQLLMN 120 
        : * ** * *** : ** ** * *** ** ** * . *** ** ** : * *** : * ** ** . ** ** : *** *** *** ** * *  
 
sheep   ASKESPLNEELMVQI HSI LAKI GPKDKKFGVKARI NGALNI TLNLVKQNLQNHRLVLPCL 180 
cat t l e  ASKESPLNEELMVQI HSI LAKI GPKDKKFGVKARI NGALNI TLNLVKQNLQNHRLVLPCL 180 
human   ASKESPPHEDLMVQI HSI LAKI GPKDKKFGVKARI NGALNI TLNLVKQNLQNHRLVLPCL 180 
mouse   ASKDSPPHEEVMVQTHSI LAKI GPKDKKFGVKARVNGALTVTLNLVKQHFQNYRLVLPCL 180 
        ** *: * *  : * : : ** *  ** ** ** ** *** ** ** ** ** : ** ** . : *** *** * : : ** : *** ** * *  
 
sheep   QLLRVYSANSVNSVSLGKNGVVELMFKI I GPFSKKNSSLMKVALDTLAALLKSKTNARRA 240 
cat t l e  QLLRVYSANSVNSVSLGKNGVVELMFKI I GPFSKKNSNLMKVALDTLAALLKSKTNARRA 240 
human   QLLRVYSANSVNSVSLGKNGVVELMFKI I GPFSKKNSSLI KVALDTLAALLKSKTNARRA 240 
mouse   QLLRVYSTNSVNSVSLGKNGVVELMFKI I GPFSKKNSGLMKVALDTLAALLKSKTNARRA 240 
        ** ** * ** : *** ** * *** ** ** ** *** ** ** ** *** ** . * : * *** * ** ** ** ** *** ** **  
 
sheep   VDRGYVQVLLTI YVDWHRHDNRHRNMLI RKGI LQSLKSVTNI KLGRKAFI DANGMKI LYN 300 
cat t l e  VDRGYVQVLLTI YVDWHRHDNRHRNMLI RKGI LQSLKSVTNI KLGRKAFI DANGMKI LYN 300 
human   VDRGYVQVLLTI YVDWHRHDNRHRNMLI RKGI LQSLKSVTNI KLGRKAFI DANGMKI LYN 300 
mouse   VDRGYVQVLLTI YVDWHRHDNRHRNMLI RKGI LQSLKSVTNI KLGRKAFI DANGMKI LYN 300 
        ** ** * *** *** ** * *** ** ** ** *** ** ** ** *** ** ** ** *** *** *** *** *** ** * *  
 
sheep   TSQECLAVRTLDPLVNTSSLI MRKCFPKNRLPLPTI KSSFHFQLPVI PVTGPVAQLYSLP 360 
cat t l e  TSQECLAVRTLDPLVNTSSLI MRKCFPKNRLPLSTI KSSFHFQLPVI PVTGPVAQLYSLP 360 
human   TS- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - QLPVI PVTGPVAQLYSLP 320 
mouse   TSQECLAVRTLDPLVNTSSLI MRKCFPKNRLPLPTI KSSFHFQLPI I PVTGPVAQLYSLP 360 
        **                                         ** * : * ** ** ** *** *** *  
             
sheep   PEVDDVVDESDDNDDI DLEAENETENEDDLDQNFKNDDI ETDI NKLKPQQEPGRTI EELK 420 
cat t l e  PEVDDVVDESDDNDDI DLEAENETENEDDLDQNFKNDDI ETDI NKLKPQQEPGRTI EELK 420 
human   PEVDDVVDESDDNDDI DVEAENETENEDDLDQNFKNDDI ETDI NKLKPQQEPGRTI EDLK 380 
mouse   PEVDDVVDESDDNDDI DLEVENELENEDDLDQSFKNDDI ETDI NKLRPQQVPGRTI EELK 420 
        ** ** * *** *** ** * *** : * . * **  ** ** ** ** . ** ** ** ** *** ** : ***  ** *** *: * *  
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Figure S3. Secondary structure modeling of the AGTPBP1 protein indicates critical 
amino acid residues.  The fold structure of the carboxypeptidase (CP) domain (orange 
box in upper panel) of the AGTPBP1 protein in sheep and mouse were predicted using 
the 3D_PSSM software.  The sequences of CPA2-human (PDB ID: 1DTD) and 
CPA_cattle (PDB ID: 1HDU) which have known tertiary structures were also included 
in the alignment.  Green highlighting indicates β-sheet and blue highlighting indicates 
α-helix.  The conserved amino acids being critical for substrate binding and catalysis 
are in red color (His920, Glu923, Arg970, Asn979, Arg980 and Glu1102).  The location 
of arginine 970 in sheep AGTPBP1 gene is marked with an asterisk on its top.  The 
numbering is based on the sheep AGTPBP1 protein. 
 AGTPBP1 
 
 
 
 
Agtpbp1_mouse      ICPLVTITAMPESNYYEHICQFR-TRPYIFLSARVHPGETNASWVMKGTLEYLMS---NS  
AGTPBP1_sheep      SCPLVTITAMPESNYYEHICQFR-NRPYVFLSARVHPGETNASWVMKGTLEYLMS---NN  
CPA2_human         PMNVLKF------------STGG-DKPAIWLDAGIHAREWVTQATALWTANKIVSDYGKD  
CPA_cattle         PIYVLKF------------STGGSNRPAIWIDLGIHSREWITQATGVWFAKKFTENYGQN  
 
                                                    * 
Agtpbp1_mouse      PTAQSLRESYIFKIVPMLNPDGV-----INGNHRCSLS---------GEGLNRQW----Q  
AGTPBP1_sheep      PTAQSLRESYIFKIVPMLNPDGV-----INGNHRCSLS---------GEDLNRQW----Q  
CPA2_human         PSITSILDALDIFLLPVTNPDGYVFSQTKNRMWRKTRSKVSAGSLCVGVDPNRNWDAGFG  
CPA_cattle         PSFTAILDSMDIFLEIVTNPNGFAFTHSENRLWRKTRSKVTSSSLCVGVDANRNWDAGFG  
                     
 
Agtpbp1_mouse      SP----NP---ELH-------PTIYHAKGLLQYLAAVKRLPLVYCDYHGHSRKKNVFMYG  
AGTPBP1_sheep      SP----NP---DLH-------PTIYHAKGLLQYLAAVKRLPLVYCDYHGHSRKKNVFMYG  
CPA2_human         GPGASSNPCSDSYHGPSANSEVEVKSIVDFIKSHG----KVKAFIILH--S-YSQLLMFP  
CPA_cattle         KAGASSSPCSETYHGKYANSEVEVKSIVDFVKNHG----NFKAFLSIH--S-YSQLLLYP  
                    
 
Agtpbp1_mouse      CSIKETVWHTHDNSASCDIVEGMGYRTLPKILSHIAPAFCMSSCSFVVEKSKESTARVVV  
AGTPBP1_sheep      CSIKETVWHTNDNAASCDVVEDVGYRTLPKILSHIAPAFCMSSCSFVVEKSKESTARVVV  
CPA2_human         YGYKCT--KLDD-FDELSEVAQKAAQSLSRLHGTKY--KVGPICSVIYQASGGSIDWSYD  
CPA_cattle         YGYT-T-QSIPD-KTELNQVAKSAVAALKSLYGTSY--KYGSIITTIYQASGGSIDWSYN  
 
 
Agtpbp1_mouse      WREIGVQRSYTMESTLCGCDQGRYKGLQIGTRELEEMGAQFCVGLLRLKRLTSSLEYNLP  
AGTPBP1_sheep      WREIGVQRSYTMESTLCGCDQGKYKGLQIGTRELEEMGAKFCVGLLRLKRLTSPLEYNLP  
CPA2_human         Y---GIKYSFAFELR----DTGRYG-FLLPARQILPTAEETWLGLKAIMEHVRDHPY---  
CPA_cattle         Q---GIKYSFTFELR----DTGRYG-FLLPASQIIPTAQETWLGVLTIMEHTVNN----- 
 
 
 
                     200                      400                    600                     800                    1000 
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CHAPTER 4. IN A SHAKE OF A LAMB’S TAIL: USING GENOMICS TO 
UNRAVEL A CAUSE OF CHONDRODYSPLASIA IN TEXEL SHEEP 
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SUMMARY  
Chondrodysplasia in Texel sheep is a recessively inherited disorder characterized by 
dwarfism and angular deformities of the forelimbs.  A genome-wide association study using 
the Illumina OvineSNP50 BeadChip on 15 sheep diagnosed as affected and 8 carriers 
descended from 3 affected rams was conducted to uncover the genetic cause.  A homozygous 
region of 25 consecutive SNP loci was identified in all affected sheep, covering a region of 
1Mbp on ovine chromosome 4.  Seven positional candidate genes including solute carrier 
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family 13, member 1 (SLC13A1) were identified and used to search for new single nucleotide 
polymorphisms (SNPs) for fine mapping of the causal locus.  The SLC13A1 gene, encoding a 
sodium/sulfate transporter, was the primary candidate gene due to similar phenotypes 
observed in the Slc13a1_knockout mouse model.  We discovered a 1-bp deletion of T 
(g.25513delT) at 107 bp position of exon 3 in the SLC13A1 gene.  Genotyping by direct 
sequencing and restriction fragment length polymorphism analysis for this mutation showed 
that, all 15 affected sheep were “g.25513delT/g.25513delT”; the 8 carriers were 
“g.25513delT/T” and 54 normal controls were “T/T”.  The mutation g.25513delT shifts the 
open reading frame of SLC13A1 to introduce a stop codon and truncate C-terminal amino 
acids.  It was concluded that the g.25513delT mutation in the SLC13A1 gene was responsible 
for the chondrodysplasia seen in these Texel sheep.  The knowledge can be used to identify 
carriers with the defective g.[25513delT] allele in order to avoid at-risk matings to improve 
animal welfare and decrease economic losses.  
INTRODUCTION 
Nearly 30 years have passed since the seminal research of Soller and colleagues (Soller & 
Beckman 1983; Beckman & Soller 1983) which described the use of genetic markers for 
genetic improvement of crops and livestock.  Considerable advancements have allowed 
animal geneticists to springboard from these original marker papers to the development of 
genetic maps, quantitative trait loci analyses and on to genome sequencing and resultant 
development of high-density panels of single nucleotide polymorphisms (SNPs). These 
recent tools greatly facilitate the exploration of genetic abnormalities in livestock species. 
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Chondrodysplasia is a general term for diseases of development of cartilage that are present 
in human beings and many animal species.  Other terms like achondroplasia, 
achondrogenesis, hypochondrogenesis and chondrodystrophy have been used to describe 
various forms of chondrodysplasia in published clinical and research literature (Thompson et 
al. 2005; Martínez et al. 2000; Superti_Furga et al. 1999; Zankl et al. 2008; Hastbacka et al. 
1999).  Chondrodysplasia is primarily caused by defective genes affecting normal 
chondrogenesis and cartilage development; these display phenotypically as abnormal shape 
and structure of the skeleton.  
Mutations in several genes related to the synthesis of collagen or proteoglycans, or the 
signal-transduction mechanisms have been reported to be involved in inherited 
chondrodysplasia.  Three forms of chondrodysplasia in humans including 
achondrodrogenesis 1B, atelosteogenesis type II and diastrophic dysplasia are due to 
mutations in the solute carrier family 26, member 2 (SLC26A2) gene, which encodes a sulfate 
transporter protein (DTDST).  The impaired sulfate uptake affected the normal development 
of cartilage (Superti_Furga et al. 1999; Hastbacka et al. 1996; Hastbacka et al. 1999).  A 
nonsense mutation of the collagen, type X, alpha 1 (COL10A1) gene has been found to be 
responsible for Schmid type metaphyseal chondrodysplasia (MCDS) in a human patient 
(Woelfle et al. 2011).  A multibreed association study in domestic dogs demonstrated that an 
evolutionarily recently acquired fgf4 retrogene, an extra copy of the fibroblast growth factor 
4 gene (FGF4), was strongly associated with chondrodysplasia (Parker et al. 2009).  The 
most common inherited chondrodysplasia of sheep is the “spider lamb syndrome” (SLS) in 
the Suffolk breed.  The mutation responsible for the disease is a non-synonymous T > A 
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transversion on the highly conserved tyrosine kinase II domain of the fibroblast growth factor 
receptor 3 (FGFR3) gene (Cockett et al. 1999; Beever et al. 2006).  
Chondrodysplasia in Texel sheep has been determined by outcross and backcross 
experiments to be a simple autosomal recessive disorder (Byrne et al. 2008).  It was 
distinguished from SLS and other chondrodysplasias of sheep by gross phenotypic 
observations and microscopic analysis (Thompson et al. 2005; Piripi 2008).  
Chondrodysplasia in Texel sheep is phenotypically characterized by disproportionate 
dwarfism, a stocky appearance with shortened neck and limbs, bilateral varus deformities of 
the forelimbs, flexion of the carpal joints, a barrel-shaped chest and wide-based stance (Fig. 
1A &1B).  Consistent lesions were observed grossly and microscopically in many 
cartilaginous tissues especially in hyaline cartilage.  The marked narrowing of the tracheal 
lumen (Fig. 1C) in the affected lambs could result in sudden death due to tracheal collapse.  
Immunohistochemistry of cartilage in Texel chondrodysplasia demonstrated that both types 
II and VI collagen were distributed abnormally in the matrix, suggesting that the extracellular 
assembly of these collagen types was disturbed.  Moreover, a significantly reduced level of 
chondroitin 4- sulfate was observed using capillary electrophoresis in chondrodysplastic 
sheep compared to age-matched controls (Piripi et al. 2011).  Most cases were able to be 
diagnosed at 14 days of age, but all those showing a characteristic chondrodysplastic 
appearance by approximately 4 months of age were diagnosed as affected.  
Due to the similar sulfation pattern with achondrogenesis 1B and diastrophic dysplasia in 
humans, the ovine SLC26A2 gene was previously considered as a prime candidate gene for 
this disease, but no mutations were identified in 85.4% of exonic DNA sequenced (Byrne, 
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2005).  That initial investigation was followed by targeted linkage disequilibrium (LD) 
mapping to locate the causative mutation for this disorder.  However, it again failed since the 
microsatellite markers were selected only from ovine chromosomes 1, 5, 6, 13, and 22 based 
on the limited known locations of functional candidate genes or their linkage to 
chondrodysplastic diseases in other species (Piripi 2008).  
In order to understand the genetic basis for chondrodysplasia in Texel sheep, we recently 
performed a homozygosity mapping through whole genome analysis using the Illumina 
OvineSNP50 BeadChip to identify the genomic region containing the mutation, and then 
identified the disease-causing mutation by direct examination of the positional candidate 
genes.  
MATERIALS AND METHODS 
Ethics statement 
Approvals dealing with DNA or tissue collection from animals were obtained from the 
Massey University Animal Ethics Committee (APPROVAL NUMBER 05/123). Iowa State 
University Animal Care & Use Committee did not require additional approvals. 
Animals 
Three related affected Texel rams were out-crossed to 221 unrelated phenotypically normal 
mixed-breed ewes.  Then 123 F1 hogget daughters were backcrossed to the same 3 rams and 
these matings produced 46 surviving back-cross lambs.  In another mating trial 22 mixed-
breed ewes, which either had chondrodysplasia or had previously produced chondrodyplastic 
offspring, were mated to the 3 affected Texel rams and produced 26 lambs.  The 3 affected 
rams and the 22 ewes with chondrodysplasia background were purchased from the Southland 
 
 
 
92
property in New Zealand which was the original source for this disease.  A total of 23 lambs 
were genotyped using the OvineSNP50 BeadChip for genome wide homozygosity mapping 
and the following fine mapping experiments. These lambs included 11 affected (5 males and 
6 females) and 7 presumed carriers (4 males and 3 females) chosen from the back-cross 
lambs, and 4 affected females with 1 presumed male carrier chosen from the lambs produced 
in the second mating trial.  The pedigree information for these 23 lambs is provided (Fig. S1).  
Fine mapping also included 54 Romney control sheep from an unrelated population without 
evidence of this inherited chondrodysplasia. 
DNA extraction 
DNA was extracted from samples of spleen collected during necropsy.  Most samples were 
extracted using the Wizard genomic DNA extraction kit (Promega, Madison, WI, USA).  
DNA for an additional 2 samples were extracted with a GenRlute mammalian genomic DNA 
miniprep kit (Sigma_Aldrich Corp., St. Louis, MO, USA), and a high pure PCR template 
preparation kit (Roche Diagnostics, Mannheim, Germany).  The DNA extractions were made 
following standard procedures for each of the kits. 
Genome wide homozygosity mapping 
DNA samples from the 23 Texel crossbred sheep were genotyped using the Ovine SNP50 
BeadChip (Illumina, San Diego, CA, USA) with standard procedures at GeneSeek Inc. 
Lincoln, NE, USA.  The homozygosity mapping was conducted using the same in-house IBD 
(identical by descent) approach implemented using command line UNIX tools as described 
previously (Zhao et al. 2011).  This approach identified common homozygous segments in 
the affected lambs.  Among those segments, it was presumed that one would contain the 
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mutation associated with chondrodysplasia in Texel sheep.  A list of positional candidate 
genes were obtained when the targeted IBD segments were identified using comparative 
maps between ovine and bovine genomes accessed through the Ovine Genome Assembly 
v1.0. 
Copy number variation (CNV) analysis 
The CNV analysis based on the whole genome SNP chip genotyping data was carried out 
with the CNV partition software, a plug-in within the GenomeStudio program (V1.0 
Illumina). The CNV partition software helped to count the copies of probes for each SNP on 
the ovineSNP50 BeadChip within each individual.  Three files including the sample sheet, 
the intensity and the manifest files were required for data evaluations in this program.  
Software parameters were kept at the developers’ default values.  The CNV value and 
confidence for chromosomal regions in each sample were computed.  An estimated copy 
number for each allele was represented by the CNV value.  Viewing the results of CNV 
analyses was accomplished by the heat map produced using the CNV partition software. 
Each column in the heat map represents the copy numbers of SNP loci across the genome for 
one individual animal. 
New genetic variants discovery  
In order to amplify exons and adjacent genomic sequences for the sheep positional candidate 
genes located in the homozygous region, primers (IDT, Coralville, IA, USA) were designed 
using the online Primer3 tool (Rozen & Skaletsky 2000) targeting the sheep genomic 
sequences which were downloaded from the Ovine Genome Assembly v1.0 (Table S1).  
PCR was performed using a 10 µl system, which included 1x GoTaq reaction buffer 
 
 
 
94
containing 1.5 mM Mg2+ (Promega, Madison, WI, USA), 0.125 mM of each dNTPs, 2.5 pM 
of each primer, 12.5 ng of genomic DNA, and 0.25 units of GoTaq DNA polymerase 
(Promega, Madison, WI, USA).  The PCR program was 35 cycles of 30 s at 94°, 30 s at the 
corresponding annealing temperature, and 30 s at 72°C with additional 3 min denaturation in 
the first cycle and 5 min extension in the last cycle.  In all reactions, negative controls were 
performed to check for the presence of contaminants.  PCR products were verified by 1.5% 
agarose gel electrophoresis, and treated with ExoSAP-IT®.  The PCR pools from 2 affected 
sheep, 2 carriers and 2 normal controls, were used for commercial re-sequencing using the 
3730xl DNA Analyzer.  The sequences were aligned and compared to discover new genetic 
variants using Sequencher software version 3.0.  
Mutation analyses 
The cattle reference SLC13A1 mRNA (GenBank: NM_001193219) was used as a query in 
cross-species BLAST searches to identify sheep ESTs.  The sheep re-sequencing results 
using templates from the affected, carrier and normal control sheep along with identified 
sheep ESTs were used to predict a complete ovine SLC13A1 mRNA sequence. The ovine 
mRNA sequence was then translated into a protein sequence by applying the ExPASy 
translate tool.  The predicted sheep SLC13A1 protein sequence was compared to proteins in 
other species including cattle (Bos Taurus, GenBank: DAA30458), human (Homo sapiens, 
GenBank: NP_071889), mouse (Mus musculus, GenBank: AAH22672), rat (Rattus 
norvegicus, GenBank: NP_113839), dog (Canis lupus familiaris, GenBank: XP_539548) and 
Zebrafish (Danio rerio, GenBank: NP_954975) using the CLUSTALW alignment tool to 
check the completeness of the sheep protein sequence and the conserved regions.  The 
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topology prediction of transmembrane domains (TMDs) was undertaken using the online tool 
TopPred 0.01.  The upper and lower cutoff values were set as 1 and 0.6.  Each genetic variant 
was analyzed to check whether it was a missense, or nonsense mutation or whether it could 
shift the open reading frame of the candidate gene. Every suspected genetic variant was 
genotyped on all the sheep samples to check whether it was concordant with the recessive 
inheritance pattern of the disease.  
Mutation “g.25513delT” genotyping 
Direct sequencing and PCR restriction enzyme digestion (PCR-RFLP) were carried out to 
genotype the suspected causative mutation “g.25513delT” on all Texel crossbred sheep with 
clear status of chondrodysplasia as well as 54 Romney control sheep.  The restriction enzyme 
digestion procedures were as follows: DNA fragments from PCR reactions were subjected to 
restriction enzyme digestion with HpyAV (New England Biolabs Inc., USA).  The 10 µl 
system reaction mix contained 1 µl of NEB buffer 4, 3 units of HpyAV (1.5 µl), 0.1 µl of 
BSA (100X) and 3 µl of PCR products.  Then the reaction mix was incubated at 37º C 
overnight, and the products were analyzed on a 2.5% (w/v) ultra-pure agarose gel. 
RESULTS 
Identity by descent region  
The IBD analysis narrowed the defective region down to a single 1 Mb homozygous segment 
consisting of 25 consecutive SNP loci on sheep chromosome 4 (OAR 4) in all 15 affected 
sheep, by using a larger than 10-SNP threshold in our IBD approach (Fig. S2).  This region 
was heterozygous for 7 presumed carriers but not for lamb 14-04.  Lamb 14-04 was 
phenotypically normal but produced affected offspring.  It was considered as a carrier, but 
 
 
 
96
was homozygous in the 1 Mb segment with the same haplotype as affected sheep.  The 25-
SNP homozygous segment was defined by SNP OAR4_92447165.1 to SNP 
OAR4_93438733.1, spanned a chromosomal region between 92.45 Mb and 93.44 Mb (Fig. 
2A & 2B).  It encompassed 7 genes based on the cow reference sequences including Ca2+ 
dependent activator protein for secretion 2 (CADPS2) (OAR4:92155977..92738612), solute 
carrier family 13 member 1 (SLC13A1) (OAR4:92888272..92993056), IQ motif and 
ubiquitin domain containing (IQUB) (OAR4:93209447..93265179), ring finger protein 148 
(RNF148) (OAR4:92554935..92556138), ankyrin repeat and SOCS box-containing 15 
(ASB15) (OAR4:93343952..93353409), leiomodin 2 (cardiac) 
(LMOD2)(OAR4:93370342..93377214) and Wiskott-Aldrich syndrome-like 
(WASL)(OAR4:93431017..93481693) (Fig. 2C).  The SLC13A1 gene, spanning over 79 kb in 
length, was the most plausible candidate due to its biological functions and previous reports 
of its involvement with chondrodysplasia in other species.  Most of the subsequent effort 
then focused on this gene in further mutation analyses.  
CNV analysis 
The heat map from CNV analyses showed copy numbers of SNP loci for each individual 
sheep.  No CNVs were discovered that were associated with chondrodysplasia in Texel sheep.  
There were only two loci with CNV values from 0 to 0.5 on OAR1 and OAR3, respectively 
(the dark red horizontal bars in Fig. S3).  However, the 2 CNVs with rare copy numbers 
showed up mostly among the first 12 animals on the heat map, and did not occur specifically 
in either the affected group or the carrier group (Fig. S3). Therefore, the CNV analysis was 
not pursued further. 
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Mutation analysis 
Two corresponding ovine EST entries (GenBank: FE030665.1, FE030666.1) were found 
using the cattle reference SLC13A1 mRNA as a query.  The putative ovine genomic structure 
was determined by alignments of the 2 ovine ESTs, the complete bovine SLC13A1 mRNA 
and the human SLC13A1 mRNA.  Even though the human SLC13A1 gene contains 15 exons 
and spanned 83 kb in length (Lee et al. 2000), the evidence from the alignments with the 
bovine homolog showed the presence of exon 16 in both bovine and ovine SLC13A1 mRNA, 
in which exon 16 only contained a long 3’ un-translated region.  The “GT-AG” splice site 
groups in the ovine SLC13A1 gene support this genomic structure.  The translated protein 
length ranged from 583 to 597 amino acids in the 7 species.  In sheep and cattle, it is 597 
amino acids long, 2 amino acids longer than in humans.  There are many conserved regions 
in this protein shared by the 7 species (Fig. S4). The topology prediction showed the 
predicted SLC13A1 protein was comprised of 13 transmembrane domains (TMDs) in sheep.  
Each peak above the upper cut-off value represents a TMD (Fig. 3).  
Re-sequencing all available exons and the adjacent introns of the SLC13A1 gene identified a 
mutation potentially responsible for this disease, with one base pair deletion T 
(JN108880:g.25513delT) at the 107 bp position of exon 3 (148 bp on the “sRFLPdelT” 
fragment, Table S1) by comparing affected, carriers and normal controls.  This 1-bp deletion 
was 3,751 bp far away from the nearest published SNP OAR4_92963794.1 on one side and 
27,654 bp from SNP s11336.1 on another side.  An additional 11 novel SNPs in this 
candidate gene and 5 genetic variants in the other 6 candidate genes were identified to be 
either intronic or synonymous, and were excluded as mutations for this defect (Table S1).  
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The g.25513delT deletion on SLC13A1 gene changed the open reading frame and induced a 
nonsense transition (p.Val113Stop) at amino acid 113on the predicted ovine SLC13A1 
protein sequence (Fig 2D).  
Genotyping of mutation g.25513delT 
Genotyping all the sheep including unrelated controls by direct sequencing showed that all 
the affected Texel sheep were homozygous with the deletion of “T” 
(g.25513delT/g.25513delT) on the exon 3 of SLC13A1 gene, the 8 carriers including lamb 
14-04 were heterozygous with a single “T” allele (g.25513delT/T) and the pooled normal 
controls were all homozygous with “T” allele (T/T) (Fig. 4).  The g.25513delT mutation 
created a HpyAV restriction endonuclease recognizing site for specific cuttings on the PCR 
fragment “sRFLPdelT”, which was used to distinguish the affected, carriers and normal 
controls.  In the PCR-RFLP experiment, PCR fragment “sRFLPdelT” with a 
“g.25513delT/g.25513delT” genotype was cut into 2 fragments with the lengths of 192bp and 
156bp; the one with a “g.25513delT/T” genotype was cut into 4 fragments with lengths of 
349bp, 348bp, 192bp, and 156bp; and the one with a “T/T” genotype could not be cut and 
kept the original fragment size with a length of 349bp.  The PCR-RFLP genotyping results 
were consistent with the results deduced from direct sequencing.  This g.25513delT mutation 
was the only polymorphism 100% concordant with the recessive pattern of inheritance in 
affected, carriers and unrelated normal individuals (Table 1).  
Taken together, our results strongly support the conclusion that the deletion “T” on exon 3 of 
SLC13A1 gene is the causative mutation for inherited chondrodysplasia in Texel sheep.  
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DISCUSSION 
The use of genetic markers to either develop a genetic map or for QTL analysis has come a 
long way since early reports suggesting their use (Soller & Beckmann, 1983).  However, 
with the advent of the ovine genome sequence and a high density SNP chip, the tools for 
analyses of quantitative inherited traits and genetic disorders have improved markedly.  
These tools, combined with comparative genomic approaches to determine useful candidate 
genes (Rothschild & Soller, 1997), make it possible to find genetic causes of both 
quantitative traits and monogenic simple recessive disorders in a relatively short time. 
Previous reports showed that the mutations in the SLC26A2 gene were responsible for human 
achondrogenesis.  The structural, microscopic, and biochemical analyses on 
chondrodysplasia in Texel sheep suggested a similar pathogenic mechanism involved in this 
defect.  The genes called solute carriers, encoding membrane transport proteins, especially 
the sulfate transporters, are prime candidate genes.  However, there are almost 300 members 
for solute carrier genes distributed throughout the human genome and these are organized 
into 51 gene families (Hediger et al. 2004).  Both the low density microsatellite - based 
linkage mapping and the direct candidate gene method were not suitable to handle these data 
directly and were incapable of localizing the mutations underlying this Mendelian disease. 
The recent development of the ovine SNP chip containing more than 50,000 SNP markers 
well-distributed across the sheep genome has become the best and most efficient tool for the 
genome-wide dissection of likely mutant loci (Becker et al. 2010).  The rationale for this is as 
follows.  Provided a disease is recessive, accurately diagnosed when present, and the 
defective allele is non-existent in that part of the population not descended from the founder, 
then regardless of the level of penetrance the affected animals must all be identical by 
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descent at the causative mutation and most likely in the surrounding area.  The expected size 
of the IBD region that contains the causative mutation will depend in part upon the number 
of meioses that separate the common ancestor from the affected individual, and the number 
of affected individuals.  In our mapping strategy, a homozygous fragment spanning larger 
than 10 SNPs was chosen as a threshold for valid candidate regions that needed to be 
examined (Zhao et al. 2011).  A 10-SNP interval on the sex-average map (Sheep Best 
Positions Linkage Map Version 4.7, http://rubens.its.unimelb.edu.au/~jillm/jill.htm) is about 
0.64 cM.  The probability that a 0.64 cM region would be inherited intact is 1-0.0064=0.9936, 
and that this would occur in all three meioses that separate a founder and a back-crossed 
affected individual is 0.9936^3=0.9810.  The 10-SNP region will only be IBD if it was 
inherited intact in all 11 backcross offspring, that outcome having a probability of 0.9810^11 
=0.81.  This value is large enough to give us confidence that the causative mutation would be 
contained in regions of larger than 10 consecutive SNP and that we should examine those 
regions first as they had the highest likelihood of carrying the mutation. 
In this study, only one such IBD fragment was detected, which comprised 25 SNP loci and 
the causative mutation was right located on this fragment.  The results from our current and 
previous studies (Zhao et al. 2011) show our genome wide homozygosity mapping strategy 
has enough power to detect causative loci for rare recessive genetic diseases where 
consanguineous matings are available.  The candidate gene approach (Rothschild & Soller, 
1997) can act like a bridge between the targeted genomic regions and the causative mutations.  
This helps to verify and find the mutation.  Candidate gene analysis can be accomplished by 
direct sequencing or PCR-RFLP tests.  The RFLP method was first described by Dr. Soller 
and colleagues in 1983 (Soller & Beckmann, 1983; Beckmann & Soller, 1983).  It has been 
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successfully applied for about 30 years for a variety of polymorphism analyses including the 
SNP analysis associated with many interesting traits (Rothschild et al. 1997; Zhao et al. 2009; 
Zhao et al. 2010, etc.).  The candidate gene approach using RFLP tests is usually more 
convenient and historically more economic than using direct sequencing.  Our work provides 
a successful example for combining GWAS and the standard candidate gene analysis. 
In this study, the presumed carrier lamb 14-04 was not heterozygous for the consecutive 25 
SNPs in this targeted IBD region as were the other carriers, but was homozygous with the 
same haplotype as the affected sheep.  This was probably due to this lamb carrying the 
ancestral genomic region within which the g.25513delT mutation arose in some other 
ancestor.  The genotyping results of g.25513delTfor lamb 14-04 demonstrated it was in fact 
heterozygous which was consistent with the presumed disease status. 
The SLC13A1 gene was considered as the most plausible functional candidate gene within 
the 1Mb-interval on OAR 4.  This gene belongs to the solute-linked carrier gene family 13 
(SLC13) and encodes a protein called renal Na+ - dependent inorganic sulfate transporter-1 
(Sodium/sulfate cotransporter, NaS1).  DNA sequencing revealed the 1-bp deletion of “T” 
was perfectly associated with the chondrodysplasia phenotype in Texel sheep.  We also 
demonstrated that this deletion was not observed in any of the 54 normal Romney sheep 
controls.  We confirmed the presence of this deletion as a mutation on the genomic DNA and 
believe that the ovine NaS1 protein in the affected sheep may undergo a nonsense mRNA 
mediated decay, a process which detects nonsense mutations and prevents the expression of 
truncated or erroneous proteins.  The RT-PCR analysis on SLC13A1 mRNA could provide 
further evidence to support our conclusions.  Unfortunately, most of the originally affected 
 
 
 
102
animals either died due to tracheal collapse or were euthanized at approximately 5 months of 
age.  New lambs from designed matings between carrier animals would need to be produced 
for any future experiments. 
Our study is the first report showing that the mutation in the SLC13A1 gene is responsible for 
inherited chondrodysplasia in a large mammal species.  A previous research described that a 
homologous Slc13a1 knockout mouse model produced similar clinical phenotypes as our 
affected Texel sheep, including reduced serum sulfate concentration and a general growth 
retardation throughout adulthood (Dawson et al. 2003).  The knockout mouse model further 
supports our findings. 
The NaS1 co-transporter locates on the brush border membranes of epithelial cells lining the 
renal proximal tubule and the gastrointestinal tract.  It helps to absorb inorganic sulfate in the 
small intestine and to reabsorb in the kidney proximal tubule to maintain the concentration of 
serum sulfate (Markovich, 2001).  Sulfate is the fourth most abundant anion in human plasma, 
and plays an essential role during growth, development, cellular metabolism, and 
bone/cartilage formation. For example, the sulfated proteoglycans as the largest group of 
sulfoconjugate in mammals, are required for the maintenance of normal structure of bone and 
cartilage (Fernandes, et al. 1997).  The SLC13 family was believed to be distinct functionally 
and structurally from the SLC26 gene family which constitutes Na+ - independent inorganic 
sulfate transporter (Markovich, 2008).  A recent study has indicated that the SLC26A2 
protein expression was limited to the microvillus membrane of kidney proximal tubule 
(Chapman & Karniski, 2010).  We believe NaS1 and SLC26A2 proteins would share similar 
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functions during the sulfate transportation due to their similar localizations.  The exact roles 
of sulfate transportation for each of the two proteins are still uncertain. 
Copy number variation analysis is receiving more attention since the development of high 
density SNP chips as well as the dramatic improvements in new sequencing technologies.  
Several CNVs have been found associated with human diseases such as obesity (Chen et al. 
2011), autoimmune disease (Mamtani et al. 2010) and autism (Sebat et al. 2007). Moreover, 
an extra copy of the FGF4 gene, as a form of evolutionarily acquired fgf4 retrogene, was 
identified strongly associated with chondrodysplasia in dogs (Parker et al. 2009). With the 
intention of determining whether CNVs were associated with this inherited chondrodysplasia 
in Texel sheep, we performed a CNV analysis based on the SNP chip genotyping data. 
However, there were no CNVs apparently associated only with this defect. The CNV 
variations detected on OAR1 and OAR3 using the partition software probably came from the 
SNP chips themselves rather than being due to the disease status themselves. 
In summary, our study indicates the 1-bp coding deletion of “T” in the ovine SLC13A1 gene 
is responsible for this form of inherited chondrodysplasia in Texel sheep.  Our results suggest 
NaS1 is essential for maintaining sulfate homeostasis in sheep.  The comparison of the gene 
expression of SLC13A1 or directly detecting the levels of the NaS1 protein using in situ 
hybridization in the kidney tissues among chondrodysplasia affected, carriers and normal 
Texel sheep should be done in the future.  Using the ovine high density SNP array with a 
candidate gene approach was confirmed again by this study as an efficient way for 
localization of a mutation locus causing a simple recessive inherited defect in sheep.  Similar 
methodologies have been carried out to identify mutations in other recessive inherited defects 
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in sheep, such as microphthalmia and inherited rickets (Becker et al. 2010; Zhao et al. 2011).  
The SLC13A1 gene can be rapidly applied as a selection marker to identify carriers with the 
defective g.[25513delT] allele in order to cull carriers, or avoid at-risk matings to improve 
animal welfare and decrease economic losses.  Due to the moderate size and the relatively 
low cost of maintenance of carriers, sheep with chondrodysplasia could be used as a potential 
animal model for future human chondrodysplasia clinical drug development if any similar 
human cases are diagnosed in the future. 
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Table 1. The genotyping results of the causative mutation (g.25513delT) 
Sheep 
breed 
Phenotype  Genotype 
Rate of 
concordance Status 
No. of 
sheep 
 Direct 
sequencing 
PCR-RFLP 
No. of 
Sheep 
Texela 
Affected 15  
g.25513delT/ 
g.25513delT 
g.25513delT/ 
g.25513delT 
15 100% 
Presumed 
Carrier 
8  g.25513delT/T g.25513delT/T 8 100% 
Romney Normal 54  T/T T/T 54 100% 
aThese sheep include pure Texel sheep and Texel crossbred sheep. 
  
 
 
 
109
 
Figure 1. Chondrodysplasia of Texel sheep (A) A pair of full sibling lambs at 56 days. 
The left lamb (lamb ID: 23-04) was phenotypically normal and its twin brother (lamb 
ID: 24-04) was characterized with stunted growth. (B) A thirty-two day-old 
chondrodysplasia lamb with characteristic short neck and wide-based stance. (C) 
Sections through the trachea of a chondrodysplastic lamb (bottom) and a normal lamb 
(top) illustrating the thickened, flattened cartilage ring in the affected lamb. 
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Figure 2. Work flow chart for discovering the mutation locus of chondrodysplasia in 
Texel sheep. (A) The sheep chromosome 4 (OAR 4). (B) The IBD region containing the 
causative locus is located on OAR 4 between 92.45 and 93.44 Mb. (C) Seven cow 
reference genes including SLC13A1 encompassing the sheep IBD region based on the 
comparative genomic maps. (D) The comparisons of the partial SLC13A1 mRNA 
sequences and the partial protein sequences between the normal (wide type) and 
chondrodysplasic sheep. The 3 underlined nucleotides in the mRNA sequence 
highlighted with yellow color represent the codon affected by the g.25513delT mutation. 
The corresponding amino acids were also underlined in the protein sequences. The next 
following codon in the protein sequence of affected sheep, highlighted in red color, 
introduced a stop codon represented by “X”.  WT: wild type; A: affected sheep 
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Figure 3. The topology prediction of transmembrane domains (TMDs) of ovine 
SLC13A1 protein. The peaks above the cut-off value of 1 represent the TMDs. There 
are 13 putative TMDs in this protein. 
  
 
 
 
112
 
 
Figure 4. The direct sequencing results of the causative mutation g.25513delT. All the 
affected sheep with two copies of deletion T; the presumed carriers show one copy of 
deletion T; the pooled normal controls show no copy of deletion T. 
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Figure S1. The pedigree information for the 23 sheep genotyped by Ovine SNP chip. 
The result was attained from microsatellite results (data not shown). The boxes below 
animal identifiers indicate the status of chondrodysplasia. The 3 terminal rams are at 
the top-left.  They sired dams 3-17 in the out-cross trials, and F1 daughters in the back-
cross and other 4 ewes with chondrodysplasia background.  Arrows indicate parentage 
results deduced by observation of maternal behavior soon after birth of lambs and 
microsatellite makers.  M: male; F: female. 
  
 
 
 
114
 
Figure S2. The distribution of homozygous fragments commonly in affected lambs.  
Based on the different number of SNPs spanning the homozygous fragment, the counts 
of homozygous fragments commonly in all affected lambs were shown.  Only one 
homozygous fragment spanning 25 SNPs was identified commonly in all 15 affected 
lambs (pointed by the blue color arrow), when the “larger than 10-SNP” threshold was 
applied. 
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Figure S3. The CNV region display. Each column represents one individual sheep with 
the copy numbers of SNP loci across the whole genome. Different colour shows different 
ranges of copy numbers. The chondrodysplasia status for each sheep was listed on the 
top of the display map.  A: affected; C: presumed carriers. 
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Figure S4. The comparison of the SLC13A1 protein sequences among 7 species. The 
comparison was conducted using the multiple sequence alignment tool (CLUSTALW). 
CLUSTALW ( 1. 81)  mul t i pl e sequence al i gnment  
Mouse           MKLLNYALVYRRFLLVVFTI LVFLPLPLI I RTKEAQCAYI LFVI AI FWI TEALPLSI TAL 
Rat              MKLLNYAFVYRRFLLVVFTVLVLLPLPLI I RSKEAECAYI LFVI ATFWI TEALPLSI TAL 
Sheep           MKFFSYVLVYRRLLLVVFTLLI LLPLPLI LRSKEAECAYTLFVVAI FWLTEALPLSI TAL 
Cat t l e          MKFFSYI LVYRRLLLI VFTLLI LLPLPLI LRSKEAECAYTLFVI AI FWLTEALPLSI TAL 
Human           MKFFSYI LVYRRFLFVVFTVLVLLPLPI VLHTKEAECAYTLFVVATFWLTEALPLSVTAL 
Dog             MKVFSYI LVYRRFLLI VLPPLVLLPLPI I VRTKEAECAYTWAVVAALWLTEALPLPVTAL 
Zebr af i sh       MRRLRCSWSALKPLI I I STPLAI LPLPLVI KTKEAECAYVLI LMAVYWMTEVLPLSVTAL 
                * :  :        :  * : : :  .  *  : ** * * : : : : : * ** : * **    : : *   * : * * . * ** . : ** *  
 
Mouse           LPGLMFPMFGI MRSSQVAS- AYFKDFHLLLI GVI CLATSI EKWNLHKRI ALRMVMMVGVN 
Rat              LPGLMFPMFGI MSSTHVAS- AYFKDFHLLLI GVI CLATSI EKWNLHKRI ALRMVMMVGVN 
Sheep           LPGLMFPMFGI MPSKEVAS- AYFKDFHLLLI GVI CLATSI EKWNLHKRI ALRMVMMVGVN 
Cat t l e          LPGLMFPMFGI MTSKEVAS- AYFKDFHLLLI GVI CLATSI EKWNLHKRI ALRMVMMVGVN 
Human           LPSLMLPMFGI MPSKKVAS- AYFKDFHLLLI GVI CLATSI EKWNLHKRI ALKMVMMVGVN 
Dog             LPGLLFPLFGI TASKEVVASAYFKDFHLLLI GVI CLATSI EKWNLHTRI ALRMVMTVGVN 
Zebr af i sh       I PALLFPLFGI MKSSQVAS- QYFKDFHLLLLGVI CLATSI EKWGLHRRI ALRLVTGLGVN 
                : * . * : : * : * * *   * . . * . :   * * ** ***** : * * ********** . * *  ** * *: : *   : ** *  
 
Mouse           PAWLTLGFMSSTAFLSMWLSNTSTAAMVMPI VEAVAQQI I SAEAEAEATQMTYFNESAAH 
Rat              PAWLTLGFMSSTAFLSMWLSNTSTAAMVMPI VEAVAQQI TSAEAEAEATQMTYFNESAAQ 
Sheep           PAWLSLGFMSSTAFLSMWLSNTSTAAMVMPI VEAVAQQVI SAEAEVEATQMTYFSGSTNQ 
Cat t l e          PAWLSLGFMSSTAFLSMWLSNTSTAAMVMPI VEAVAQQVI SAEAEVEATQMTYFSGSTNQ 
Human           PAWLTLGFMSSTAFLSMWLSNTSTAAMVMPI AEAVVQQI I NAEAEVEATQMTYFNGSTNH 
Dog             PTWLTLGLMSSTAFLSMWLSNTSTAAMVMPI VEAVAQQI I SAQAEVEATQMTSLGGSTNH 
Zebr af i sh       PGMLMLGFMVGCAFLSMWLSNTSTVAMVMPI VEAVI QQVLSASEEANKDHKGALNGI SNP 
                *   *  * * : *  .  * ** * ********. * * ****. * **  * * :  . * .  * . :   :    : .   :    
 
Mouse           GLDI DETVI GQETNEKKEKTKPAPGSSHDKGKVSRKMETEKNAVTG- - AKYRSRKDHMMC 
Rat              GLEVDETI I GQETNERKEKTKPALGSSNDKGKVSSKMETEKNTVTG- - AKYRSKKDHMMC 
Sheep           ALEI DESI NGQEANERKEKTKPVPGYSNDAGKI SSKMELEKNSGTNSGNKYRTKKDHMMC 
Cat t l e          ALEI DESI NGQEANERKEKTKPVPGYSNDAGKI SSKMELEKNSGTNSGNKYRTKKDHMMC 
Human           GLEI DESVNGHEI NERKEKTKPVPGYNNDTGKI SSKVELEKNSGMR- - TKYRTKKGHVTR 
Dog             GLEI DESVNGQETNERNEKTI PAPGYGNDAGKI SSKTEPEKNSDTG- - TKYRTKKDHMMC 
Zebr af i sh       ALQLEDI EAQHDQSE- - - KI KSI EAGI TEPEPTSEEHETAKAPTPPYSGKYRTREDHMMC 
                . * : : : :     : :  . *    *   .   .    :     *  :  *   *  .       * * * : : : . * :    
 
Mouse           KLMCLSVAYSSTI GGLTTI TGTSTNLI FSEHFNTRYPDCRCLNFGSWFLFSFPVALI LLL 
Rat              KLMCLCI AYSSTI GGLTTI TGTSTNLI FSEHFNTRYPDCRCLNFGSWFLFSFPVAVI LLL 
Sheep           KLMCLCI AYSSTI GGLTTI TGTSTNLI FAEHFNMRYPDCRCI NFGSWFI MSFPAAI I I LL 
Cat t l e          KLMCLCI AYSSTI GGLTTI TGTSTNLI FAEHFNMRYPDCQCI NFGSWFI MSFPAAI VI LL 
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Table S1. A list of candidate gene symbol, primer sequence, annealing temperature, PCR amplicon information, genetic 
variants identified by sequencing and accessed template sequence. 
Gene 
symbol 
Primer name Primer sequence 
Annealing 
Temp. (ºC) 
Size 
(bp) 
Fragment 
name 
Genetic variant 
(position in the 
fragment) 
Variant name 
SNP 
characteristic 
Sequence access 
No. 
(GenBank/Ovine 
1.0) 
SLC13A1 sSLCre1F 5’AGCCACCTGTGCAAGACAAT3’ 60 472 sSLCe1 no - - JN108880 
 sSLCre1R 5’CGCATTGCTGCCTAGTCTC3’        
 sSLCre2F 5’AATAACCATTTGCGGCCCTA3’ 60 301 sSLCe2 no - - OAR4:92886000-
92995055 
 sSLCre2R 5’AAGTCAAACATTCGCAGGAAA3’        
 sSLCdelrF 5’TGGATAAGGGATGTGGAACTG3’ 56 411 sSLCdel C > T (170bp) g.25395C>T intronic JN108880 
 sSLCdelrR 5’TGCCTGGATGTGCATTACTT3’    Deletion T (288bp) g.25513delTb exonic  
 sRFLPdelTFa 5’TGAATTACACTGCCATACAAATG
A3’ 
58 349 sRFLPdelT Deletion T (148bp) g.25513delTb exonic JN108880 
 sRFLPdelTRa 5’GGTCAAAGTTAGGAGCAGCAA3’        
 sSLCre5_6F  5’TCCACCTTCACACACACACA3’ 64 510 sSLCe5_6 A > G (181bp) g.78757A>G intronic OAR4:92886000-
92995055 
 sSLCre5_6R 5’TGCAAACTGCCATCACTATG3’    A > G (261bp) g.78677A>G intronic  
 sSLCre8F 5’CTGTTCCCAGGTCTGCTTGT3’ 64 585 sSLCe8 C > T (381bp) g.59017C>T intronic JN108880 
 sSLCre8R 5’AGAACACGGAACCCAGACAC3        
 sSLCre9F 5’CTCGCCACCATATCCCTCTA3’ 58 711 sSLCre9 C > T (61bp) g.63875C>T  JN108880 
 sSLCre9R 5’AACCAGAAACAAAGCCAGGA3’    A > G (212bp) g.64026A>G exonic, 
synonymous 
 
 sSLCre10F 5’CCAGGTAGAAGGATAAGAAGCTG
A3’ 
58 609 sSLCre10 no - - JN108880 
 sSLCre10R 5’GCTCCAAGGTCTCTACTCCTGA3’        
 sSLCre11F 5’AAGGGAACTTTTGGCCTAGC3’ 60 545 sSLCre11 G > T (169bp) g.39802G>T intronic OAR4:92886000-
92995055 
 sSLCre11R 5’AGAGGAAGGGTGCAGTCTGA3’    A > C (239bp) g.39732A>C intronic  
      C > T (444bp) g.39527C>T intronic  
 sSLCre12F 5’AAAATGCAAAGAAGTTTTCCAA3’ 60 535 sSLCre12 no - - OAR4:92886000-
92995055 
 sSLCre12R 5’GCTGGGACATCATAAAAATGG3’        
 sSLCre13F 5’AAAAACCACAGGAAAATATGAAA
GA3’ 
60 505 sSLCre13 no - - OAR4:92886000-
92995055 
 sSLCre13R 5’CTGCTGCTTGAACATGGAAT3’        
 sSLCre14F 5’CAATCACCATATAAACAACCGAA
A3’ 
60 507 sSLCre14 A > T (54bp) g.30951A>T intronic OAR4:92886000-
92995055 
 sSLCre14R 5’GCACGTTTGCTCCAGGTTAT3’        
 sSLCre15F 5’GAAACTTCTCTGATGCTCTCCAA3’ 58 529 sSLCre15 A > G (27bp) g.29232A>G intronic OAR4:92886000-
92995055 
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Table S1. (continued) 
Gene 
symbol 
Primer 
name 
Primer sequence 
Annealing 
Temp. (ºC) 
Size 
(bp) 
Fragment 
name 
Genetic variant 
(position in the 
fragment) 
Variant 
name 
SNP 
characteristic 
Sequence access 
No. 
(GenBank/Ovine 
1.0) 
SLC13A1 sSLCre15R 5’GGCACATAGATGCTCTTGGTT3’        
 sSLCre16F 5’TGTTGAGTAGCCAGTTGTGGTT3’ 58 567 sSLCre16 no - - OAR4:92886000-
92995055 
 sSLCre16R 5’TTGCAATTGACTTTCCTTGC3’        
CADPS2 sCADPS2-
1F   
5’TGGTGGGCAATTCACTTCTT3’ 58 339 sCADPS-1 no - - OAR4:92155745-
92255745 
 sCADPS2-
1F   
5’CGGGTCAACTTAGCAGGTTT3’        
 sCADPS2-
2F        
5’TTGCAGACACACCCTCAAAA3’ 58 405 sCADPS-2 no - - OAR4:92155745-
92255745 
 sCADPS2-
2R        
5’GGACAGAGAAGCCTGGAGTG3’        
 sCADPS2-
3F 
5’GAACCTTCCTGTTGATGCAAG3’ 60 515 sCADPS2-3 no - - OAR4:92155745-
92255745 
 sCADPS2-
3R 
5’CCATGTTTCCAGATAAATTCTGTTC3’        
 sCADPS2-
4F   
5’AAATCATGGGCATTCAGACC3’ 58 353 sCADPS2-4 no - - OAR4:92155745-
92255745 
 sCADPS2-
4R   
5’CATGAAAGGCAGCATGAGAA3’        
IQUB sIQUB-1F   5’AGTTCCAGGGAGACCATTCC3’ 58 302 sIQUB-1 no - - OAR4:93209752-
93265179 
 sIQUB-1R   5’TGATTAAACCACCAGCACCA3’        
 sIQUB-2F   5’GAATACAGGGCAGGGAAAGG3’ 58 320 sIQUB-2 no - - OAR4:93209752-
93265179 
 sIQUB-2R   5’GCAATGGTTCATTACTTTTGGA3’        
 sIQUB-3R   5’CCCCCAAAAGCAGAACTTTA3’ 58 392 sIQUB-3 no - - OAR4:93209752-
93265179 
 sIQUB-3R   5’GCATATCTACTTCAGAGGGCTTT3’        
 sIQUB-4F   5’AAATGAAGCCAGTAGCGGAAT3’ 58 404 sIQUB-4 no - - OAR4:93209752-
93265179 
 sIQUB-4R   5’TTTGTTATCATGGAAGAGACTTGC3’        
ASB15 sASB15_1F 5’ CTGTGTGAAGCGATGGTCAG3’ 58 607 sASB15-1 A > G (150bp) g.150A>G exonic JN108881 
 sASB15_1R 5’GGCACTCGGATTTGTAGGTC3’        
 sASB15_2F 5’GGGGACCTACAAATCCGAGT3’ 58 519 sASB15-2 no - - JN108881 
 sASB15_2R 5’GGGGAAAGTGGTCTGTTTGA3’        
 sASB15_3F 5’TTGAAAAGGCCAAGAACACA3’ 58 404 sASB15-3 no - - JN108881 
 sASB15_3R 5’CTGTTTGGATTTTGGGAGACA3’        
 sASB15_4F 5’TTGCCTGTGGCTCTCATACA3’ 58 343 sASB15-4 no - - OAR4:93343948-
93353368 
 sASB15_4R 5’TTACCAGCACAGCCATACGA3’        
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Table S1. (continued) 
Gene 
symbol 
Primer 
name 
Primer sequence 
Annealing 
Temp. (ºC) 
Size 
(bp) 
Fragment 
name 
Genetic variant 
(position in the 
fragment) 
Variant 
name 
SNP 
characteristic 
Sequence access 
No. 
(GenBank/Ovine 
1.0) 
ASB15 sASB15_5F 5’TGCAGATGCCCTCATTGTTA3’ 58 307 sASB15-5 no - - OAR4:93343948-
93353368 
 sASB15_5R 5’CCTGTTGAACGGAGCGTAA3’        
 sASB15_6F 5’TCCAAACATGCAATCCAGAA3’ 58 372 sASB15-6 no - - OAR4:93343948-
93353368 
 sASB15_6R 5’ACTGTATGGCACTGGGGAAG3’        
LMOD2 sLMOD2-1F 5’AGCTGGACGACATTGAACCT3’ 58 434 sLMOD2-1 C > T (207bp) g.470C>T intronic OAR4:93370239-
93377211 
 sLMOD2-1R 5’TCTAAACCCGTGCTTTGCTT3’    G > T (230bp) g.493G>T intronic  
 sLMOD2-2F 5’GGGTGTCAACCCATTTCAAC3’ 58 444 sLMOD2-2 no - - OAR4:93370239-
93377211 
 sLMOD2-2R 5’GTGCCAACAGGACTTGGTTT3’        
 sLMOD2-3F 5’TGTGAGTTCATCCCTGGTCA3’ 58 337 sLMOD2-3 no - - OAR4:93370239-
93377211 
 sLMOD2-3R 5’TGCTCTGGAAAACCCTTGAT3’        
 sLMOD2-4F 5’CAGCGAAGGAGAGGAAAGAA3’ 63 430 sLMOD2-4 no - - OAR4:93370239-
93377211 
 sLMOD2-4R 5’GATGTTGACGCTGGTGATGT3’        
 sLMOD2-5F 5’CCTTTGGCTACAGGAGAGGA3’ 58 306 sLMOD2-5 no - - OAR4:93370239-
93377211 
 sLMOD2-5R 5’GGGATTGGGAATAGCTGAGG3’        
WASL sWASL-1F 5’GGGGGTCTCGTCTTTTCTCT3’ 63 466 sWASL-1 C > T (248bp) g.256C>T intronic OAR4: 
93431017-
93481693 
 sWASL-1R 5’TTGTCCCTCTGCTGTCACTG3’        
 sWASL-2F 5’TGTTTTGTGTAAAGGGCCAGA3’ 60 494 sWASL-2 no - - OAR4: 
93431017-
93481693 
 sWASL-2R 5’TCCATGCTTTTTGCCTTCTT3’        
 sWASL-3F 5’CGTTGCTTCCTATTAAGGCGTA3’ 58 381 sWASL-3 Deletion A (309bp) g.5692delA intronic OAR4: 
93431017-
93481693 
 sWASL-3R 5’TGCTCTGTGTGTAAAGGCTGTT3’        
 sWASL-4F 5’AACGCCCATGCTTCAATATC3’ 58 399 sWALS-4 no - - OAR4: 
93431017-
93481693 
 sWASL-4R 5’GGGGTTCTGGTTCAGTGTCT3’        
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ABSTRACT 
Cryptorchidism is a condition whereby one or both testes fail to descend into the scrotal 
sac.  It is a common congenital disorder prevalent in many mammalian species.  
Cryptorchidism is a complex genetic disease considered to be caused by the interaction of 
genetic, epigenetic and environmental factors.  No single mutated gene has been found to 
cause more than 10% of cryptorchids.  Here we performed a genome wide association 
study (GWAS) using case-control analysis in PLINK software and the BayesB approach 
in GenSel software with a 1Mb window of SNPs or haplotypes.  The haplotypes were 
constructed from a genealogical tree on the population of 204 Siberian Huskies and its 3 
subgroups clustered by genomic relationships to account for population structure.  No 
significant association was observed in the case-control analyses after FDR corrections in 
PLINK.  In contrast, the BayesB analysis identified a 1Mb region on dog chromosome 27 
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(CFA27) containing the AMHR2 (anti-mullerian hormone type II receptor) gene that 
explained a high percentage of genetic variance in subgroup 1 (~ 10 fold greater than the 
expected value for an infinitesimal model in the SNP window analysis and ~ 9 fold 
greater in the haplotype window analysis).  It is known that mutations in AMHR2 cause 
persistent mullerian duct syndrome (PMDS) in humans and the majority of such patients 
with PMDS exhibit cryptorchidism.  In conclusion, we identified a putative candidate 
region at the 4th Mb on CFA27 (CanFam2.0) harboring a very promising functional 
candidate gene AMHR2 associated with the development of cryptorchidism in a subgroup 
of our Siberian Husky population. 
INTRODUCTION 
Testicular descent is an essential developmental stage for normal reproduction in male 
individuals of many mammalian species.  Normally, testes descend from an intra-
abdominal position down into the scrotal sac.  That environment with 2 - 4 °C below 
normal body temperature is a prerequisite for spermatogenesis in humans and many other 
mammals (Klonisch et al. 2004; Thonneau et al. 1998).  The approximate timing of 
testicular descent varies in different species.  In mice, rats and especially dogs, testicular 
descent is normally completed postnatally, while in humans, rabbits, pigs and horses, this 
process is normally completed before birth (Amann and Veeramachaneni, 2007; Hughes 
and Acerini, 2008).  The failure of a testis to descend into the scrotal sac is called 
cryptorchidism (Greek: hidden testicle).  This defect is regarded as one of the most 
common congenital human defects.  About 3% of full term and 30% of premature infant 
boys are born with at least one testicle undescended (Klonisch et al. 2004). 
Cryptorchidism has been observed in other mammalian species, such as dogs (Cox et al. 
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1978), cats (Yates et al. 2003), horses (Cox et al. 1979), pigs (Rothschild et al. 1988), 
goats (Singh and Ezeasor 1989), sheep (Smith et al. 2007) and cattle (St Jean et al. 1992), 
as well as in wild animals like maned wolves (Burton and Ramsay, 1986), black bears 
(Dunbar et al. 1996) and reindeer (Leader-Williams 1979).  An undescended testicle is 
considered a risk factor for germ-cell tumors and bilateral cryptorchidism can result in 
male infertility (Berkowitz et al. 1993; Carizza et al. 1990). 
A general perception of causes for cryptorchidism is a multiplicity of factors including 
genetic, epigenetic and environmental components (Spencer et al. 1991; Klonisch et al. 
2004; Thonneau et al. 2003; Hutson and Hasthorpe, 2005; Amann and Veeramachaneni 
2007).  A number of environmental factors have been recognized to be associated with an 
undescended testis in humans, and these factors include low birth weight, premature birth, 
maternal consumption of alcohol, smoking and caffeine, gestational diabetes and prenatal 
exposure to pesticides (Hughes and Acerini 2008; Wang and Wang 2002).  
Familial analyses show that cryptorchidism is a genetic disorder.  Various genes 
implicated in the regulation of testicular descent have been investigated for 
cryptorchidism. The processes of testicular descent have been proposed as a biphasic 
model, with a “transabdominal” phase followed by an “inguinalscrotal” phase (Hutson 
1985).  Androgens might play a role in both phases.  Impaired fetal androgen action can 
result in cryptorchidism.  Genes related to androgen action have been investigated in the 
study of cryptorchidism.  The androgen receptor gene (AR) is strongly expressed in the 
gubernaculums (George and Peterson 1988).  The length variant of trinucleotide repeats 
like GGN (encoding glycine) or CAG (encoding glutamine) in AR was identified 
respectively to be associated with a risk of cryptorchidism in an Iranian population and in 
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Hispanic boys (Radpour et al. 2007; Davis_Dao et al. 2012).  Mice with conditional 
inactivation of Ar developed cryptorchidism with testes located in a suprascrotal position 
(Kaftanovskaya et al. 2012).  Androgens act on testicular descent via the release of a 
calcitonin gene-related peptide by the genitofemoral nerve.  Calcitonin gene-related 
peptides are encoded by two separated genes named CALCA (CGRP-alpha) and CALCB 
(CGRP-beta).  Exogenous calcitonin gene-related peptides injection into the scrotum can 
change the direction of gubernacular migration in the mutant trans-scrotal (TS) rat 
(Griffiths et al. 1993; Clarnette and Hutson 1999).  However, the CGRP gene was not 
found to be a major factor for cryptorchidism based on a mutation association analysis in 
a human study (Zuccarello et al. 2004).  
The swelling and migration of male gubernaculum with relaxation of the cranial 
suspensory ligament in the process of testicular descent allow testes to move from the 
posterior abdominal wall to the internal inguinal ring (Hutson 1985).  The gubernaculum 
is a continuous column of mesenchyme connecting the testis to the scrotal sac.  Insulin-
like factor 3 (INSL3) is expressed in the pre-and postnatal Leydig cells of the testis and 
postnatal theca cells of the ovary, and is a member of the insulin-like hormone 
superfamily (Zimmermann et al. 1997).  Targeted disruption of this gene prevents 
gubernaculum growth and causes bilateral cryptorchidism in mice (Nef and Parada 1999; 
Zimmermann et al. 1999).  The receptor of INSL3 is encoded by a gene called 
relaxin/insulin-like family peptide receptor 2 (RXFP2), also named the leucine-rich 
repeat-containing G protein-coupled receptor 8 gene (LGR8).  LGR8 is highly expressed 
in the gubernaculum and is responsible for mediating hormonal signals that control 
normal testicular descent (Bogatcheva et al. 2003). Mutant mice for this gene exhibit 
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bilateral intra-abdominal cryptorchidism due to the undifferentiated gubernaculum 
(Gorlov et al. 2002).  Summarized from previous reports, only a minority of affected 
cases have a mutation either in the INSL3 gene or its receptor gene LGR8.   
Disruptions of other hormone related genes also show associations with aberrant 
testicular descent.  Mullerian inhibiting substance (MIS), or anti-Mullerian hormone 
(AMH), encoding a 140-kDa glycoprotein produced by Sertoli cells is critical for the 
mullerian duct regression during male sexual differentiation (Bashir and Wells 1995) and 
is associated with the swelling reaction of gubernaculum occurring during the first phase 
of testicular descent (Kubota et al. 2002).  The mutated gonadotropin-releasing hormone 
receptor (Gnrhr) gene is associated with undescended testes in mice (Pask et al. 2005).  
In humans, maternal exposure to the synthetic nonsteroidal estrogen, diethylstilbestrol 
(DES), results in a high risk of offspring with cryptorchidism (Gill et al. 1979).  The 
receptor of estrogen, estrogen receptor 1 (ESR1), is one of the ligand-activated 
transcription factors and is important in the process of testicular descent (Donaldson et al. 
1996; Przewratil et al. 2004).  Retracted gonads in knockout male mice of Esr1 suggest 
estrogens played a direct role in the scrotal positioning of the testis (Donaldson et al. 
1996). Investigations have also been carried out on homeobox (Hox) genes in mice for 
cryptorchidism.  Homeobox A10 (Hoxa10) is highly expressed in the gubernaculum and 
this gene has been found to be essential for the gubernacular migration during testicular 
descent (Nightingale et al. 2008).  In mice, disruption of this gene and another Hox gene, 
called Hoxa11, results in the development of cryptorchidism (Satokata et al. 1995; Hsieh-
Li et al. 1995). 
 
 
 
125
There is a high prevalence (about ~14%) of cryptorchidism in Siberian Husky dogs (Zhao 
et al. 2010).   Although several studies show association of some candidate genes with 
cryptorchidism, the genetic basis of the development of cryptorchidism is still 
controversial.  Here we performed a genome wide association study in Siberian Husky 
dogs using the Illumina CanineHD BeadChip with more than 170,000 single nucleotide 
polymorphisms (SNPs) and tried to identify genomic regions and propose some 
positional candidate genes associated with variation in the incidence of cryptorchids. 
METHODS  
Animals and phenotypes 
A total of 205 male Siberian Huskies and 12 male Chinooks were included in this study.  
Among them, 43 Siberian Huskies were from the UK, 8 from Canada, and the remaining 
154 Siberian Huskies and all Chinooks were from USA.  Dogs were diagnosed at 6 
months of age by veterinarians or dog owners as being either unilateral or bilateral 
cryptorchids, or as normal unaffected dogs.  In this study, there are 106 dogs with 
cryptorchidism and 99 diagnosed normal in the Siberian Husky breed.  Six affected and 6 
control Chinooks were included as a control population for population stratification. 
Samples and DNA preparation 
Buccal samples were collected by owners from 186 Siberian Huskies and 12 male 
Chinooks using sterile cytology brushes (Fisher Scientific, Hampton, NH, USA).  The 
Canine Health Information Center (CHIC) DNA repository provided 19 male Siberian 
Huskies DNA samples with an average concentration of 50 ng/ul.  DNA was extracted 
from 2 to 3 cytology brushes per dog within a single reaction of the QIAamp DNA Mini 
Kit (QIAGEN, Inc., Valencia, CA, USA). The DNA concentrations ranged from 10.0 to 
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50.0 ng/µl.  Samples with DNA concentration less than 20 ng/µl were subjected to whole-
genome amplification (WGA) using the GenomiPhi (GE Healthcare, Buckinghamshire, 
England) kit to yield high-quality DNA suitable for the Illumina infinium canine 
genotyping platform. 
Data generation and analyses 
SNP array genotyping and quality control 
DNA samples with a total DNA amount of 700-1,000 ng were sent to GeneSeek, Inc. 
(Lincoln, NE, USA) for genotyping on the CanineHD BeadChip.  The SNPs with call 
rate ≤ 40%, Gentrain score ≤ 40%, and minor allele frequency ≤ 0.01 were excluded from 
the data set. 
Analyses of population structure 
Genotypes of all 217 dogs including 205 Siberian Huskies and 12 Chinooks were 
imported into Haploview v4.2 software (Barrett et al. 2005).  Pairwise linkage 
disequilibrium (LD) comparisons among markers of each chromosome were performed.  
Tagging SNPs were identified using the TAGGER routine implemented in Haploview. 
In order to remove the underlying group effects we stratified the population, using the 
model-based clustering method in STRUCTURE v2.3 software (Pritchard et al. 2000) for 
inferring population structure using multi-locus Illumina 170K CanineHD BeadChip 
genotypes for all animals.  The admixture model was chosen in STRUCTURE on 
selected tagging SNP makers and most of the parameters were at their default values.  
The length of both the burn-in and post burn in Markov chain Monte Carlo (MCMC) 
interations were 5,000 wth 3 runs for each K (the number of presumed population 
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clusters).  The presumed value of K was varied from 1 to 7.  To detect the true value of K, 
a second order rate of changes of the likelihood function with respect to K represented as 
∆K was applied.  The highest value of the ∆K distribution was used as an indicator of the 
strength of the signal detected by STRUCTURE (Evanno et al., 2005).  The dogs were 
assigned into different subgroups according to the constitution of Q values (estimated 
membership coefficient) in presumed clusters for each individual.   
Genome wide association studies 
Genome wide association studies were carried out on each of the subgroups assigned by 
STRUCTURE as well as on all male Siberian Huskies.  Three approaches were applied 
for the data analyses.  The first approach was the case-control analysis implemented in 
PLINK v1.06 software (Purcell et al. 2007) using single SNP markers. The linear step-up 
procedure of Benjamini and Hochberg FDR control in PLINK was utilized in order to 
correct for multiple testing.  The second approach was a BayesB model averaging 
approach using the GenSel v4R software (http:// bigs.ansci.iastate.edu) with the 
categorical analysis option, to obtain the variance explained by SNPs in one megabase 
(1Mb) genomic windows (which we refer SNP model).  The statistical model used for 
BayesB was as follows: 
  1   	


	
	   
where  is the phenotype of animal i,  is an overall mean,  is the total number of SNPs 
in the panel, 	 is genotype at marker j in individual i, 	  is a random substitution effect 
for marker  with its own variance   0 ( with a probability 1- ) or   0 (with a 
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probability of ), and ei is the random residual on animal i that are assumed to be 
normally distributed N (0,  .  The parameter  was assumed to be 0.9999 so as to fit 
10-20 markers (0.0001x 170K) per iteration of the Markov chain in a mixture model for 
the estimation of individual SNP effects.  A total of 51,050 MCMC iterations with burn-
in of 1,000 iterations and with an output frequency of 50 iterations were used for 
inference.  There were 2,346 unique 1Mb windows across the dog genome based on the 
genotyped markers.  The number of markers in each 1Mb window varied according to the 
genomic regions.  It was assumed that under an infinitestimal model all windows would 
account for the same variance of about 0.04%.  Hence, the 1Mb windows explaining at 
least 0.4% of genetic variance, which is 10 fold greater than expected, were considered as 
indicative candidate regions for a gene influencing the incidence of cryptorchids.  
In order to utilize haplotype information for identifying genes underlying complex traits, 
a tree-based association method that captures information about the evolutionary history 
(genealogy) of the genome were implemented in the analysis.  The third approach, we 
refer to as the BayesB analysis with haplotype model, was carried out on each of the 
subgroups and their combined dataset to further verify regions showing associations with 
cryptorchidism in the BayesB analysis with SNP model.  To perform this analysis, 
genotypes for each individual were phased on each chromosome (based on the CanFam 
2.0 assembly) using BEAGLE v3.3 software in which a localized haplotype-cluster mode 
was fitted using an EM algorithm (Browning & Browning 2007).  Subsequently, local 
phylogenetic trees were constructed for each SNP marker with default values in Blossoc 
software (Mailund et al. 2006) and were drawn as a rooted binary tree (Sahana et al. 
2011).  At the third level of each tree, there are eight possible nodes and all haplotypes 
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descending from each of the nodes (with the same phylogenetic lineage) were considered 
as a cluster.  A new incidence matrix was developed to relate each of the genotyped 
animals to the detected haplotype clusters and its original SNP genotypes.  The same 
BayesB model was applied to the new incidence matrix and the genetic variance 
explained by each 1 Mb genomic window was obtained using GenSel software.  The 
windows passing the criteria (> 0.40% of genetic variance) in the SNP model and also 
explaining at least 0.20% of genetic variance, which is 5 fold greater than expected, were 
retained as candidate regions in this study. 
RESULTS  
There were 143,286 SNPs for GWAS analyses after quality control edits.  One Siberian 
Husky dog was excluded due to its low genotype call rate and the remaining 105 affected 
and 99 controls were included for the GWAS analyses.  A total of 47,672 tagging SNP 
markers were selected using Haploview (data not shown) and then used to run 
simulations in STRUCTURE.  Under a model assuming admixture, the results recover 3 
population clusters (K=3) according to the ∆K statistic which is based on the rate of 
change in the log probability of the data (Figure 1B).  The estimated proportion of 
ancestry (Q value) derived from the 3 assumed population clusters varied among 
individual dogs.  The 12 Chinook dogs were distinct from the Siberian Husky dogs 
(Figure 1A).  Here we re-assigned dog samples into 4 subgroups according to their 
constitution of Q values in the 3 population clusters (Figure 1C, Supplementary Table S1).  
The first 3 subgroups are Siberian Huskies and subgroup 4 included all 12 Chinooks with 
extreme Q values of cluster 3 (0.928 to 1).  Due to the small sample size, the Chinook 
dogs in subgroup 4 were used only as a control breed for the structure clustering, but not 
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included in subsequent GWAS.  There were 129 dogs in subgroup 1 with a range of Q 
values from 0.709 to 1 for cluster 1, the majority of these dogs were collected from USA 
(95%) and 5% were from Canada.  Sixty dogs are cryptorchids and 69 are controls in this 
subgroup.  Subgroup 3 included 20 cryptorchids and 15 control dogs, with high Q values 
of cluster 2 (0.700-0.838).  Most of these dogs were sampled from the UK (94%).  
Individuals in the subgroup 2 had intermediate Q values for both clusters 1 and 2.  These 
dogs were of mixed origins, being sampled from USA (71%), the UK (24%) and Canada 
(5%).  There were 41 individuals in subgroup 2, and 26 were cryptorchids.  The sample 
sources and breeds for each dog subgroup are in Figure 1C and the supplementary Table 
S1. 
Twelve 1Mb SNP windows showed a high percentage of genetic variance (> 0.4%, 10 
fold greater than the expected value) when the BayesB analyses were conducted in 
subgroup 1. These regions include one window on each of dog chromosomes CFA1, 
CFA3, CFA14 and CFA18, four windows on each of CFA5 and CFA27.  Notably, the 
four windows on CFA27 explain 4.67% of genetic variance and one of them located at 
the 5th Mb explains 3.24% of genetic variance by itself (Table 1, Figure 2).  Furthermore, 
three out of these four windows on CFA27 remain with high genetic variance compared 
to other regions (> 5 fold of the expected values, 0.34%, 0.53% and 0.22% for the 1Mb 
windows located at the 4th, 5th and 6th Mb on CFA27, respectively) when the window 
approach using haplotype model was conducted in BayesB analyses for subgroup 1 
(Table 1). The windows on CFA1 and CFA14 were both at 50 Mb and were also detected 
by the haplotype analysis accounting for genetic variance over 0.2% (Table 1, Figure 2).  
By searching the database of CanFam 2.0 using Ensembl browser, 74 characterized genes 
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have been mapped between the 4th to the 6th Mb on CFA27, 8 on the 50th Mb of CFA1, 
and 5 on the 50th Mb of CFA14 (Supplementary Table S2).  Among them, a candidate 
gene named anti-mullerian hormone type II receptor (AMHR2) was found to be located in 
the region of the 4th Mb of CFA27 (Figure 2, Supplementary Table S2).  Human patients 
with mutations in this gene typically develop cryptorchidism (Clarnette et al. 1997).  
Moreover, a cluster of HOX-C genes including HOXC4, HOXC5, HOXC6 HOXC8, 
HOXC10, HOXC11, HOXC12 and HOXC13 were identified as being located within the 
5th Mb window on CFA27 (Table S2). 
The results from BayesB analyses by SNP model for subgroup 2 and subgroup 3 
identified six different regions.  Among those six 1Mb regions, only two of the 1Mb 
windows were also identified as candidate regions with the haplotype model, those 
windows at 75 Mb on CFA4 for subgroup 2 (Table 1, Supplementary Figure S1) and 18 
Mb on CFA31 for subgroup 3 (Table 1, Supplementary Figure S2).  Eight characterized 
genes such as CAPSL (calcyphosine-like), IL7R (interleukin 7 receptor) and SPEF2 
(sperm flagellar 2) etc. have been mapped to 75 Mb of CFA4 and two types of U6 
spliceosomal RNA have been mapped to 18 Mb of CFA31 (Supplementary Table S3). No 
apparent genes in these regions have been reported so far to be associated with the 
processes of testicular descent or the development of cryptorchidism.  The sample size 
for these two subgroups is relative small.  More samples are needed in the future for 
discovering new loci if it is the fact that dogs with cryptorchidism in these two subgroups 
have distinct causative mutations from individuals in subgroup1. 
The results from GWAS analyses using all Siberian Huskies (105 affected and 99 
controls) show that 1Mb SNP windows on CFA3, 6, 9, 24, 27, X explain a high 
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percentage of genetic variance (higher than 0.40%) (Table 1).  Among those, four regions 
including the 31st and 33rd Mb windows on CFAX, 56th Mb on CFA9 and 13th Mb 
window on CFA27 also showed a high percentage of variance (higher than 0.20%) when 
the window were fitted using the haplotype model (Table 1, Supplementary Figure S3).   
Comparing the results of this pooled analysis with previous analyses from each of the 3 
subgroups separately, we did not identify a common window explaining high percentage 
of genetic variance. 
It is to be noted that most of the SNPs with lowest raw P-values on each chromosome in 
the case-control analyses in PLINK were located within the windows detected from the 
BayesB analyses (Figure 2A, Supplementary Figure S1A, S2A and S3A), even though 
their significance disappeared after FDR corrections (data not shown). 
Additionally, we summarized the results from the BayesB analyses for genes that had 
previously been shown to be associated with cryptorchidism, including ESR1, NR5A1 
(nuclear receptor subfamily 5, group a, member 1), GNRHR, HOXA10, HOXA11, FGFR1 
(fibroblast growth factor receptor 1), SOS1 (son of sevenless, drosophila, homolog 1), 
WT-1 (Wilms tumor gene 1), INSL3, AMH, CALCA, PROKR2 (prokineticin receptor 2), 
LGR8, COL2A1, KAL1 (Kallmann syndrome interval gene 1) and AR (Table 2).  There 
are no regions covering these genes passing the criteria set in this study to show apparent 
associations with cryptorchidism, neither in the three subgroup analyses nor in the pooled 
analysis of the Siberian Husky population.  The causative loci for cryptorchidism in our 
study do not seem to coincide with those previously reported candidate genes.   
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DISCUSSION 
Genetic association studies relate differences in disease status reflected as case and 
control groups with differences in allele frequencies at SNPs.  Undetected population 
substructure in an admixed population can lead to spurious allelic associations (Cardon 
and Palmer 2003).  Diseases could be heterogeneous when the same condition is caused 
by different genes or different alleles at the same gene in different populations.  The 
genetic basis for cryptorchidism is likely heterogeneous in different populations.  Perhaps 
at least 20 genes might be associated with cryptorchidism, since no single mutated gene 
has been found to cause more than 10% of cryptorchids (Klonisch et al. 2004; Amann 
and Veeramachaneni 2007).  Previous studies have shown that only 3-5% cryptorchid 
men exhibit gene aberrance for INSL3 or GREAT and < 16% for AR or ESR1 (Amann and 
Veeramachaneni 2007).  In another instance, a specific haplotype of ESR1 has been 
found to be associated with cryptorchidism status in a Japanese population (Yoshida et al. 
2005), but only being associated with the level of severity of cryptorchidism in other 
populations (Wang et al. 2008).  In such cases, isolating a relatively homogeneous 
subpopulation from a heterogeneous population is necessary for cryptorchidism studies.  
Here we used STRUCTURE to infer the presence of distinct population clusters and then 
re-assigned individuals to 4 new subgroups in order to discover aberrant genes associated 
with the condition in each subsample.  The re-assigned dog subgroups were consistent for 
the most part with their geographic distribution but the regions (windows) identified in 
each subgroups were distinctly different in each sub population.  It demonstrates that 
different genes might contribute to cryptorchidism in different groups of dogs.  
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Comparing the results of the pooled analyses (all 204 Siberian Huskies) using BayesB 
approaches with results from the three subgroups separately, we did not identify a 
common window accounting for high genetic variance. This may be due to fact that dogs 
from different geographical backgrounds in the pooled population blended the allele 
frequencies of SNPs associated with the disease in any particular subgroup. 
In this study, the AMHR2 gene was considered a promising candidate gene for canine 
cryptorchidism in Siberian Husky subgroup 1 based on results from BayesB analyses 
using the window approaches.  The SNP （BICF2G630137913, 4791435bp on CFA27）
located within AMHR2 gene was not significantly associated with cryptorchidism from 
the results of single marker analysis in PLINK after FDR corrections (praw = 0.002, pgenome 
= 0.9971).  This marker is about 0.59Mb away on CFA27 from SNP BICF2G6301380 
which has the smallest raw P value in the analyses (praw = 2.39E-05).  By checking the 
LD structure for SNPs on CFA27 using Haploview, BICF2G630137913 did not show 
strong LD with nearby SNPs (r2 = 0.2 with the left SNP BICF2G630137904 or the right 
SNP BICF2G630137922). The average LD for BICF2G630137913 with other markers 
on CFA27 was very low (r2 = 0.04).  It is not surprising to find that the window 
containing BICF2G630137913 shows high percentage of genetic variance, but no 
significant association was observed between this SNP and cryptorchidism in the single 
marker analysis using PLINK.  Supposing a true causative mutation in AMHR2 is not in 
high LD with SNP BICF2G630137913, the single SNP analysis will not help to capture 
the association with the studied disease.  Therefore, the cumulative effects of 1Mb SNP 
windows or windows with integration of haplotype information would facilitate detection 
of regions harboring the causative loci that may not be apparent in single SNP analyses.  
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To confirm whether AMHR2 is a causative locus for cryptorchidism, expression array 
studies and/or fine mapping by sequencing the whole gene are necessary. 
The case-control analysis using single SNP tests in the PLINK program is a frequentist 
approach by calculating a p-value for the null hypothesis of no association. Multiple 
testing corrections like FDR and Bonferroni adjustment are usually performed (Noble 
2009).  The sample size and minor allele frequency will strongly affect the results using 
this approach (Stephens and Balding 2009).  In this study, there is no significant 
association remaining after FDR corrections for SNPs on the BeadChip with the given 
disease in any data sets.  The relatively small sample size would limit the power of 
detecting associated markers or regions for a complex disease.  In this study, Bayesian 
approaches with SNP or haplotype windows were also used to assess evidence for an 
association between genomic regions containing multiple genetic variants and 
cryptorchidism. The 1Mb window approach accounts for linkage disequilibrium among 
adjacent SNP and accumulates the effects from multiple genetic variants in any particular 
region.  This method reduces the chance of spurious associations that can easily occur 
from a single locus analysis (Balding, 2006).  Incorporating biological information of 
genes with GWAS analyses may also help find causative gene loci.  Here we found a 
potential gene AMHR2 that has a known biological function on sex differentiation and is 
plausibly related to the development of cryptorchidism.   
It is known that anti-mullerian hormone (AMH) is one of the hormones mediating male 
sex differentiation by regression of mullerian ducts which would otherwise differentiate 
into the uterus and fallopian tubes (Behringer 1994).  Double-knockout mouse models for 
AMH and AMHR2 suggest that AMH is the only ligand of the AMHR2 receptor (Mishina 
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et al. 1996).  Mutations in AMH and AMHR2 have been found to cause persistent 
mullerian duct syndrome (PMDS), a rare form of male pseudohermaphroditism (Imbeaud 
et al. 1995; Messika-Zeitoun et al. 2001).  There are 60-70% patients with PMDS that 
have their testes located in the abdomen at a position analogous to the ovaries without 
descending into the normal scrotal destinations (Clarnette et al. 1997).  Many PMDS 
patients have been found with the absence of gubernacular structures or feminized 
gubernaculum (Clarnette et al. 1997).   The disruptions of AMH or AMHRs may cause 
human cryptorchidism by preventing transabdominal descent through failure of the 
gubernacular swelling reaction (Clarnette et al. 1997).   It was reported that a boy carried 
a heterozygous WT1 nonsense mutation had bilateral cryptorchidism, nystagmu and 
Wilms’ tumor.  The nonsense mutation leads to a truncated protein by losing three zinc-
finger domains for DNA binding (Terenziani et al. 2009).  The cDNA microarray 
analyses on Wt1 (Wilms’ tumor suppressor gene) knockout mice have shown that 
inactivation of the Wt1 gene dramatically down-regulates gene expression of Amkr2.  
This shows that Amkr2 is a target gene of Wt1 when it plays the role in urogenital and 
gonadal development during sex differentiation (Klattig et al. 2007).  Therefore, the WT1, 
AMHR2 and AMH genes might be within the same pathway to regulate sex differentiation.  
Gene disruptions of one of these genes could prompt the development of undescended 
testicles in males.  
It is known that HOX genes are a group of related genes determining the regional identity 
of an embryo along the anterior- posterior axia and the type of segment structure (Joseph 
et al. 2005).  The gubernaculum is central to testicular descent, with evidence suggesting 
that it elongates to the scrotum like a limb bud (Huynh et al. 2007).  The genes HOXA10 
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and HOXA11 involved in limb bud outgrowth are expressed within the gubernaculum 
(Yuan et al. 2006), and these two genes have been found to play a role in the developing 
genito-urinary tract.  The Hoxa10-/- and Hoxa11-/- mutant male mice present 
cryptorchidism (Satokata et al. 1995; Hsieh-Li et al. 1995).  Disrupted gene functions or 
ectopic expression of some of the Hoxc genes such as Hoxc4, Hoxc6 or Hoxc8 have been 
considered being responsible for the lack of hindlimb phenotypes in chickens (Nelson et 
al. 1996).  However, there is no sufficient research evidence to show relationships 
between any of the HOX-C genes with cryptorchidism. 
In conclusion, the important findings in this present GWAS are (i) the AMHR2 gene was 
identified in a putative candidate region associated with canine cryptorchidism by using 
1Mb window approach and Bayesian inference (ii) different chromosomal regions and 
thus different genes appear to be associated with the disease in dogs from pedigrees from 
different geographical regions.  Population structure clustering will help correct for 
stratification; (iii) cryptorchidism is a complex disease and shows genetic heterogeneity; 
(iv) single SNP analyses may not capture the genomic regions harboring the causative 
loci when there is not enough LD between markers on the chip nearby the causative 
mutations.  The 1Mb window approach along with BayesB analysis may help to resolve 
this problem; (v) whole genome sequencing for pairs of affected and unaffected dogs 
from the same family may facilitate finding causative mutations without needing to 
consider LD structure and disease heterogeneity. 
Software 
BEAGLE: http://faculty.washington.edu/browning/beagle/beagle.html 
Blossoc: http://www.daimi.au.dk/~mailund/Blossoc/index.html 
GenSel: http://bigs.ansci.iastate.edu 
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Haploview:  
http://www.broadinstitute.org/scientific-community/science/programs/medical-and-
population-genetics/haploview/haploview 
PLINK: http://pngu.mgh.harvard.edu/~purcell/plink/ 
STRUCTURE: http://pritch.bsd.uchicago.edu/structure.html  
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Figure 1. Re-grouping dogs based on the value of cluster membership estimated 
from STRUCTURE.  A. Summary plot of estimated Q values (cluster membership 
coefficients) for each individual dog collected from USA, UK and Canada.  Each 
individual is represented by a single vertical line broken into K colored segments, 
with lengths proportional to each of the K inferred clusters. B. Identification of the 
most possible estimate of K calculated from 47
calculated for K=1 through K=
best estimate based on ∆K
subgroups based on Q values when K=3. The re
the dogs’ geographical distributio
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,672 tagging SNPs.  Delta K was 
 6 under a model assuming admixture.  K=3 is the 
 statistics on the plot. C. Dogs were assigned into 4 
-grouping of dogs is consistent with 
ns. SH: Siberian Husky; CHI: Chinook.
 
 
 
 
 
 
 
Figure 2. Whole genome association analyses for subgroup 1 comprising 129 mostly 
USA sourced (60 cases and 69 controls) Siberian Huskies.
marker analyses in PLINK before false discov
Depicts results from the GenSel 1Mb SNP window analyses
is a 1Mb window containing a group of consecutive SNPs. 
haplotypes and SNP genotypes together in GenSel
spot is a 1Mb window containing a group of consecutive SNPs 
red breaking arrows link SNPs in PLINK to their 1Mb SNP windows with genetic 
variance being over 0.40%
arrows show windows repeatedly identified with high variance (>
than the expected value) 
GenSel.  The most promising putative regions for cryptorchidism 
subpopulation are on CFA27
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Figure S1. Whole genome association analyses for subgroup 2 comprising 41 mixed 
sourced (26 cases and 15 controls) Siberian Huskies.  A. Shows results of single 
marker analyses in PLINK before false discov
Depicts results from the GenSel 1Mb SNP window analyses
is a 1Mb window containing a group of consecutive SNPs. C. Displays results using 
haplotypes and SNP genotypes together in GenSel
spot is a 1Mb window containing a group of consecutive SNPs 
red breaking arrows link SNPs in PLINK to their 1Mb SNP windows with genetic 
variance being over 0.40%
arrows show windows repeatedly i
than the expected value) 
GenSel.  The most promising putative regions for cryptorchidism 
subgroup 2.  
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Figure S2. Whole genome association
UK sourced (20 cases and 15 controls) Siberian Huskies.  A. Shows results of single 
marker analyses in PLINK before false discov
Depicts results from the GenSel 1Mb SNP window 
is a 1Mb window containing a group of consecutive SNPs. C. Displays results using 
haplotypes and SNP genotypes together in GenSel
spot is a 1Mb window containing a group of consecutive SNPs 
red breaking arrows link SNPs in PLINK to their 1Mb SNP windows with genetic 
variance being over 0.40%
arrows show windows repeatedly identified with high variance (>
than the expected value) 
GenSel.  The most promising putative region for cryptorchidism 
subgroup 3.  
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S3. Whole genome association analyses for a 
in which 105 were diagnosed 
analyses in PLINK before false discov
results from the GenSel 1Mb SNP window analyses
1Mb window containing a group of consecutive SNPs. C. Displays results using 
haplotypes and SNP genotypes together in GenSel
spot is a 1Mb window containing a group of consecutive SNPs 
red breaking arrows link SNPs 
variance being over 0.40%
arrows show windows repeatedly identified with high variance (>
than the expected value) 
GenSel.  Windows on CFA9, 27 and X were identified as putative candidate regions 
for cryptorchidism in the joined population
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Table1. The top 1 Mb windows with the highest percentage of genetic variance 
obtained from BayesB analyses in different Siberian Husky subgroups 
 
Group 
Window 
(Chr_Mb) 
1Mb window 
SNP model 
(%) 
SNP & haplotype 
models (%) 
Subgroup 1 
(60 A & 69 U) 
1_50 0.73 0.22 
3_86 0.44 0.08 
5_8 0.54 0.16 
5_10 0.47 0.07 
5_12 0.68 0.06 
5_16 1.04 0.05 
14_50* 0.4 0.22 
18_11 0.55 0.18 
27_4* 0.42 0.34 
27_5* 3.24 0.53 
27_6* 0.59 0.22 
27_18 0.42 0.07 
Subgroup 2 
(26 A & 15 U) 
4_75* 0.56 0.23 
27_13 0.58 0.16 
35_26 0.4 0.02 
Subgroup 3 
(20 A & 15 U) 
24_37 0.39 0.04 
25_14 0.47 0.14 
31_18* 0.52 0.33 
Pooled 
(subgroup1, 
subgroup 2 and 
subgroup 3) 
(106 A & 99 U) 
3_87 0.42 0.15 
6_62 0.45 0.16 
9_56* 1.42 0.27 
24_31 0.55 0.11 
24_36 0.55 0.16 
27_13* 1.14 0.21 
27_18 0.43 0.14 
X_31* 0.71 0.31 
X_33* 1.1 0.39 
X_34 0.43 0.15 
X_35 0.53 0.14 
*These windows were considered as putative candidate regions for cryptorchidism with 
genetic variance over 0.40% (10 fold than the expected value) in the 1Mb SNP window 
analyses (SNP model) and repeatedly being with over 0.20% (5 fold than the expected 
value) for the 1Mb window analyses by integrating with haplotypes (SNP & haplotype 
models).  The positional candidate genes were listed in the supplementary Table S2, S3 
&S4. 
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Table 2. The results of BayesB analyses on 17 previously reported genes being associated with cryptorchidism 
Gene 
symbol 
Chromosom
e (CFA) 
Gene name 
Genome position 
(CanFam2.0) 
window 
(chr_Mb) 
Ref. 
Percentage of Genetic Variance (%) 
(1Mb window with BayesB approach) 
Subpop1 Subpop2 Subpop3 
Pooled 
population 
SNP Haplo. SNP Haplo. SNP Haplo. SNP Haplo. 
ESR1 CFA1 Estrogen receptor 1 45129993-
45409811 
1_45 Yoshida et al. 2005 0.01 0.05 0 0.04 0.03 0.07 0.03 0.03 
NR5A1 
(SF1) 
CFA9 nuclear receptor 
subfamily 5, group 
A, member 1 
61804755-
61824397 
9_61 Wada et al. 2005 0.05 0.01 0.03 0.05 0.08 0.09 0.08 0.06 
GNRHR CFA13 gonadotropin-
releasing hormone 
receptor 
61190588-
61204076 
13_61 Pask et al. 2005 0 0.04 0.03 0.02 0.04 0.03 0.01 0.04 
HOXA1
0 
CFA14 homeobox A10 43301964-
43304348 
14_43 Satokata et al. 1996 0 0.07 0.08 0.09 0.02 0.03 0 0.05 
HOXA1
1 
CFA14 homeobox A11 43312981-
43315443 
14_43 Hsieh-Li et al. 1995 0 0.07 0.08 0.09 0.02 0.03 0 0.05 
FGFR1 CFA16 fibroblast growth 
factor receptor 1 
29991434-
30031766 
16_30 Hadziselimovic et al. 
2010 
0.15 0.17 0.12 0.06 0.03 0.05 0.14 0.03 
SOS1 CFA17 son of sevenless 
homolog 1 
34112601-
34186729 
17_34 Hadziselimovic et al. 
2010 
0 0.02 0.07 0.01 0.02 0.03 0.04 0.06 
WT-1 CFA 18 Wilms tumor 1 38119539-
3167266 
18_38 Terenziani et al. 2008 0.09 0.11 0.08 0.04 0.03 0.05 0.04 0.13 
INSL3 CFA20 insulin-like factor 3 48072721-
48074397 
20_48 Nef and Parada 1999 0.12 0.1 0.04 0.04 0.1 0.03 0.09 0.07 
AMH 
(MIS) 
CFA20 anti-Mullerian 
hormone 
59926297-
59928993 
20_59 Behringer et al. 1994 0.02 0.05 0.03 0.04 0 0.03 0.02 0.04 
RAF1 CFA8 v-raf-1 murine 
leukemia viral 
oncogene homolog 1 
8899094-
8975879 
20_8 Hadziselimovic et al. 
2010 
0.02 0.04 0.04 0.05 0.06 0.05 0.1 0.06 
CALCA CFA21 Calcitonin/calcitonin
-related polypeptide, 
alpha 
41104822-
41108840 
21_41 Griffiths et al. 1993; 
Clarnette and Hutson 
1999) 
0.03 0.02 0.04 0.04 0.06 0.04 0.14 0.03 
PROKR2 CFA24 prokineticin receptor 
2 
19351537-
19359239 
24_19 Sarfati et al. 2010 0.01 0.03 0.07 0.09 0.02 0.06 0 0.04 
LGR8 CFA 25 Relaxin receptor 2 11294671-
11340203 
25_11 Tomyama et al. 2003 0.01 0.03 0.02 0.12 0.13 0.05 0.03 0.03 
COL2A1 CFA27 collagen, type II, 
alpha 1 
9768511-
9799248 
27_9 Zhao et al. 2010 0.06 0.07 0.06 0.07 0.06 0.03 0.03 0.05 
KAL1 CFA X Kallmann syndrome 
1 sequence 
5369941-
5428059 
X_5 Hou et al. 1999 0 0.03 0 0.06 0 0.05 0 0.01 
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Table S1. Re-grouping dogs based on the value of cluster membership (K=3) 
 
The Q value represents the estimated proportion of ancestry when 3 assumed populations were given.  SH: Siberian Husky; CHI: Chinook. 
 
K=3 Breed 
No. of 
cases 
No. of 
controls 
 Q value  Geographical distribution  
 Cluster1 Cluster2 Cluster3  USA_SH Canada_SH UK_SH USA_CHI 
Subgroup 1 SH 60 69  0.709-1 0-0.291 0-0.036  0.95 0.05 0 0 
Subgroup 2 SH 26 15  0.304-0.694 0.306-0.696 0-0.092  0.71 0.05 0.24 0 
Subgroup 3 SH 20 15  0.162-0.3 0.7-0.838 0-0.024  0.06 0 0.94 0 
Subgroup 4 CHI 6 6  0.01-0.031 0-0.041 0.928-1  0 0 0 1 
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Table S2. A list of genes in the putative regions for subgroup1  
Window 
(chr_Mb) 
CFA Gene Start 
(bp) 
Gene End 
(bp) 
Ensembl Gene ID Gene symbol Description 
1_50
th
  1 50145766 50258876 ENSCAFG00000000618 ZDHHC14 zinc finger, DHHC-type containing 14  
 1 50286593 50286847 ENSCAFG00000028358 7SK 7SK RNA  
 1 50340242 50341092 ENSCAFG00000000624 Novel gene pseudogene Ensembl genes 
 1 50436290 50498735 ENSCAFG00000000627 SNX9 sorting nexin 9 
 1 50550972 50622090 ENSCAFG00000000644 SYNJ2 synaptojanin 2  
 1 50642818 50692684 ENSCAFG00000000647 SERAC1 serine active site containing 1 
 1 50711829 50723881 ENSCAFG00000000648 GTF2H5 general transcription factor IIH, polypeptide 5 
 1 50919150 50993873 ENSCAFG00000000652 TULP4 tubby like protein 4 
 1 50935969 50936076 ENSCAFG00000028188 U6 U6 spliceosomal RNA 
14_50
th
  14 50199420 50200394 ENSCAFG00000003182 NOVEL pseudogene 
 14 50211571 50244090 ENSCAFG00000003194 HERPUD2 homocysteine-responsive endoplasmic 
reticulum-resident ubiquitin-like domain, 
member 2 protein 
 14 50219951 50220703 ENSCAFG00000003199 NOVEL_pseudogene 
 14 50373100 50456616 ENSCAFG00000003216 SEPT7L septin 7-like 
 14 50573856 50682597 ENSCAFG00000003227 EEPD1 endonuclease/exonuclease/phosphatase 
family domain containing 1 
 14 50708853 50745061 ENSCAFG00000003232 KIAA0895 KIAA0895 
 14 50773901 50815300 ENSCAFG00000003243 ANLN Actin-binding protein anillin 
 14 50856685 50950463 ENSCAFG00000003252 AOAH Acyloxyacyl hydrolase (neutrophil) 
27_4
th
  27 4008479 4010926 ENSCAFG00000006572 NFE2 nuclear factor (erythroid-derived 2) 
 27 4016380 4020656 ENSCAFG00000006580 Novel gene Uncharacterized protein  
 27 4038247 4050570 ENSCAFG00000006593 CBX5 chromobox homolog 5  
 27 4090107 4092358 ENSCAFG00000006603 SMUG1 single-strand-selective monofunctional uracil-
DNA glycosylase 1  
 27 4211932 4213230 ENSCAFG00000006611 HOXC4 homeobox C4  
 27 4231278 4232665 ENSCAFG00000006618 HOXC5 homeobox C5 
 27 4231753 4231837 ENSCAFG00000028294 cfa-mir-615 cfa-mir-615 
 27 4235965 4237469 ENSCAFG00000006622 HOXC6 homeobox C6 
 27 4254284 4256431 ENSCAFG00000006626 HOXC8 homeobox C8  
 27 4272335 4272444 ENSCAFG00000020562 cfa-mir-196a-2 cfa-mir-196a-2  
 27 4274730 4278914 ENSCAFG00000006636 HOXC10 homeobox C10 
 27 4288980 4291010 ENSCAFG00000025599 HOXC11 homeobox C11  
 27 4307265 4308845 ENSCAFG00000006645 HOXC12 homeobox C12  
 27 4318372 4324857 ENSCAFG00000006648 HOXC13 homeobox C13  
 27 4408336 4408471 ENSCAFG00000025595 Novel gene Uncharacterized protein  
 27 4465522 4465593 ENSCAFG00000028208 Novel gene miRNA ncRNAs 
 27 4471215 4473053 ENSCAFG00000006653 Novel gene Uncharacterized protein  
 27 4526984 4543023 ENSCAFG00000006699 CALCOCO1 calcium binding and coiled-coil domain 1 
 27 4618776 4707507 ENSCAFG00000006726 ATF7 activating transcription factor 7  
 27 4716529 4721245 ENSCAFG00000006874 TARBP2 TAR (HIV-1) RNA binding protein 2  
 27 4730433 4736128 ENSCAFG00000006918 MAP3K12 mitogen-activated protein kinase kinase 
kinase 12 
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Table S2. (continued) 
Window 
(chr_Mb) 
CFA Gene Start 
(bp) 
Gene End 
(bp) 
Ensembl Gene ID Gene symbol Description 
 27 4737476 4760860 ENSCAFG00000006821 PCBP2 poly(rC) binding protein 2  
 27 4771276 4771641 ENSCAFG00000006927 PRR13 proline rich 13 
 27 4790871 4796699 ENSCAFG00000006934 AMHR2 anti-Mullerian hormone receptor, type II  
 27 4808070 4846934 ENSCAFG00000006950 SP1 Sp1 transcription factor 
 27 4852684 4913472 ENSCAFG00000007016 PFDN5 prefoldin subunit 5   
 27 4886171 4888554 ENSCAFG00000025559 SP7 Sp7 transcription factor 
 27 4893129 4903977 ENSCAFG00000006963 AAAS achalasia, adrenocortical insufficiency, 
alacrimia  
 27 4904239 4909825 ENSCAFG00000006981 C12orf10 chromosome 12 open reading frame 10  
 27 4915195 4937670 ENSCAFG00000007030 ESPL1 extra spindle pole bodies homolog 1 (S. 
cerevisiae) 
 27 4945566 4947561 ENSCAFG00000007035 MFSD5 major facilitator superfamily domain 
containing 5  
 27 4962069 4981222 ENSCAFG00000007050 RARG retinoic acid receptor, gamma  
 27 4993303 4998519 ENSCAFG00000007065 ITGB7 integrin, beta 7  
27_5
th
  27 5002178 5004869 ENSCAFG00000007070 ZNF740 zinc finger protein 740  
 27 5028008 5039893 ENSCAFG00000007077 CSAD cysteine sulfinic acid decarboxylase 
 27 5056925 5066187 ENSCAFG00000007085 SOAT2 sterol O-acyltransferase 2  
 27 5067628 5071493 ENSCAFG00000007097 IGFBP6 insulin-like growth factor binding protein 6  
 27 5084602 5098690 ENSCAFG00000007101 SPRYD3 SPRY domain containing 3  
 27 5100630 5115952 ENSCAFG00000007105 TENC1 tensin like C1 domain containing phosphatase 
(tensin 2)  
 27 5123868 5154188 ENSCAFG00000007117 EIF4B eukaryotic translation initiation factor 4B  
 27 5193231 5197229 ENSCAFG00000007154 Novel gene Uncharacterized protein   
 27 5214844 5215090 ENSCAFG00000025408 Novel gene Uncharacterized protein   
 27 5225567 5233056 ENSCAFG00000007199 Novel gene Uncharacterized protein   
 27 5261219 5268719 ENSCAFG00000025402 KRT78 keratin 78  
 27 5273786 5283987 ENSCAFG00000007204 KRT79 keratin 79 
 27 5294126 5300384 ENSCAFG00000007208 KRT4 keratin 4 
 27 5403819 5415836 ENSCAFG00000025382 KRT77 keratin 77  
 27 5425745 5458087 ENSCAFG00000007212 K2C1_CANFA Keratin, type II cytoskeletal 1   
 27 5481521 5490471 ENSCAFG00000007233 KRT73 keratin 73  
 27 5498594 5510056 ENSCAFG00000025358 KRT72 keratin 72 
 27 5523441 5530483 ENSCAFG00000025346 KRT74 keratin 74  
 27 5540426 5547762 ENSCAFG00000007278 D6BR72_CANFA keratin 71  
 27 5570885 5576777 ENSCAFG00000007223 KRT5 keratin 5  
 27 5595688 5601257 ENSCAFG00000007251 Novel gene Uncharacterized protein   
 27 5613256 5618136 ENSCAFG00000007209 Novel gene Uncharacterized protein  
 27 5625571 5627338 ENSCAFG00000025323 Novel gene Uncharacterized protein  
 27 5638886 5648810 ENSCAFG00000025322 KRT75 keratin 75  
 27 5650991 5663478 ENSCAFG00000025318 Novel gene Uncharacterized protein  
 27 5667080 5678048 ENSCAFG00000007281 KRT82 keratin 82 
 27 5686336 5686456 ENSCAFG00000028307 5S_rRNA 5S ribosomal RNA   
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Table S2. (continued) 
Window 
(chr_Mb) 
CFA Gene Start 
(bp) 
Gene End 
(bp) 
Ensembl Gene ID Gene symbol Description 
 27 5687503 5695036 ENSCAFG00000007284 KRT84 keratin 84  
 27 5709947 5716497 ENSCAFG00000007286 KRT85 keratin 85 
 27 5722652 5735581 ENSCAFG00000007293 Novel gene Uncharacterized protein  
 27 5749848 5755811 ENSCAFG00000007311 Novel gene Uncharacterized protein  
 27 5764377 5770662 ENSCAFG00000007307 Novel gene Uncharacterized protein  
 27 5779873 5784692 ENSCAFG00000007300 Novel gene Uncharacterized protein  
 27 5790522 5794208 ENSCAFG00000007318 Novel gene Uncharacterized protein  
 27 5808380 5814164 ENSCAFG00000007320 Novel gene Uncharacterized protein   
 27 5816046 5830969 ENSCAFG00000007322 KRT7 keratin 7  
 27 5865148 5884620 ENSCAFG00000007328 KRT80 keratin 80  
 27 5931294 5931569 ENSCAFG00000014784 Novel gene Uncharacterized protein  
 27 5934133 5936981 ENSCAFG00000007331 C12orf44 chromosome 12 open reading frame 44  
 27 5949972 5957895 ENSCAFG00000007338 NR4A1_CANFA Nuclear receptor subfamily 4 group A 
member 1  
 27 5996708 6003640 ENSCAFG00000025231 GRASP GRP1 (general receptor for phosphoinositides 
1)-associated scaffold protein  
27_6
th
  27 6014634 6032573 ENSCAFG00000007357 ACVR1B activin A receptor, type IB  
 27 6079269 6086578 ENSCAFG00000025220 ACVRL1 activin A receptor type II-like 1  
 27 6104064 6106685 ENSCAFG00000007345 ANKRD33 ankyrin repeat domain 33 
 27 6179810 6298254 ENSCAFG00000007600 SCN8A sodium channel, voltage gated, type VIII, 
alpha subunit  
 27 6242075 6242213 ENSCAFG00000027574 U2 U2 spliceosomal RNA  
 27 6407456 6462367 ENSCAFG00000007728 Q9GK56_CANFA Uncharacterized protein   
 27 6517095 6538877 ENSCAFG00000007758 GALNT6 UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-
acetylgalactosaminyltransferase 6 (GalNAc-
T6)  
 27 6544212 6733918 ENSCAFG00000007774 CELA1_CANFA Chymotrypsin-like elastase family member 1  
 27 6565180 6596945 ENSCAFG00000007778 BIN2 bridging integrator 2 
 27 6619721 6620699 ENSCAFG00000007785 SMAGP small cell adhesion glycoprotein  
 27 6622959 6626272 ENSCAFG00000007787 DAZAP2 DAZ associated protein 2  
 27 6656427 6671622 ENSCAFG00000007790 POU6F1 POU class 6 homeobox 1 
 27 6682523 6741630 ENSCAFG00000007831 TFCP2 transcription factor CP2 
 27 6755279 6763644 ENSCAFG00000007860 CSRNP2 cysteine-serine-rich nuclear protein 2 
 27 6767612 6774873 ENSCAFG00000007872 LETMD1 LETM1 domain containing 1  
 27 6805741 6820814 ENSCAFG00000007902 SLC11A2 solute carrier family 11 (proton-coupled 
divalent metal ion transporters), member 2  
 27 6831874 6871607 ENSCAFG00000007924 METTL7A methyltransferase like 7A  
 27 6924625 6954071 ENSCAFG00000007928 ATF1 activating transcription factor 1  
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Table S3. A list of genes in the putative regions for subgroup2 and subgroup3 
Group  
Window 
(chr_Mb) 
CFA 
Gene Start 
(bp) 
Gene End 
(bp) 
Ensembl Gene ID  Gene symbol Description 
Subgroup
2 
4_75
th
 
 
4 75800049 75809381 ENSCAFG00000018745 CAPSL calcyphosine-like 
 
 
4 75832871 75860982 ENSCAFG00000018752 IL7R interleukin 7 receptor  
 
 
4 75896215 76060543 ENSCAFG00000018767 SPEF2 sperm flagellar 2 
 
 
4 75133068 75211061 ENSCAFG00000018704 
Q9N280_CAN
FA 
excitatory amino acid 
transporter 1  
 
 
4 75464205 75489129 ENSCAFG00000018711 RANBP3L 
RAN binding protein 3-
like 
 
 
4 75494657 75536151 ENSCAFG00000018721 NADKD1 
NAD kinase domain 
containing 1  
 
 
4 75551591 75571161 ENSCAFG00000018725 SKP2 
S-phase kinase-
associated protein 2, E3 
ubiquitin protein ligase 
 
 
4 75591977 75621896 ENSCAFG00000018731 LMBRD2 
LMBR1 domain 
containing 2  
 
 
4 75658019 75676510 ENSCAFG00000023144 Novel gene Uncharacterized protein  
 
 
4 75680288 75711566 ENSCAFG00000018738 Novel gene Uncharacterized protein 
 
 
4 75751766 75776502 ENSCAFG00000018743 Novel gene Uncharacterized protein 
Subgroup
3 
31_18
th
  31 18049292 18049396 ENSCAFG00000021702 U6 U6 spliceosomal RNA  
  31 18936469 18936573 ENSCAFG00000027925 U6 U6 spliceosomal RNA   
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Table S4. A list of genes in the putative regions for all Siberian Huskies (including 
subgroup1, 2 and 3) 
Window 
(chr_Mb) 
CFA Gene 
Start 
(bp) 
Gene End (bp) Ensembl Gene 
ID 
Gene symbol 
9_56th  56770082 56817552 ENSCAFG00000019945 ASS1 argininosuccinate synthase 1  
 
56765474 56765884 ENSCAFG00000019944 HBXIP hepatitis B virus x interacting protein 
 
56458287 56458469 ENSCAFG00000024407 QRFP pyroglutamylated RFamide peptide 
 56831407 56978021 ENSCAFG00000019950 Novel gene Uncharacterized protein 
 
55986530 56045429 ENSCAFG00000019908 PRRC2B proline-rich coiled-coil 2B  
 
56125301 56139605 ENSCAFG00000019911 PPAPDC3 
phosphatidic acid phosphatase type 2 domain containing 
3 
 
56151597 56164178 ENSCAFG00000019912 FAM78A family with sequence similarity 78, member A  
 
56187199 56289132 ENSCAFG00000019920 NUP214 nucleoporin 214kDa  
 
56292948 56418185 ENSCAFG00000019926 AIF1L allograft inflammatory factor 1-like  
 
56316975 56360237 ENSCAFG00000019927 LAMC3 laminin, gamma 3 
 
56419461 56448416 ENSCAFG00000019930 FIBCD1 fibrinogen C domain containing 1 
 
56465925 56487400 ENSCAFG00000019938 ABL1 c-abl oncogene 1, non-receptor tyrosine kinase  
 56495457 56496470 ENSCAFG00000023093 Novel gene Uncharacterized protein 
 
56612649 56621679 ENSCAFG00000019941 EXOSC2 exosome component 2  
 
56629556 56644738 ENSCAFG00000023076 PRDM12 PR domain containing 12 
 
56662039 56688826 ENSCAFG00000019942 FUBP3 far upstream element (FUSE) binding protein 3 
 
56235131 56235229 ENSCAFG00000021075 U6 U6 spliceosomal RNA  
27_13th  13293117 13305402 ENSCAFG00000009652 TWF1 twinfilin, actin-binding protein, homolog 1 (Drosophila)  
 
13326156 13343992 ENSCAFG00000009700 IRAK4 interleukin-1 receptor-associated kinase 4 
 
13356837 13379958 ENSCAFG00000009729 PUS7L pseudouridylate synthase 7 homolog (S. cerevisiae)-like 
 
13504107 13665614 ENSCAFG00000009744 ADAMTS20 
ADAM metallopeptidase with thrombospondin type 1 
motif, 20  
 
13189041 13189531 ENSCAFG00000025198 Novel gene pseudogene Ensembl genes 
 
13159473 13160267 ENSCAFG00000024514 Novel gene protein coding Ensembl genes 
X_31st  31935641 31936435 ENSCAFG00000024521 Novel gene protein coding Ensembl gene 
 
31622005 31623093 ENSCAFG00000013845 PCBP1 poly(rC) binding protein 1 
 
31853711 31854505 ENSCAFG00000024210 Novel gene Uncharacterized protein  
 
30996456 31056775 ENSCAFG00000013840 CXorf59 chromosome X open reading frame 59  
 
31148254 31150659 ENSCAFG00000023630 Novel gene Uncharacterized protein  
 
31277509 31342758 ENSCAFG00000023600 CXorf30 chromosome X open reading frame 30 
 
31820228 31821353 ENSCAFG00000023558 Novel gene Uncharacterized protein  
X_33rd  33390642 33413474 ENSCAFG00000014051 Novel gene Uncharacterized protein  
 
33498639 33499190 ENSCAFG00000014056 MID1IP1 MID1 interacting protein 1  
 
33792251 33794292 ENSCAFG00000014059 Novel gene Uncharacterized protein  
 
33006703 33055120 ENSCAFG00000014003 RPGR_CANFA X-linked retinitis pigmentosa GTPase regulator   
 
33080945 33149321 ENSCAFG00000014023 OTC ornithine carbamoyltransferase  
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CHAPTER 6. GENERAL CONCLUSIONS 
Mapping causative mutations responsible for genetic diseases is the primary goal for medical 
geneticists.  Precisely mapped genetic variants can contribute to future use of gene therapy to 
cure patients.  Therefore, understanding the inherited mode of a given disease and utilizing a 
suitable mapping strategy to identify causative mutations are very important.  Moreover, 
given that animals and humans share many genetic diseases, animal models such as dogs and 
sheep are useful for investigating gene functions and human diseases.  By examining gene 
alterations in these animal models, one can map the gene loci for a given disease to help 
understand the causal relationship between mutations in homologous genes and the 
corresponding human disease. 
The relationship between phenotypes and genotypes  
The classical forward genetics approach allows researchers to locate the gene on its 
chromosome associated with a trait of interest.  The genotype is the genetic makeup of an 
individual that represents a specific genetic character under consideration.  Measuring the 
genotype of several individuals will provide information on the differences among 
individuals in a population.  Using various mapping strategies, genotype data will help to 
map the causative or major genes responsible for the traits being studied.  In the past several 
decades, a lot of efforts have been done to improve genotyping techniques in order to obtain 
accurate genotypes with less expense.  To gain a highly successful rate of mapping traits in a 
population, researchers have realized that improving only the quality of genotypes is not 
enough when the measurement and categorization of phenotypes is not precise for 
quantitative and categorical traits.  In this dissertation, we have successfully mapped three 
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monogenic sheep disorders (Chapters 2, 3 and 4).  The prerequisites for being successful in 
these studies were: the accurate diagnoses of disease statuses of each sheep; and the very 
clear inherited mode of each disorder.  Without those accomplishments, we would not have 
so quickly located the candidate genes, performed the fine mapping processes and eventually 
found the putative causative mutations.  Moreover, in the canine cryptorchidism study in this 
dissertation (Chapter 5), dogs without one or two testicles in the scrotal sac were diagnosed 
as cryptorchidism.  It is known that disruptions of different regulatory factors during 
testicular descent will lead to gonads remain in various positions inside the body, such as the 
abdominal cavity close to the kidneys, the locations nearby the internal/external inguinal ring 
or the inguinal canal.  Therefore, the undescended testicle staying at different body locations 
in affected dogs has likely increased the complexity and heterogeneity of this disease and has 
made gene mapping difficult.  Since different hormones regulate testicular descent in 
different descending phases, it is important to know exact details of cryptorchidism in each 
dog in order to efficiently find the associated genes for this disorder.  Therefore, improving 
the measurement and categorization of phenotypes becomes a new challenge for many 
studies involved in a forward genetics approach. 
Comparative genomics for monogenic disorders and complex diseases 
Finding the genetic variations for a disease is just a start.  Providing evidence to confirm that 
the genetic variant is a causative mutation needs a lot of work.  Studies in comparative 
genomics, for example, biochemical or genetic studies in other species for the homologous 
gene will provide detailed functions of the studied genes.  Gene knock-out mouse models are 
likely to show similar phenotypes as in affected human patients with a loss of function of 
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genes.  However, many knock-out mice exhibit apparently different or no phenotypes due to 
different physiological systems between humans and mice.  Selecting a suitable animal 
model is important for studying of human diseases.  Similar characteristics in specific disease 
affected dogs, sheep or other animal species will provide an alternative choice of selecting a 
good model system for human diseases rather than mouse models.  
Comparing expression panels of genes in the same pathway between different species will 
give some hints for key genes affecting phenotypes of interest.  For example, testicular 
descent is a prerequisite for normal spermatogenesis in many mammalian species.  
Cryptorchidism is an abnormal condition of testicular descent.  It is interesting to know that 
elephants do not perform the process of testicular descent.  The comparisons of gene 
expression, gene coding sequence and translated protein sequence among elephants, 
cryptorchid dogs and normal dogs to produce a list of genes involved in testicular descent in 
dogs might show some interesting findings. 
From candidate gene approach to whole genome scan 
Scientists have applied the candidate gene approach to search for causative mutations or 
associated DNA markers on a given trait for several decades.  Biological functions of 
candidate genes should be clear when performing this approach.  Reverse genetics by 
utilizing multiple techniques such as mutagenesis, gene targeting, or targeting induced local 
lesions in genomes (TILLING) to engineer a change or disruption in the DNA can provide 
information of how a gene influences phenotypes.  If there is not sufficient research evidence 
to show gene functions, it will be hard to decide where to start in the genome to map the 
causative gene.  Whole genome scans using different forms of genetic markers may solve 
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this problem.  A SNP array based whole genome association study has been widely applied 
for study of disease traits.  The higher the density of markers, the higher the level of 
resolution that can be obtained for mapping associated genes.  SNPs are DNA markers with 
the highest density in the genome.  Due to their widely distributions in the genome, one can 
detect association signals for almost every chromosome. 
From DNA marker assisted mapping to whole genome sequencing 
Advanced sequencing technology has pushed the reality of direct sequencing of genomic or 
coding sequences in a genome wide scale into the fact.  Compared to traditional mapping 
approaches by using linkage and linkage disequilibrium, whole genome sequencing is not as 
abstract to understand as linkage mapping but it is straight forward because the researcher 
could observe almost any changes in the DNA sequences.  This will help many scientists 
quickly search for disease loci without devoting too many efforts for preparing suitable 
populations for a specific marker assisted mapping approach.  However, DNA sequencing 
generates large volumes of genomic sequence data relatively rapidly. There are too many 
genetic changes across the genome to be identified and that will increase the difficulty in 
finding the real mutation.  Monogenic disorders usually have a clear mode of inheritance and 
the corresponding phenotypes are mostly caused by mutations that disrupt protein functions.  
Therefore, whole genome sequencing can be an efficient method to discover genes causing 
monogenic disorders.  To map causative mutations and risk alleles for common complex 
diseases, a larger sample size is still preferred to find the common genetic variants 
responsible for common disease.  DNA marker assisted mapping and whole genome 
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sequencing can be applied together to efficiently and economically identify genes 
contributing to diseases. 
The genetic basis underlying phenotypes is not simple for many cases.  The common 
mutations found are likely changes in DNA sequences.  However, more and more evidence 
shows that epigenetic changes such as changes in the pattern of methylation, or changes of 
histone modification play important roles in the development of specific phenotypes.  
Therefore, it is necessary to screen epigenetic changes in the genome in disease studies.  The 
robust and cheaper technologies are under developed in commercial companies.  A new era 
is expected for genetic disease mapping when powerful tools become available by integrating 
genetic and epigenetic knowledge for discovering causative mutations responsible for genetic 
disorders in humans and other species. 
FUTURE RESEARCH 
Future uses for our findings in the sheep industry in relation to the three sheep disorders are 
to exclude affected individuals and carriers by using genetic tests based on the mutations we 
discovered in the sheep populations to avoid at risk mating.  Additionally, the disease 
affected sheep and carriers can be retained as animal models for studying of related human 
diseases.  Gene expression and protein analyses can be done for these causative gene loci in 
the sheep model to further understand the gene functions involved in the normal bone and 
cartilage metabolisms as well as motor neuron activities. 
Future research plans regarding cryptorchidism should include fine mapping of the promising 
candidate gene AMHR2 by screening its promoter region, exons and splicing regions to 
discover causative mutations responsible for cryptorchidism.  Gene expression analysis 
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should also be done for the AMHR2 gene using gubernaculum tissues from dogs diagnosed as 
affected and normal to provide solid evidence for the causative relationship between this 
gene and cryptorchidism.  Second, collecting more Siberian Husky samples is desirable to 
increase the power of the experiment for studying cryptorchidism.  Multiple offspring from 
closely related dog families will help to decipher the genetic basis for cryptorchid dogs with 
a similar genetic background.  Third, whole genome sequencing can be done with a small 
group of dogs.  Whole genome sequencing for pairs of affected and unaffected dogs from the 
same family may facilitate finding causative mutations without needing to consider LD 
structure and disease heterogeneity. 
CONCLUSIONS 
In conclusion, we have successfully found putative causative mutations for the three sheep 
monogenic diseases including a nonsense mutation in DMP1 for inherited rickets, a missense 
mutation in AGTPBP1 for lower motor neuron disease, and 1 base pair deletion in SLC13A1 
for chondrodysplasia.  This conclusion is based on 100% concordant rate of genotypes with 
the recessive pattern of inheritance in affected, carrier and phenotypically normal individuals, 
as well as implication of gene functions in other species. 
Moreover, by applying Bayesian inference, we identified a candidate region at the 4th Mb 
window on dog chromosome CFA27 associated with the development of cryptorchidism in a 
subgroup of our Siberian Husky population.  The candidate region harbors a very promising 
functional candidate gene AMHR2 based on the studies for human diseases.  Once 
significantly associated markers or causative mutations are identified in AMHR2 for 
cryptorchidism, this information could be quickly applied to design a genetic test for the dog 
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breeding program to cull dogs carrying the deleterious allele and to test other breeds.  
Moreover, our finding implicates the promising role of the AMHR2 gene during the normal 
testicular descent.  This result will shed light on the future studies of genes in the same 
pathway for development of human cryptorchidism.  
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